Compound
resveratrol
A stilbene and non-flavonoid polyphenol produced by various plants including grapes and blueberries. It has anti-oxidant, anti-inflammatory, cardioprotective, anti-mutagenic, and anti-carcinogenic properties. It also inhibits platelet aggregation and the activity of several DNA helicases in vitro.
Studied for
40 endpoints · 69 findings · 36 papers · 32 null
- HDL cholesterolno detected effectEvidence strength: strong. Randomised human trials or their synthesis, with the effect's size and interval recorded and no recorded weakness outstanding.
- Clinical pregnancy rateno detected effectEvidence strength: strong. Randomised human trials or their synthesis, with the effect's size and interval recorded and no recorded weakness outstanding.
- Total testosteronelowersEvidence strength: strong. Randomised human trials or their synthesis, with the effect's size and interval recorded and no recorded weakness outstanding.
- Diastolic blood pressure (setting unspecified)lowersEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.
- LDL cholesterolno detected effectEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.
Structure
A stilbenol that is stilbene in which the phenyl groups are substituted at positions 3, 5, and 4' by hydroxy groups.
Loading the model…
- Class
- Organic compound
- Formula
- C14H12O3
- Mass
- 228.247 g/mol
- Charge
- 0
- InChIKey
- LUKBXSAWLPMMSZ-UHFFFAOYSA-N
- SMILES
- [H]C(=C([H])c1cc(O)cc(O)c1)c1ccc(O)cc1
- Look it up
- ChEBIPubChemBy InChIKey
Identity from ChEBI, geometry from PubChem. Not evidence.
What the evidence says
How to read these marks69 findings · 40 endpoints · 36 papers · 32 null · by evidence strength
- Evidence strength
- Strong
- Moderate
- Limited
- Very limited
- Insufficient
What moved
37 findings
Decreases total testosterone
StrongEvidence strength: strong. Randomised human trials or their synthesis, with the effect's size and interval recorded and no recorded weakness outstanding.Finding“The pooled effect estimate indicated that resveratrol significantly reduced the level of testosterone, compared with the placebo (SMD = -0.40; 95% CI [-0.71, -0.10], P = 0.009).”
Quoted verbatim from Efficacy of resveratrol in women with polycystic ovary syndrome: a systematic review and meta-analysis of randomized clinical trials.. - Study
- meta-analysis
- Participants
- 169
- Dose
- 800, 1000 or 1500 mg/day oral resveratrol
- Population
- Women with polycystic ovary syndrome; 3 of 4 pooled RCTs, resveratrol vs placebo
Effect -0.4 standardised mean difference, 95% CI -0.71 to -0.1
Efficacy of resveratrol in women with polycystic ovary syndrome: a systematic review and meta-analysis of randomized clinical trials.2023PMID:37333786Permalink
Decreases fat mass
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.Finding“After resveratrol administration, a small but statistically significant reduction in body fat mass was discovered (ES: − 0.3 kg, 95% CI − 0.48 to − 0.12, p = 0.001) (Fig..”
Quoted verbatim from The effect of resveratrol supplementation on obesity indices: a critical umbrella review of interventional meta-analyses.. - Study
- meta-analysis
- Participants
- 1,375
- Dose
- 200 to >1300 mg/day resveratrol across the constituent meta-analyses
- Population
- Pooled across 5 meta-analyses of RCTs of resveratrol supplementation vs non-resveratrol control; mixed clinical and non-clinical adult populations
The effect of resveratrol supplementation on obesity indices: a critical umbrella review of interventional meta-analyses.2025PMID:41317227Permalink
Increases total cholesterol (TC)
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.Finding“As shown in, total cholesterol (MD = 0.49, 95% CI: 0.18, 0.80, P < 0.05) and LDL (MD = 0.47, 95% CI: 0.21, 0.74, P < 0.05) levels were significantly higher in subjects supplemented with resveratrol than control subjects.”
Quoted verbatim from Efficacy of Resveratrol Supplementation against Non-Alcoholic Fatty Liver Disease: A Meta-Analysis of Placebo-Controlled Clinical Trials.. - Study
- meta-analysis
- Dose
- 500-3000 mg/day resveratrol
- Population
- Adults with non-alcoholic fatty liver disease; total cholesterol pooled from 3 of the 4 placebo-controlled trials
Effect 0.49 mean difference, 95% CI 0.18 to 0.8
Efficacy of Resveratrol Supplementation against Non-Alcoholic Fatty Liver Disease: A Meta-Analysis of Placebo-Controlled Clinical Trials.2016PMID:27560482Permalink
Increases catalase activity
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.Finding“In addition, compared to placebo, Supplementation with resveratrol significantly increased glutathione peroxidase levels (SMD = 0.38, 95%CI(0.03, 0.74), P = 0.04; Level of evidence:low) and catalase levels (SMD = 0.33, 95%CI(0.03, 0.63), P = 0.03; Level of evidence: low).”
Quoted verbatim from The efficacy of resveratrol supplementation on inflammation and oxidative stress in type-2 diabetes mellitus patients: randomized double-blind placebo meta-analysis.. - Study
- meta-analysis
- Population
- patients with type 2 diabetes mellitus (T2DM)
The efficacy of resveratrol supplementation on inflammation and oxidative stress in type-2 diabetes mellitus patients: randomized double-blind placebo meta-analysis.2024PMID:39872318Permalink
Decreases glycated haemoglobin (HbA1c)
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.Findingreplicated ×2“The adjusted means showed that postintervention HbA1c was lower on resveratrol (35.8 ± 0.43 mmol/mol) compared with placebo (37.6 ± 0.44 mmol/mol).”
Quoted verbatim from No effect of resveratrol supplementation after 6 months on insulin sensitivity in overweight adults: a randomized trial.. - Study
- RCT
- Dose
- 150 mg/d
- Population
- Overweight men and women, BMI 27-35 kg/m2, aged 40-70 y; resveratrol versus placebo, postintervention ANCOVA-adjusted means
No effect of resveratrol supplementation after 6 months on insulin sensitivity in overweight adults: a randomized trial.2020PMID:32492138Permalink
Increases malondialdehyde (circulating)
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.Finding“After 12 weeks, MDA levels increased significantly in both groups, with a larger rise in the RES group, resulting in significantly higher MDA levels in the RES group compared to the control at the end of the study.”
Quoted verbatim from Does Resveratrol Impact Oxidative Stress Markers in Patients with Head and Neck Cancer Receiving Home Enteral Nutrition?. - Study
- RCT
- Participants
- 40
- Duration
- 3 months
- Dose
- 400 mg/day liposomal resveratrol via enteral access, in two doses
- Population
- adults with head and neck cancer on home enteral nutrition; open-label, resveratrol plus HEN versus HEN alone
Does Resveratrol Impact Oxidative Stress Markers in Patients with Head and Neck Cancer Receiving Home Enteral Nutrition?2025PMID:39940362Permalink
Show the remaining 31
Increases knee injury and Osteoarthritis Outcome Score (KOOS)
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.Finding“In Table 2, the administration of resveratrol improves significantly (P < 0.05) both KOOS and WOMAC total scores at the end of the treatment, compared with baseline values and those reported in the control group postintervention.”
Quoted verbatim from Correlation between serum pro inflammatory cytokines and clinical scores of knee osteoarthritic patients using resveratrol as a supplementary therapy with meloxicam.. - Study
- RCT
- Duration
- 3 months
- Dose
- 500 mg/day
- Population
- Adults with painful knee osteoarthritis; resveratrol 500 mg/day plus meloxicam 15 mg/day versus placebo capsule plus meloxicam 15 mg/day (meloxicam in both arms)
Correlation between serum pro inflammatory cytokines and clinical scores of knee osteoarthritic patients using resveratrol as a supplementary therapy with meloxicam.2021PMID:34414904Permalink
Decreases diastolic blood pressure (setting unspecified)
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.Findingreplicated ×1“The results illustrated a significant reduction in the DBP by resveratrol after removing these studies (WMD: −3.55 mmHg, 95% CI: −5.18, −1.93; P < 0.0001;.”
Quoted verbatim from Effects of Resveratrol on Metabolic Indicators in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis.. - Study
- meta-analysis
- Dose
- 8.1-3000 mg/day resveratrol across the pooled trials
- Population
- Adults with type 2 diabetes; secondary endpoint, pooled after excluding two high-heterogeneity trials, resveratrol vs placebo
Effect -3.55 mean difference, 95% CI -5.18 to -1.93
Effects of Resveratrol on Metabolic Indicators in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis.2022PMID:35685602Permalink
Increases Mini-Mental State Examination total score
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.Finding“Compared with CG after treatment, EG obtained obviously higher MMSE score (P < 0.001) and significantly lower ADAS-cog score (P < 0.001) (see Figure 1).”
Quoted verbatim from Effect of Resveratrol Combined with Donepezil Hydrochloride on Inflammatory Factor Level and Cognitive Function Level of Patients with Alzheimer's Disease.. - Study
- RCT
- Participants
- 90
- Duration
- 2 months
- Dose
- 1-2 RES tablets (1.0 g each) daily as a dietary supplement, added to donepezil hydrochloride
- Population
- patients with Alzheimer's disease, all also receiving donepezil hydrochloride as background therapy in both arms (EG: donepezil + resveratrol; CG: donepezil alone), 2-month treatment
Effect of Resveratrol Combined with Donepezil Hydrochloride on Inflammatory Factor Level and Cognitive Function Level of Patients with Alzheimer's Disease.2022PMID:35368930Permalink
Decreases LDL cholesterol
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.Findingreplicated ×2“There was a significant decrease following RSV administration in WC with an SMD of –0.36 (95% CI: –0.59 to –0.14; P = 0.002; I2 = 88%), hemoglobin A1c (HbA1c): –0.48 (–0.69 to –0.2; P ≤ 0.001; I2 = 94%), TC: –0.15 (–0.3 to –0.01; P = 0.003; I2 = 94%), low-density lipoprotein cholesterol (LDL-C): –0.42 (–0.57 to –0.27; P ≤ 0.001; I2 = 92%), and HDL-C:0.16 (–0.31 to –0.02; P = 0.03; I2 = 81%).”
Quoted verbatim from Efficacy of Resveratrol Supplementation on Glucose and Lipid Metabolism: A Meta-Analysis and Systematic Review.. - Study
- meta-analysis
- Population
- adults, mostly obese and diabetic patients, RSV vs placebo, pooled from 25 RCTs (1,171 participants)
Effect -0.42 standardised mean difference, 95% CI -0.57 to -0.27
Efficacy of Resveratrol Supplementation on Glucose and Lipid Metabolism: A Meta-Analysis and Systematic Review.2022PMID:35431994Permalink
Decreases LDL cholesterol
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.Findingreplicated ×2“The applied random-effects model showed that resveratrol intake significantly decreased the LDL-C level (Mean difference = −5.69; 95%CI: −11.07, −0.31, p = 0.038, I2 = 64.2%, C).”
Quoted verbatim from The Effect of Resveratrol on Blood Lipid Profile: A Dose-Response Meta-Analysis of Randomized Controlled Trials.. - Study
- meta-analysis
- Dose
- 10-3000 mg/day resveratrol across the pooled trials
- Population
- Adults aged 18-85 in 15 placebo-controlled RCTs (16 comparisons), resveratrol vs placebo
Effect -5.69 mean difference, 95% CI -11.07 to -0.31
The Effect of Resveratrol on Blood Lipid Profile: A Dose-Response Meta-Analysis of Randomized Controlled Trials.2022PMID:36145131Permalink
Decreases glycated haemoglobin (HbA1c)
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.Findingreplicated ×2“There was a significant decrease following RSV administration in WC with an SMD of –0.36 (95% CI: –0.59 to –0.14; P = 0.002; I2 = 88%), hemoglobin A1c (HbA1c): –0.48 (–0.69 to –0.2; P ≤ 0.001; I2 = 94%), TC: –0.15 (–0.3 to –0.01; P = 0.003; I2 = 94%), low-density lipoprotein cholesterol (LDL-C): –0.42 (–0.57 to –0.27; P ≤ 0.001; I2 = 92%), and HDL-C:0.16 (–0.31 to –0.02; P = 0.03; I2 = 81%).”
Quoted verbatim from Efficacy of Resveratrol Supplementation on Glucose and Lipid Metabolism: A Meta-Analysis and Systematic Review.. - Study
- meta-analysis
- Population
- adults, mostly obese and diabetic patients, RSV vs placebo, pooled from 25 RCTs (1,171 participants)
Effect -0.48 standardised mean difference, 95% CI -0.69 to -0.2
Efficacy of Resveratrol Supplementation on Glucose and Lipid Metabolism: A Meta-Analysis and Systematic Review.2022PMID:35431994Permalink
Increases glutathione peroxidase activity
LimitedEvidence strength: limited. Human evidence with several recorded weaknesses, or a design that tops out at limited.Finding“In addition, compared to placebo, Supplementation with resveratrol significantly increased glutathione peroxidase levels (SMD = 0.38, 95%CI(0.03, 0.74), P = 0.04; Level of evidence:low) and catalase levels (SMD = 0.33, 95%CI(0.03, 0.63), P = 0.03; Level of evidence: low).”
Quoted verbatim from The efficacy of resveratrol supplementation on inflammation and oxidative stress in type-2 diabetes mellitus patients: randomized double-blind placebo meta-analysis.. - Study
- meta-analysis
- Population
- patients with type 2 diabetes mellitus (T2DM)
The efficacy of resveratrol supplementation on inflammation and oxidative stress in type-2 diabetes mellitus patients: randomized double-blind placebo meta-analysis.2024PMID:39872318Permalink
Decreases tumour necrosis factor alpha concentration
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Findingreplicated ×1“Resveratrol treatment significantly decreased TNF-α (P < 0.001), and MDA (P < 0.001) compared to the placebo.”
Quoted verbatim from Effects of resveratrol supplementation on inflammatory markers, fatigue scale, fasting blood sugar and lipid profile in relapsing-remitting multiple sclerosis patients: a double-blind, randomized placebo-controlled trial.. - Study
- RCT
- Duration
- 8 weeks
- Dose
- 500 mg/day
- Population
- patients with multiple sclerosis (MS)
Effects of resveratrol supplementation on inflammatory markers, fatigue scale, fasting blood sugar and lipid profile in relapsing-remitting multiple sclerosis patients: a double-blind, randomized placebo-controlled trial.2025PMID:39565038Permalink
Decreases systolic blood pressure (setting unspecified)
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Findingreplicated ×1“Compared to the control group, RES intake significantly reduced systolic blood pressure (SBP), triglyceride (TG), total cholesterol (TC), low-density lipoprotein (LDL), and improved ejection fraction (EF).”
Quoted verbatim from Resveratrol improves lipid profile and recovers heart function in postoperative CABG patients.. - Study
- RCT
- Duration
- 2 months
- Population
- patients undergoing coronary artery bypass grafting (CABG)
Resveratrol improves lipid profile and recovers heart function in postoperative CABG patients.2025PMID:40676400Permalink
Decreases systolic blood pressure (setting unspecified)
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Findingreplicated ×1“Subgroup analyses indicated that higher-dose of resveratrol consumption (≥ 150 mg/d) significantly reduces SBP of -11.90 mmHg (95% CI: -20.99, -2.81 mmHg, P = 0.01), whereas lower dose of resveratrol did not show a significant lowering effect on SBP.”
Quoted verbatim from Effect of resveratrol on blood pressure: a meta-analysis of randomized controlled trials.. - Study
- meta-analysis
- Dose
- ≥150 mg/day
- Population
- Meta-analysis of randomized controlled trials of resveratrol supplementation; dose-stratified subgroup receiving ≥150 mg/day resveratrol, not the full 6-trial, 247-subject pooled sample
Effect -11.9 mean difference, 95% CI -20.99 to -2.81
Effect of resveratrol on blood pressure: a meta-analysis of randomized controlled trials.2015PMID:24731650Permalink
Decreases triglycerides
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Findingreplicated ×1“Compared to the control group, RES intake significantly reduced systolic blood pressure (SBP), triglyceride (TG), total cholesterol (TC), low-density lipoprotein (LDL), and improved ejection fraction (EF).”
Quoted verbatim from Resveratrol improves lipid profile and recovers heart function in postoperative CABG patients.. - Study
- RCT
- Duration
- 2 months
- Population
- patients undergoing coronary artery bypass grafting (CABG)
Resveratrol improves lipid profile and recovers heart function in postoperative CABG patients.2025PMID:40676400Permalink
Decreases total cholesterol (TC)
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Finding“Compared to the control group, RES intake significantly reduced systolic blood pressure (SBP), triglyceride (TG), total cholesterol (TC), low-density lipoprotein (LDL), and improved ejection fraction (EF).”
Quoted verbatim from Resveratrol improves lipid profile and recovers heart function in postoperative CABG patients.. - Study
- RCT
- Duration
- 2 months
- Population
- patients undergoing coronary artery bypass grafting (CABG)
Resveratrol improves lipid profile and recovers heart function in postoperative CABG patients.2025PMID:40676400Permalink
Inhibits MTOR
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Finding“Moreover, resveratrol decreased mTOR protein levels (both total and phosphorylated forms), particularly after longer incubation times (1 week and 1 month).”
Quoted verbatim from Time Does Matter: The Cellular Response to Resveratrol Varies Depending on the Exposure Duration.. - Study
- in vitro · not in humans
- Dose
- 5 µM, 1 week and 1 month exposure
- Population
- human cardiomyocytes (Celprogen #1311001-09)
Time Does Matter: The Cellular Response to Resveratrol Varies Depending on the Exposure Duration.2025PMID:40565004Permalink
Decreases diastolic blood pressure (setting unspecified)
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Findingreplicated ×1“Resveratrol intervention exerted significant reductions in systolic blood pressure (SBP) and diastolic blood pressure (DBP) in subjects with type 2 diabetes mellitus (T2DM).”
Quoted verbatim from Effects of resveratrol supplementation on risk factors of non-communicable diseases: A meta-analysis of randomized controlled trials.. - Study
- meta-analysis
- Population
- subjects with type 2 diabetes mellitus (T2DM)
Effects of resveratrol supplementation on risk factors of non-communicable diseases: A meta-analysis of randomized controlled trials.2018PMID:28933578Permalink
Increases alanine aminotransferase
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Finding“ALT also increased in older adults (+2.33 U/L) following resveratrol supplementation.”
Quoted verbatim from The effect of resveratrol supplementation on biomarkers of liver health: A systematic review and meta-analysis of randomized controlled trials.. - Study
- meta-analysis
- Population
- older adults
The effect of resveratrol supplementation on biomarkers of liver health: A systematic review and meta-analysis of randomized controlled trials.2023PMID:36642444Permalink
Decreases C-reactive protein concentration
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Finding“This meta-analysis demonstrates that resveratrol consumption is effective in lowering the levels of CRP and hs-CRP in inflammatory conditions, especially if supplementation takes place for ≥10 weeks with ≥500 mg/day.”
Quoted verbatim from Effect of resveratrol on C-reactive protein: An updated meta-analysis of randomized controlled trials.. - Study
- meta-analysis
- Population
- patients with various inflammatory disorders
Effect of resveratrol on C-reactive protein: An updated meta-analysis of randomized controlled trials.2021PMID:34472150Permalink
Increases serum adiponectin
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Finding“Resveratrol significantly improves adiponectin but does not affect leptin concentrations.”
Quoted verbatim from Resveratrol supplementation and plasma adipokines concentrations? A systematic review and meta-analysis of randomized controlled trials.. - Study
- meta-analysis
- Population
- Meta-analysis pooling 10 of 11 treatment arms from 9 randomized placebo-controlled trials of resveratrol supplementation
Resveratrol supplementation and plasma adipokines concentrations? A systematic review and meta-analysis of randomized controlled trials.2017PMID:28089943Permalink
Decreases HOMA-IR
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Finding“Resveratrol consumption significantly reduced fasting glucose, insulin, glycated hemoglobin, and insulin resistance (measured by using the homeostatic model assessment) levels in participants with diabetes.”
Quoted verbatim from Effect of resveratrol on glucose control and insulin sensitivity: a meta-analysis of 11 randomized controlled trials.. - Study
- meta-analysis
- Population
- participants with diabetes
Effect of resveratrol on glucose control and insulin sensitivity: a meta-analysis of 11 randomized controlled trials.2014PMID:24695890Permalink
Increases flow-mediated dilation
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Findingreplicated ×1“Compared with placebo, resveratrol supplementation increased flow-mediated dilation (ratio of geometric mean changes and 95% confidence interval for between-group comparisons, 1.43 (1.15 to 1.77); P value = 0.001).”
Quoted verbatim from Effect of Resveratrol on Endothelial Function in Patients with CKD and Diabetes: A Randomized Controlled Trial.. - Study
- crossover
- Participants
- 28
- Duration
- 6 weeks
- Dose
- 400 mg/d
- Population
- adults aged 68 +/- 7 years (84% men) with stage 3 CKD and diabetes; abstract only; primary endpoint
Effect of Resveratrol on Endothelial Function in Patients with CKD and Diabetes: A Randomized Controlled Trial.2024PMID:37843843Permalink
Increases flow-mediated dilation
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Findingreplicated ×1“The findings showed that resveratrol intervention significantly increased flow-mediated dilatation (FMD) levels (SMD 1.77; 95% CI 0.25, 3.29; P = 0.02; I2: 96.5).”
Quoted verbatim from The Effects of Resveratrol Supplementation on Endothelial Function and Blood Pressures Among Patients with Metabolic Syndrome and Related Disorders: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.. - Study
- meta-analysis
- Population
- Adults with metabolic syndrome and related disorders across 28 pooled randomized controlled trials (33 findings) of resveratrol supplementation
Effect 1.77 standardised mean difference, 95% CI 0.25 to 3.29
The Effects of Resveratrol Supplementation on Endothelial Function and Blood Pressures Among Patients with Metabolic Syndrome and Related Disorders: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.2019PMID:31264084Permalink
Decreases visual analogue scale pain intensity
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Finding“Resveratrol treatment significantly reduced pain intensity and WOMAC scores, while increasing OKS scores, ROM, gait velocity, HGS, and overall SPPB performance (p < 0.05).”
Quoted verbatim from Resveratrol supplementation improves functional performance in knee osteoarthritis by upregulating sirtuin 1: a randomized study.. - Study
- RCT
- Duration
- 3 months
- Dose
- 500 mg/day
- Population
- Patients with knee osteoarthritis, aged 63-73 years, in a 12-week double-blind placebo-controlled trial (n=122 analyzed after dropouts: placebo n=65, resveratrol n=57)
Resveratrol supplementation improves functional performance in knee osteoarthritis by upregulating sirtuin 1: a randomized study.2025PMID:41037125Permalink
Decreases triglycerides
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Findingreplicated ×1“Notably, serum insulin and triglycerides significantly decreased in the resveratrol group compared to placebo.”
Quoted verbatim from Supplementation with resveratrol modified gut microbiota improving insulin sensitivity and lipid metabolism in subjects with obesity and insulin resistance.. - Study
- RCT
- Population
- adults with obesity and insulin resistance
Supplementation with resveratrol modified gut microbiota improving insulin sensitivity and lipid metabolism in subjects with obesity and insulin resistance.2025PMID:41359054Permalink
Decreases subjective fatigue
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Finding“Two parameters of Profile of Mood States (POMS) including vigor and fatigue, decreased significantly by resveratrol.”
Quoted verbatim from Effect of resveratrol on cognitive and memory performance and mood: A meta-analysis of 225 patients.. - Study
- meta-analysis
- Population
- Adults across 4 pooled randomized controlled trials (226 individuals) evaluating resveratrol's effect on cognition, memory and mood
Effect of resveratrol on cognitive and memory performance and mood: A meta-analysis of 225 patients.2018PMID:28844841Permalink
Decreases tumour necrosis factor alpha concentration
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Findingreplicated ×1“Analysis in the overall population showed a significant effect of resveratrol consumption in reducing serum TNF-α levels (WMD = -0.66 pg/ml, 95% CI = -1.05 to -0.27, P = 0.001).”
Quoted verbatim from Effect of resveratrol on inflammatory cytokines: A meta-analysis of randomized controlled trials.. - Study
- meta-analysis
- Population
- Adults with inflammatory disease, overall pooled population across resveratrol RCTs (21 studies contributed to the TNF-α analysis per Methods).
Effect of resveratrol on inflammatory cytokines: A meta-analysis of randomized controlled trials.2021PMID:34303665Permalink
Decreases malondialdehyde (circulating)
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Finding“Resveratrol treatment significantly decreased TNF-α (P < 0.001), and MDA (P < 0.001) compared to the placebo.”
Quoted verbatim from Effects of resveratrol supplementation on inflammatory markers, fatigue scale, fasting blood sugar and lipid profile in relapsing-remitting multiple sclerosis patients: a double-blind, randomized placebo-controlled trial.. - Study
- RCT
- Duration
- 8 weeks
- Dose
- 500 mg/day
- Population
- patients with multiple sclerosis (MS)
Effects of resveratrol supplementation on inflammatory markers, fatigue scale, fasting blood sugar and lipid profile in relapsing-remitting multiple sclerosis patients: a double-blind, randomized placebo-controlled trial.2025PMID:39565038Permalink
Increases total antioxidant capacity
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Finding“Although, resveratrol supplementation increased significantly circulating total antioxidant capacity (TAC) concentrations (SMD (0.52), (95% CI -0.02 to 1.07), p=0.05).”
Quoted verbatim from Therapeutic effect of resveratrol supplementation on oxidative stress: a systematic review and meta-analysis of randomised controlled trials.. - Study
- meta-analysis
- Population
- adults in randomised controlled trials of resveratrol supplementation
Therapeutic effect of resveratrol supplementation on oxidative stress: a systematic review and meta-analysis of randomised controlled trials.2020PMID:31628212Permalink
Decreases interleukin-6 concentration
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Finding“A significant reduction of IL-6 concentration was observed only in the patients receiving ≥500 mg/day dose of resveratrol (WMD = -1.89 pg/ml, 95% CI = -3.73 to -0.05, P = 0.04) with inter-study heterogeneity (I2 = 94.4%, P < 0.001).”
Quoted verbatim from Effect of resveratrol on inflammatory cytokines: A meta-analysis of randomized controlled trials.. - Study
- meta-analysis
- Dose
- ≥500 mg/day (dose-stratified subgroup)
- Population
- Adults with inflammatory disease receiving ≥500 mg/day resveratrol (dose subgroup, one of 26 studies on IL-6 per Methods); the abstract does not report a significant result for the overall/lower-dose population.
Effect of resveratrol on inflammatory cytokines: A meta-analysis of randomized controlled trials.2021PMID:34303665Permalink
Decreases glycated haemoglobin (HbA1c)
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Findingreplicated ×2“Resveratrol consumption significantly reduced fasting glucose, insulin, glycated hemoglobin, and insulin resistance (measured by using the homeostatic model assessment) levels in participants with diabetes.”
Quoted verbatim from Effect of resveratrol on glucose control and insulin sensitivity: a meta-analysis of 11 randomized controlled trials.. - Study
- meta-analysis
- Population
- participants with diabetes
Effect of resveratrol on glucose control and insulin sensitivity: a meta-analysis of 11 randomized controlled trials.2014PMID:24695890Permalink
Decreases fasting blood glucose
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Finding“Resveratrol consumption significantly reduced fasting glucose, insulin, glycated hemoglobin, and insulin resistance (measured by using the homeostatic model assessment) levels in participants with diabetes.”
Quoted verbatim from Effect of resveratrol on glucose control and insulin sensitivity: a meta-analysis of 11 randomized controlled trials.. - Study
- meta-analysis
- Population
- participants with diabetes
Effect of resveratrol on glucose control and insulin sensitivity: a meta-analysis of 11 randomized controlled trials.2014PMID:24695890Permalink
Decreases LDL cholesterol
InsufficientEvidence strength: insufficient. Mechanistic inference, no evidence found, or evidence weakened below very limited.Findingreplicated ×2“Compared with model group, the resveratrol group manifested a significant reducing effect on LDL-C level [SMD = −2.01, 95% CI (−2.77, −1.25), p < 0.0001] (Supplementary Figure S3A A).”
Quoted verbatim from Integrative evidence construction for resveratrol treatment of nonalcoholic fatty liver disease: preclinical and clinical meta-analyses.. - Study
- animal · not in humans
- Participants
- 208
- Dose
- 20-400 mg/kg, 4-20 weeks, pooled across studies
- Population
- rodents with diet-induced NAFLD models, resveratrol vs model/control group, preclinical meta-analysis, 13 studies, 208 animals
Effect -2.01 standardised mean difference, 95% CI -2.77 to -1.25
Integrative evidence construction for resveratrol treatment of nonalcoholic fatty liver disease: preclinical and clinical meta-analyses.2023PMID:37767399Permalink
Increases organism lifespan
InsufficientEvidence strength: insufficient. Mechanistic inference, no evidence found, or evidence weakened below very limited.Finding“Overall, our results indicate that resveratrol acts as a life-extending agent.”
Quoted verbatim from The effect of resveratrol on longevity across species: a meta-analysis.. - Study
- animal · not in humans
- Population
- survival data pooled from 19 published papers across six model species -- yeast, nematodes, mice, fruitflies, Mexican fruitflies and turquoise killifish; abstract only
The effect of resveratrol on longevity across species: a meta-analysis.2012PMID:22718956Permalink
What did not
32 findings
No detected effect on HDL cholesterol
StrongEvidence strength: strong. Randomised human trials or their synthesis, with the effect's size and interval recorded and no recorded weakness outstanding.FindingNull resultreplicated ×2“The pooled effect estimate revealed no effect of resveratrol on HDL (MD = 0.24; 95% CI [-3.53, 4.00], P = 0.90).”
Quoted verbatim from Efficacy of resveratrol in women with polycystic ovary syndrome: a systematic review and meta-analysis of randomized clinical trials.. - Study
- meta-analysis
- Participants
- 108
- Population
- Women with PCOS, pooled across 2 RCTs (n=108: 54 per arm).
Effect 0.24 mean difference, 95% CI -3.53 to 4
Efficacy of resveratrol in women with polycystic ovary syndrome: a systematic review and meta-analysis of randomized clinical trials.2023PMID:37333786Permalink
No detected effect on HDL cholesterol
StrongEvidence strength: strong. Randomised human trials or their synthesis, with the effect's size and interval recorded and no recorded weakness outstanding.FindingNull resultreplicated ×2“Compared with the placebo, resveratrol did not improve HDL-C levels (WMD: −1.05 mg/dL, 95% CI: −2.44, 0.33; P=0.14;.”
Quoted verbatim from Effects of Resveratrol on Metabolic Indicators in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis.. - Study
- meta-analysis
- Participants
- 837
- Dose
- 8.1-3000 mg/day resveratrol across the pooled trials
- Population
- Adults with type 2 diabetes; secondary endpoint, 14 pooled RCTs, resveratrol vs placebo
Effect -1.05 mean difference, 95% CI -2.44 to 0.33
Effects of Resveratrol on Metabolic Indicators in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis.2022PMID:35685602Permalink
No detected effect on clinical pregnancy rate
StrongEvidence strength: strong. Randomised human trials or their synthesis, with the effect's size and interval recorded and no recorded weakness outstanding.FindingNull result“The pooled relative risk (RR) indicated no effect of resveratrol regarding clinical pregnancy rates (RR = 0.89; 95% CI [0.65, 1.23], P = 0.49).”
Quoted verbatim from Efficacy of resveratrol in women with polycystic ovary syndrome: a systematic review and meta-analysis of randomized clinical trials.. - Study
- meta-analysis
- Participants
- 101
- Population
- Women with PCOS, pooled across 2 RCTs (n=101: 50 resveratrol, 51 placebo).
Effect 0.89 risk ratio, 95% CI 0.65 to 1.23
Efficacy of resveratrol in women with polycystic ovary syndrome: a systematic review and meta-analysis of randomized clinical trials.2023PMID:37333786Permalink
No detected effect on total cholesterol (TC)
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.FindingNull resultreplicated ×1“The pooled effect estimate revealed no effect of resveratrol on cholesterol (MD = -5.91; 95% CI [-18.54, 6.72], P = 0.36).”
Quoted verbatim from Efficacy of resveratrol in women with polycystic ovary syndrome: a systematic review and meta-analysis of randomized clinical trials.. - Study
- meta-analysis
- Participants
- 108
- Dose
- 1000 or 1500 mg/day oral resveratrol
- Population
- Women with polycystic ovary syndrome; 2 pooled RCTs, resveratrol vs placebo
Effect -5.91 mean difference, 95% CI -18.54 to 6.72
Efficacy of resveratrol in women with polycystic ovary syndrome: a systematic review and meta-analysis of randomized clinical trials.2023PMID:37333786Permalink
No detected effect on triglycerides
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.FindingNull resultreplicated ×1“The pooled effect estimate revealed no effect of resveratrol on triglycerides (MD = -8.25; 95% CI [-37.25, 20.74], P = 0.58).”
Quoted verbatim from Efficacy of resveratrol in women with polycystic ovary syndrome: a systematic review and meta-analysis of randomized clinical trials.. - Study
- meta-analysis
- Participants
- 108
- Population
- Women with PCOS, pooled across 2 RCTs (n=108: 54 per arm).
Effect -8.25 mean difference, 95% CI -37.25 to 20.74
Efficacy of resveratrol in women with polycystic ovary syndrome: a systematic review and meta-analysis of randomized clinical trials.2023PMID:37333786Permalink
No detected effect on LDL cholesterol
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.FindingNull result“The pooled effect estimate revealed no effect of resveratrol on LDL (MD = -2.03; 95% CI [-10.24, 6.18], P = 0.63).”
Quoted verbatim from Efficacy of resveratrol in women with polycystic ovary syndrome: a systematic review and meta-analysis of randomized clinical trials.. - Study
- meta-analysis
- Participants
- 108
- Population
- Women with PCOS, pooled across 2 RCTs (n=108: 54 per arm).
Effect -2.03 mean difference, 95% CI -10.24 to 6.18
Efficacy of resveratrol in women with polycystic ovary syndrome: a systematic review and meta-analysis of randomized clinical trials.2023PMID:37333786Permalink
Show the remaining 26
No detected effect on hamilton Depression Rating Scale (HDRS) total score
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.FindingNull result“HDRS scores and its changes, ESRS score, and frequency of other complications were not significantly different between resveratrol and placebo groups.”
Quoted verbatim from Resveratrol Adjunct Therapy for Negative Symptoms in Patients With Stable Schizophrenia: A Double-Blind, Randomized Placebo-Controlled Trial.. - Study
- RCT
- Duration
- 8 weeks
- Dose
- 200 mg/d
- Population
- Patients with stable schizophrenia on a stable dose of risperidone in both arms; resveratrol versus matched placebo
Resveratrol Adjunct Therapy for Negative Symptoms in Patients With Stable Schizophrenia: A Double-Blind, Randomized Placebo-Controlled Trial.2020PMID:33372679Permalink
No detected effect on C-reactive protein concentration
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.FindingNull result“The pooled effect estimate revealed no effect of resveratrol on the CRP (MD = 0.00; 95% CI [-1.31, 1.31], P = 1.00).”
Quoted verbatim from Efficacy of resveratrol in women with polycystic ovary syndrome: a systematic review and meta-analysis of randomized clinical trials.. - Study
- meta-analysis
- Participants
- 148
- Dose
- 800, 1000 or 1500 mg/day oral resveratrol
- Population
- Women with polycystic ovary syndrome; 3 pooled RCTs, resveratrol vs placebo
Effect 0 mean difference, 95% CI -1.31 to 1.31
Efficacy of resveratrol in women with polycystic ovary syndrome: a systematic review and meta-analysis of randomized clinical trials.2023PMID:37333786Permalink
No detected effect on fasting blood glucose
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.FindingNull result“The results indicated that resveratrol did not improve FBG levels versus placebo (WMD: −3.54 mg/dL, 95% CI: −12.45, 5.38; P=0.44;.”
Quoted verbatim from Effects of Resveratrol on Metabolic Indicators in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis.. - Study
- meta-analysis
- Participants
- 1,151
- Dose
- 8.1-3000 mg/day resveratrol across the pooled trials
- Population
- Adults with type 2 diabetes; whole-population pooled estimate across all 19 RCTs, resveratrol vs placebo
Effect -3.54 mean difference, 95% CI -12.45 to 5.38
Effects of Resveratrol on Metabolic Indicators in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis.2022PMID:35685602Permalink
No detected effect on aspartate aminotransferase
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.FindingNull result“Interestingly, the result suggested that there was no significant efficacy of resveratrol on ALT level in NAFLD patients [SMD = −0.16, 95% CI (−0.67, 0.35), p = 0.542], nor was the efficacy in AST [SMD = −0.39, 95% CI (−0.95, 0.16), p = 0.167].”
Quoted verbatim from Integrative evidence construction for resveratrol treatment of nonalcoholic fatty liver disease: preclinical and clinical meta-analyses.. - Study
- meta-analysis
- Dose
- 300-3,000 mg/day, 8-24 weeks, pooled across trials
- Population
- adults with NAFLD, resveratrol vs placebo, 5 pooled clinical RCTs
Effect -0.39 standardised mean difference, 95% CI -0.95 to 0.16
Integrative evidence construction for resveratrol treatment of nonalcoholic fatty liver disease: preclinical and clinical meta-analyses.2023PMID:37767399Permalink
No detected effect on body mass index
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.FindingNull result“The result indicated that there was just the trend of decrease but no significance after treatment with resveratrol compared with placebo in BW [SMD = − 0.08, 95% CI (−0.35, 0.18), p = 0.544], BMI [SMD = − 0.07, 95% CI (−0.33, 0.20), p = 0.633], WC [SMD = −0.73, 95% CI (−1.97, 0.51), p = 0.249] and WHR [SMD = −0.12, 95% CI (−0.40, 0.16), p = 0.405] (Supplementary Figures S14, 15).”
Quoted verbatim from Integrative evidence construction for resveratrol treatment of nonalcoholic fatty liver disease: preclinical and clinical meta-analyses.. - Study
- meta-analysis
- Dose
- 300-3,000 mg/day, 8-24 weeks, pooled across trials
- Population
- adults with NAFLD, resveratrol vs placebo, 5 pooled clinical RCTs
Effect -0.07 standardised mean difference, 95% CI -0.33 to 0.2
Integrative evidence construction for resveratrol treatment of nonalcoholic fatty liver disease: preclinical and clinical meta-analyses.2023PMID:37767399Permalink
No detected effect on waist-to-hip ratio
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.FindingNull result“The result indicated that there was just the trend of decrease but no significance after treatment with resveratrol compared with placebo in BW [SMD = − 0.08, 95% CI (−0.35, 0.18), p = 0.544], BMI [SMD = − 0.07, 95% CI (−0.33, 0.20), p = 0.633], WC [SMD = −0.73, 95% CI (−1.97, 0.51), p = 0.249] and WHR [SMD = −0.12, 95% CI (−0.40, 0.16), p = 0.405] (Supplementary Figures S14, 15).”
Quoted verbatim from Integrative evidence construction for resveratrol treatment of nonalcoholic fatty liver disease: preclinical and clinical meta-analyses.. - Study
- meta-analysis
- Dose
- 300-3,000 mg/day, 8-24 weeks, pooled across trials
- Population
- adults with NAFLD, resveratrol vs placebo, 5 pooled clinical RCTs
Effect -0.12 standardised mean difference, 95% CI -0.4 to 0.16
Integrative evidence construction for resveratrol treatment of nonalcoholic fatty liver disease: preclinical and clinical meta-analyses.2023PMID:37767399Permalink
No detected effect on diastolic blood pressure (office/clinic)
LimitedEvidence strength: limited. Human evidence with several recorded weaknesses, or a design that tops out at limited.FindingNull result“Data analyzed using the multivariate ANOVA model revealed that resveratrol’s effects on systolic and diastolic blood pressure were not statistically significant compared with placebo (Table 3).”
Quoted verbatim from Preliminary, randomized, double-blinded, placebo-controlled cross-over study with resveratrol in hypertensive patients.. - Study
- crossover
- Participants
- 16
- Duration
- 4 weeks
- Dose
- 500 mg twice daily, oral
- Population
- pre-hypertensive and stage-1 hypertensive adults aged 20-60 years, Iran; primary outcome; 2 x 2 crossover, 16 completers analysed
Preliminary, randomized, double-blinded, placebo-controlled cross-over study with resveratrol in hypertensive patients.2025PMID:40854984Permalink
No detected effect on alanine aminotransferase
LimitedEvidence strength: limited. Human evidence with several recorded weaknesses, or a design that tops out at limited.FindingNull result“Interestingly, the result suggested that there was no significant efficacy of resveratrol on ALT level in NAFLD patients [SMD = −0.16, 95% CI (−0.67, 0.35), p = 0.542], nor was the efficacy in AST [SMD = −0.39, 95% CI (−0.95, 0.16), p = 0.167].”
Quoted verbatim from Integrative evidence construction for resveratrol treatment of nonalcoholic fatty liver disease: preclinical and clinical meta-analyses.. - Study
- meta-analysis
- Dose
- 300-3,000 mg/day, 8-24 weeks, pooled across trials
- Population
- adults with NAFLD, resveratrol vs placebo, 5 pooled clinical RCTs
Effect -0.16 standardised mean difference, 95% CI -0.67 to 0.35
Integrative evidence construction for resveratrol treatment of nonalcoholic fatty liver disease: preclinical and clinical meta-analyses.2023PMID:37767399Permalink
No detected effect on interleukin-6 concentration
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.FindingNull resultreplicated ×1“Resveratrol supplementation had no significant effect on the level of IL-6 (WMD, -0.16; 95% CI, -0.53 to 0.20; P = 0.38; Q statistic = 36.0; I2 = 72.3%; P = 0.001).”
Quoted verbatim from Effect of Resveratrol Supplementation on Inflammatory Markers: A Systematic Review and Meta-analysis of Randomized Controlled Trials.. - Study
- meta-analysis
- Population
- Adults aged 17 years and older across 17 pooled placebo-controlled randomized controlled trials (736 subjects) of resveratrol supplementation
Effect -0.16 mean difference, 95% CI -0.53 to 0.2
Effect of Resveratrol Supplementation on Inflammatory Markers: A Systematic Review and Meta-analysis of Randomized Controlled Trials.2018PMID:30017172Permalink
No detected effect on diastolic blood pressure (setting unspecified)
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.FindingNull resultreplicated ×1“Also, the two groups showed no significant differences in diastolic blood pressure (DBP), HDL, or oxidative stress markers.”
Quoted verbatim from Resveratrol improves lipid profile and recovers heart function in postoperative CABG patients.. - Study
- RCT
- Duration
- 2 months
- Population
- patients undergoing coronary artery bypass grafting (CABG)
Resveratrol improves lipid profile and recovers heart function in postoperative CABG patients.2025PMID:40676400Permalink
No detected effect on HDL cholesterol
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.FindingNull resultreplicated ×2“Also, the two groups showed no significant differences in diastolic blood pressure (DBP), HDL, or oxidative stress markers.”
Quoted verbatim from Resveratrol improves lipid profile and recovers heart function in postoperative CABG patients.. - Study
- RCT
- Duration
- 2 months
- Population
- patients undergoing coronary artery bypass grafting (CABG)
Resveratrol improves lipid profile and recovers heart function in postoperative CABG patients.2025PMID:40676400Permalink
No detected effect on total cholesterol (TC)
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.FindingNull resultreplicated ×1“The administration of resveratrol did not affect psychological parameters or blood cholesterol (p=0.091) or triglyceride (p=0.932) levels.”
Quoted verbatim from The Effects of Resveratrol in a Randomized Clinical Trial on Drug-Induced Hyperlipidemia and Psychiatric Factors in People Living with HIV.. - Study
- RCT
- Population
- people living with HIV (PLHIV)
The Effects of Resveratrol in a Randomized Clinical Trial on Drug-Induced Hyperlipidemia and Psychiatric Factors in People Living with HIV.2024PMID:39528454Permalink
No detected effect on triglycerides
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.FindingNull resultreplicated ×1“The administration of resveratrol did not affect psychological parameters or blood cholesterol (p=0.091) or triglyceride (p=0.932) levels.”
Quoted verbatim from The Effects of Resveratrol in a Randomized Clinical Trial on Drug-Induced Hyperlipidemia and Psychiatric Factors in People Living with HIV.. - Study
- RCT
- Population
- people living with HIV (PLHIV)
The Effects of Resveratrol in a Randomized Clinical Trial on Drug-Induced Hyperlipidemia and Psychiatric Factors in People Living with HIV.2024PMID:39528454Permalink
No detected effect on health-related quality of life
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.FindingNull result“The administration of resveratrol did not affect cholesterol or triglyceride levels or the rates of depression, anxiety, sleep quality, or quality of life in PLHIV.”
Quoted verbatim from The Effects of Resveratrol in a Randomized Clinical Trial on Drug-Induced Hyperlipidemia and Psychiatric Factors in People Living with HIV.. - Study
- RCT
- Population
- people living with HIV (PLHIV)
The Effects of Resveratrol in a Randomized Clinical Trial on Drug-Induced Hyperlipidemia and Psychiatric Factors in People Living with HIV.2024PMID:39528454Permalink
Activates SIRT1
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.FindingNull result“It is noteworthy that, at the selected low concentration of resveratrol, the treatment did not affect Sirt1 protein levels, regardless of the incubation time.”
Quoted verbatim from Time Does Matter: The Cellular Response to Resveratrol Varies Depending on the Exposure Duration.. - Study
- in vitro · not in humans
- Dose
- 5 µM, 1 day, 1 week or 1 month exposure
- Population
- human cardiomyocytes (Celprogen #1311001-09)
Time Does Matter: The Cellular Response to Resveratrol Varies Depending on the Exposure Duration.2025PMID:40565004Permalink
No detected effect on interleukin-6 concentration
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.FindingNull resultreplicated ×1“The effects of resveratrol on body weight and Interleukin-6 levels of participants were not significant.”
Quoted verbatim from Effects of resveratrol on the anthropometric indices and inflammatory markers: an umbrella meta-analysis.. - Study
- meta-analysis
- Population
- Adults; umbrella meta-analysis pooling 19 meta-analyses of 81 RCTs of resveratrol supplementation (anthropometric and inflammatory outcomes).
Effects of resveratrol on the anthropometric indices and inflammatory markers: an umbrella meta-analysis.2024PMID:38374352Permalink
No detected effect on glutathione peroxidase activity
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.FindingNull result“Collectively, our findings of available RCTs did no show any benefit of resveratrol supplementation on SOD, CAT and GPx except for TAC.”
Quoted verbatim from Therapeutic effect of resveratrol supplementation on oxidative stress: a systematic review and meta-analysis of randomised controlled trials.. - Study
- meta-analysis
- Population
- adults in randomised controlled trials of resveratrol supplementation
Therapeutic effect of resveratrol supplementation on oxidative stress: a systematic review and meta-analysis of randomised controlled trials.2020PMID:31628212Permalink
No detected effect on serum leptin
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.FindingNull resultreplicated ×1“Meta-analysis of data from 5 treatment arms did not find any significant change in plasma leptin concentrations following resveratrol supplementation (WMD: 3.77ng/ml, 95% CI: -2.28, 9.83, p=0.222; Q=8.00, I2=50.01%).”
Quoted verbatim from Resveratrol supplementation and plasma adipokines concentrations? A systematic review and meta-analysis of randomized controlled trials.. - Study
- meta-analysis
- Population
- Meta-analysis pooling 5 of 11 treatment arms from randomized placebo-controlled trials of resveratrol supplementation
Effect 3.77 mean difference, 95% CI -2.28 to 9.83
Resveratrol supplementation and plasma adipokines concentrations? A systematic review and meta-analysis of randomized controlled trials.2017PMID:28089943Permalink
No detected effect on HOMA-IR
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.FindingNull result“The results did not support that resveratrol intervention had favorable effects in altering high-density lipoprotein cholesterol (HDL-C), triglyceride (TAG), and homeostasis model assessment of insulin resistance (HOMA-IR).”
Quoted verbatim from Effects of resveratrol supplementation on risk factors of non-communicable diseases: A meta-analysis of randomized controlled trials.. - Study
- meta-analysis
- Population
- adults in randomized controlled trials of resveratrol supplementation
Effects of resveratrol supplementation on risk factors of non-communicable diseases: A meta-analysis of randomized controlled trials.2018PMID:28933578Permalink
No detected effect on diastolic blood pressure (setting unspecified)
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.FindingNull resultreplicated ×1“The present meta-analysis indicates that resveratrol consumption significantly decreases the SBP level at the higher dose, while resveratrol has no significant effects on DBP levels.”
Quoted verbatim from Effect of resveratrol on blood pressure: a meta-analysis of randomized controlled trials.. - Study
- meta-analysis
- Population
- Meta-analysis of 6 randomized controlled trials of resveratrol supplementation (247 subjects total); overall estimate across all doses
Effect of resveratrol on blood pressure: a meta-analysis of randomized controlled trials.2015PMID:24731650Permalink
No detected effect on serum uric acid
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.FindingNull result“However, the circulating values of albumin and uric acid were not affected by resveratrol supplementation.”
Quoted verbatim from Effects of resveratrol supplementation on renal function in adults: a systematic review and dose-response meta-analysis.. - Study
- meta-analysis
- Population
- Adults; pooled meta-analysis of RCTs of resveratrol supplementation on renal function outcomes (31 studies).
Effects of resveratrol supplementation on renal function in adults: a systematic review and dose-response meta-analysis.2025PMID:40580309Permalink
No detected effect on body mass
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.FindingNull result“The effects of resveratrol on body weight and Interleukin-6 levels of participants were not significant.”
Quoted verbatim from Effects of resveratrol on the anthropometric indices and inflammatory markers: an umbrella meta-analysis.. - Study
- meta-analysis
- Population
- Adults; umbrella meta-analysis pooling 19 meta-analyses of 81 RCTs of resveratrol supplementation (anthropometric and inflammatory outcomes).
Effects of resveratrol on the anthropometric indices and inflammatory markers: an umbrella meta-analysis.2024PMID:38374352Permalink
No detected effect on serum leptin
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.FindingNull resultreplicated ×1“We found no significant effect of resveratrol administration on leptin (SMD = -0.20; 95% CI, -0.68, 0.27; P = 0.40; I2: 85.3) and adiponectin levels (SMD = 0.08; 95% CI, -0.39, 0.55; P = 0.74; I2: 91.0).”
Quoted verbatim from The effects of resveratrol intake on weight loss: a systematic review and meta-analysis of randomized controlled trials.. - Study
- meta-analysis
- Population
- Adults across 36 pooled randomized controlled trials of resveratrol supplementation
Effect -0.2 standardised mean difference, 95% CI -0.68 to 0.27
The effects of resveratrol intake on weight loss: a systematic review and meta-analysis of randomized controlled trials.2020PMID:30421960Permalink
No detected effect on serum adiponectin
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.FindingNull result“We found no significant effect of resveratrol administration on leptin (SMD = -0.20; 95% CI, -0.68, 0.27; P = 0.40; I2: 85.3) and adiponectin levels (SMD = 0.08; 95% CI, -0.39, 0.55; P = 0.74; I2: 91.0).”
Quoted verbatim from The effects of resveratrol intake on weight loss: a systematic review and meta-analysis of randomized controlled trials.. - Study
- meta-analysis
- Population
- Adults across 36 pooled randomized controlled trials of resveratrol supplementation
Effect 0.08 standardised mean difference, 95% CI -0.39 to 0.55
The effects of resveratrol intake on weight loss: a systematic review and meta-analysis of randomized controlled trials.2020PMID:30421960Permalink
No detected effect on superoxide dismutase activity
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.FindingNull result“Collectively, our findings of available RCTs did no show any benefit of resveratrol supplementation on SOD, CAT and GPx except for TAC.”
Quoted verbatim from Therapeutic effect of resveratrol supplementation on oxidative stress: a systematic review and meta-analysis of randomised controlled trials.. - Study
- meta-analysis
- Population
- adults in randomised controlled trials of resveratrol supplementation
Therapeutic effect of resveratrol supplementation on oxidative stress: a systematic review and meta-analysis of randomised controlled trials.2020PMID:31628212Permalink
No detected effect on serum albumin
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.FindingNull result“However, the circulating values of albumin and uric acid were not affected by resveratrol supplementation.”
Quoted verbatim from Effects of resveratrol supplementation on renal function in adults: a systematic review and dose-response meta-analysis.. - Study
- meta-analysis
- Population
- Adults; pooled meta-analysis of RCTs of resveratrol supplementation on renal function outcomes (31 studies).
Effects of resveratrol supplementation on renal function in adults: a systematic review and dose-response meta-analysis.2025PMID:40580309Permalink
What it touches on the way
Mechanistic reach
2 entities
2 entities reached.
0 reported hops2 assembled from the scaffold
What the reference databases state
Regulatory determinations
LiverTox likelihood score ELiverTox
LiverTox Likelihood Score E — despite extensive use, no evidence that the agent has caused liver injury. Chapter: "Resveratrol". Source: LiverTox Master List (NBK571102).
The document·Public Domain (NLM/NIH)·Transcribed, not assessed
On the label
Labelled products
844 products
Source: NIH DSLD · Ingredient: resveratrol · 844 products · Declared amount per serving: 0.5–1,500 mg (830 products)
837 labels state an amount7 do not
- 1-800-WellMedWell HeartRed Wine (Marc) Grape seed extract250 mgper 1 Capsule(s)DSLD:79535
- 1st PhormWhole HeartPolygonum cuspidatum · Resveratrol (Form: from Polygonum cuspidatum Genus: Polygonum Species: cuspidatum)250 mgper 2 Vegan Capsule(s)DSLD:243007
- 8WeeksOutImmortal-RX250 mgper 3 Capsule(s)DSLD:228489
- Ab Cuts Sleek & LeanThermo Rise 0250 mgper 2 Softgel(s)DSLD:23446
- Absorb HealthLiposomal Resveratrol120 mgper 0.167 Ounce(s)DSLD:216066
- Adaptogen ResearchFemBalance20 mgper 4 Capsule(s)DSLD:246986
- Adaptogen ResearchInflammaEZE5 mgper 2 Capsule(s)DSLD:247046
- AdvoCareBioTunePolygonum cuspidatum Root Extract10 mgper 2 Capsule(s)DSLD:265351
- AdvoCareCore Nutrition SystemPolygonum cuspidatum Root Extract10 mgper 1 4-Packet Strip(s)DSLD:177397
- AdvoCareCore Nutrition SystemPolygonum cuspidatum10 mgper 1 Blister Card(s)DSLD:206857
- Alive By NatureLSG Resveratrol/Curcumin125 mgper 2 mLDSLD:230824
- Alive By ScienceLIPO ResveratrolLIPO125 mgper 1 Vegetarian Capsule(s)DSLD:264773
Show the remaining 832
- Allegany NutritionCardio SupportPolygonum cuspidatum · Resveratrol (Form: Polygonum cuspidatum Genus: Polygonum Species: cuspidatum Note: 98%)40 mgper 1 Capsule(s)DSLD:276042
- Allegany NutritionDaily Antioxidant EnzymePolygonum cuspidatum · 98%100 mgper 2 Capsule(s)DSLD:321190
- Allergy Research GroupGlucose Tolerance II with Gluceviapure Trans-Resveratrol · Resveratrol (Form: as 98% pure Trans-Resveratrol)250 mgper 2 Capsule(s)DSLD:233517
- Allergy Research GroupQuatreActiv Folate PlusPolygonum cuspidatum extract · Trans-Resveratrol (Form: from Polygonum cuspidatum extract Genus: Polygonum Species: cuspidatum)25 mgper 1 Capsule(s)DSLD:79267
- AmbrosiaNektar Apple SymphonyPolygonum cuspidatum root standardized extract · Resveratrol (Form: from Polygonum cuspidatum root standardized extract PlantPart: root Genus: Polygonum Species: cuspidatum)50 mgper 5.56 Gram(s)DSLD:229370
- AmbrosiaNektar Fruit SymphonyPolygonum cuspidatum root standardized extract · Resveratrol (Form: from Polygonum cuspidatum root standardized extract PlantPart: root Genus: Polygonum Species: cuspidatum)50 mgper 6.45 Gram(s)DSLD:229372
- AmbrosiaNektar Strawberry BasilPolygonum cuspidatum root standardized extract · Resveratrol (Form: from Polygonum cuspidatum root standardized extract PlantPart: root Genus: Polygonum Species: cuspidatum)50 mgper 5.5 Gram(s)DSLD:229367
- Ambrosia CollectiveNektar Fruit SymphonyPolygonum cuspidatum50 mgper 6.25 Gram(s)DSLD:293795
- American HealthMore Than A Multiple With Cardio EssentialsPolygonum cuspidatum · Resveratrol (Form: from Polygonum cuspidatum PlantPart: root Genus: Polygonum Species: cuspidatum)amount not statedper 3 Tablet(s)DSLD:44614
- AN Amazing Nutrition Amazing FormulasCardio Support66.66 mgper 2 Capsule(s)DSLD:251698
- Anabolic WarfareProject ShredJapanese Knotweed, Powder · 20%50 mgper 3 Capsule(s)DSLD:337978
- AOR Advanced Orthomolecular Research AdvancedUrica40 mgper 1 Capsule(s)DSLD:214781
- AOR Advanced Orthomolecular Research PremiumResveratrolJapanese Knotweed · Trans-Resveratrol (Form: from Japanese Knotweed Genus: Polygonum Species: cuspidatum)100 mgper 1 Softgel(s)DSLD:214877
- AOR Advanced Orthomolecular Research UltraAntioxidant Synergy1.25 mgper 1 Capsule(s)DSLD:214426
- Apex EnergeticsNeuroFlam (K-46)Polygonum cuspidatum extract · Resveratrol (Form: from Polygonum cuspidatum extract Genus: Polygonum Species: cuspidatum)50 mgper 1 Vegetarian Capsule(s)DSLD:60592
- AptogenixDetox AssistPolygonum cuspidatum Root Extract25 mgper 2 Capsule(s)DSLD:323744
- aSquared NutritionNicotinamide 500 mgPolygonum cuspidatum, Powder · 7% potency yield100 mgper 1 Capsule(s)DSLD:295339
- aSquared NutritionResveratrolPolygonum cuspidatum, Powder · 8% potency yield1,000 mgper 2 Capsule(s)DSLD:295341
- Assault LabsEstro Strike 2.0Trans Resveratrol Note: 50%250 mgper 1 Capsule(s)DSLD:246853
- Aurora NutraScienceMega-Liposomal NAD+/Resveratrol Organic Fruit Flavor50 mgper 15 mLDSLD:276656
- Baar Nature's BlessingHealthy ProstateJapanese Knotweed Root Extract10 mgper 3 Softgel(s)DSLD:334205
- Bariatric FusionMen’s Multivitamin Capsules with Iron 18 mgJapanese Knotweed Root Extract5 mgper 1 Capsule(s)DSLD:317895
- BenfoComplete.comBenfoBoost50 mgper 3 Capsule(s)DSLD:320746
- Best NaturalsResveratrol 500 mgPolygonum cuspidatum500 mgper 2 Vcap(s)DSLD:270054
- Beyond HealthCell DefenderPolygonum cuspidatum · 98% Polygonum Cuspidatum135 mgper 2 Veggie Capsule(s)DSLD:306880
- Bing Beverage CompanyBing BlackGrape skin extract1 mgper 1 Can(s)DSLD:47188
- Bing Beverage CompanyBing BlackGrape skin extract1 mgper 1 Can(s)DSLD:65113
- BioSchwartzNMN Healthy Aging Complexextract50 mgper 2 Capsule(s)DSLD:310064
- BioSource LabsRazburn10 mgper 2 Capsule(s)DSLD:278216
- Biotics Research CorporationResveraSirt-HPTrans-Resveratrol Note: purified extract250 mgper 1 Capsule(s)DSLD:22562
- Biotics Research CorporationResveraSirt-HPTrans-Resveratrol Note: purified extract250 mgper 1 Capsule(s)DSLD:22563
- BiotiviaAcai Bio EdgeResveratrol Note: 50%50 mgper 1 Capsule(s)DSLD:21481
- BiotiviaBio SpanPolygonum cuspidatum root extract · Trans-Resveratrol (Form: Polygonum cuspidatum root extract PlantPart: root) Note: 75%100 mgper 1 Vegetarian Capsule(s)DSLD:58303
- BiotiviaBiofortePolygonum cuspidatum root extract · 50% Trans-Resveratrol (Form: Polygonum cuspidatum root extract PlantPart: root Genus: Polygonum Species: cuspidatum) Note: yielding500 mgper 1 Vegetarian Capsule(s)DSLD:56264
- BiotiviaPtero MaxPolygonum cuspidatum root extract · Trans-resveratrol (Form: Polygonum cuspidatum root extract PlantPart: root Genus: Polygonum Species: cuspidatum) Note: 50%250 mgper 1 Vegetarian Capsule(s)DSLD:58351
- BiotiviaTransmax Tr98% Trans-Resveratrol Polygonum cuspidatum rhizome extract PlantPart: rhizome Genus: Polygonum Species: cuspidatum Note: Yielding500 mgper 1 Capsule(s)DSLD:33100
- BiotiviaTransMax TRPolygonum cuspidatum root extract · MicroActive Resveratrol (Form: 98% Trans-Resveratrol, Polygonum cuspidatum root extract PlantPart: root Genus: Polygonum Species: cuspidatum)500 mgper 1 Vegetarian Capsule(s)DSLD:58370
- BiotiviaTransmax Trans-Resveratrol 500 mg98% Trans-Resveratrol Polygonum cuspidatum rhizome extract PlantPart: rhizome Genus: Polygonum Species: cuspidatum Note: Yielding510 mgper 1 Capsule(s)DSLD:33096
- Biotivia Longevity BioceuticalsAcai Bio EdgeResveratrol Note: 50%50 mgper 1 Capsule(s)DSLD:4923
- BIOVEAResveratrol 250 mgPolygonum cuspidatum root extract · Trans-Resveratrol (Form: from Polygonum cuspidatum root extract PlantPart: root Genus: Polygonum Species: cuspidatum Note: 50%)250 mgper 1 Vegetarian Tablet(s)DSLD:249271
- BIOVEAResveratrol 40 mgPolygonum cuspidatum root extract · Trans-Resveratrol (Form: Polygonum cuspidatum root extract PlantPart: root Genus: Polygonum Species: cuspidatum, std. to 50% Trans-Resveratrol)40 mgper 1 Vegetarian Capsule(s)DSLD:209089
- Bluebonnet Beautiful AllyHair, Skin & NailsJapanese Knotweed Root Extract20 mgper 2 Capsule(s)DSLD:332519
- Bluebonnet Beautiful AllyHair, Skin & NailsJapanese Knotweed Root Extract20 mgper 2 Capsule(s)DSLD:332520
- Bluebonnet Beautiful AllyKeratin CareJapanese Knotweed Root Extract20 mgper 1 Capsule(s)DSLD:268187
- Bluebonnet Super EarthAntiOxidantJapanese Knotweed Root Extract100 mgper 2 Caplet(s)DSLD:177813
- Bluebonnet Super EarthAntiOxidantJapanese Knotweed Root Extract100 mgper 2 Caplet(s)DSLD:177815
- Body KitchenCollagen EnrichPolygonum cuspidatum20 mgper 2 Capsule(s)DSLD:276319
- Body KitchenKeratin EnrichPolygonum cuspidatum20 mgper 2 Capsule(s)DSLD:276320
- BodyLogicMD ElitePure EnergyPolygonum cuspidatum · Trans-Resveratrol (Form: from Polygonum cuspidatum PlantPart: root Genus: Polygonum Species: cuspidatum)10 mgper 4 Capsule(s)DSLD:211566
- Botanic ChoiceResveratrol PlusPolygonum cuspidatum extract · Trans-Resveratrol (Form: from 50% Polygonum cuspidatum extract PlantPart: root Genus: Polygonum Species: cuspidatum)50 mgper 1 Capsule(s)DSLD:77814
- Bricker LabsOptiFlow30 mgper 1 Capsule(s)DSLD:211610
- Bricker LabsResforte With Trans-Resveratrol50 mgper 1 Softgel Capsule(s)DSLD:38427
- BronsonResveratrol Complex 500 mgJapanese Knotweed250 mgper 1 Capsule(s)DSLD:317336
- Bronson LaboratoriesNutri Ear10 mgper 1 Capsule(s)DSLD:8258
- Bronson LaboratoriesRePlenish10 mgper 3 Capsule(s)DSLD:298905
- BulkSupplements.comResveratrol (500 mg)Polygonum cuspidatum500 mgper 1 Capsule(s)DSLD:294551
- BulkSupplements.comResveratrol (500 mg)Polygonum cuspidatum500 mgper 1 Capsule(s)DSLD:294552
- BulkSupplements.comResveratrol (500 mg)Polygonum cuspidatum500 mgper 1 Capsule(s)DSLD:294553
- BulkSupplements.comResveratrol (500 mg)Polygonum cuspidatum500 mgper 1 Capsule(s)DSLD:294554
- BulkSupplements.comResveratrol 1000 mg CapsulesPolygonum cuspidatum1,000 mgper 2 Capsule(s)DSLD:312951
- BulkSupplements.comResveratrol 1000 mg CapsulesPolygonum cuspidatum1,000 mgper 2 Capsule(s)DSLD:330071
- BulkSupplements.comResveratrol Capsules 500 mgPolygonum cuspidatum500 mgper 1 Capsule(s)DSLD:330070
- BulkSupplements.comResveratrol Powder 1000 mgPolygonum cuspidatum1,000 mgper 1000 mgDSLD:330515
- BulkSupplements.comResveratrol Powder 1000 mgPolygonum cuspidatum1,000 mgper 1000 mgDSLD:330549
- BulkSupplements.comResveratrol Powder 1000 mgPolygonum cuspidatum1,000 mgper 1000 Milligram(s)DSLD:330550
- BulkSupplements.comResveratrol Powder 1000 mgPolygonum cuspidatum1,000 mgper 1000 mgDSLD:330551
- BulkSupplements.comResveratrol Powder 1000 mgPolygonum cuspidatum1,000 mgper 1000 Milligram(s)DSLD:330553
- BulkSupplements.comResveratrol Powder 1000 mgPolygonum cuspidatum1,000 mgper 1000 mgDSLD:330569
- BulkSupplements.comResveratrol Powder 1000 mgPolygonum cuspidatum1,000 mgper 1000 Milligram(s)DSLD:330570
- Buried Treasure Liquid NutrientsLive YoungResveratrol Note: 98%125 mgper 2 TbspDSLD:71206
- California Academy of HealthLiquid Natural H.R.T. AdvancedPolygonum cuspidatum4 mgper 0.5 TbspDSLD:206487
- California Academy of HealthResveratrol Natur'elle50% natural Trans-Resveratrol Note: from100 mgper 2 Vegicap(s)DSLD:193278
- California Gold NutritionLife BoostPolygonum cuspidatum Root Extract250 mgper 2 Capsule(s)DSLD:299641
- California Gold NutritionLife BoostPolygonum cuspidatum Root Extract250 mgper 2 Capsule(s)DSLD:299642
- California Gold Nutritiontrans-Resveratrol 200 mg200 mgper 1 Capsule(s)DSLD:318831
- California Gold Nutritiontrans-Resveratrol 600 mgPolygonum cuspidatum Root Extract600 mgper 1 Capsule(s)DSLD:275335
- Cardiovascular ResearchResveratrolPolygonum cuspidatum250 mgper 1 Capsule(s)DSLD:304424
- Cata-KorNAD+ Advanced 500 mg50 mgper 2 Capsule(s)DSLD:339371
- CATALOAntioxidants Complex Ultimate FormulaTrans-Resveratrol · Trans-resveratrol 95% (yeast fermented)25 mgper 1 Capsule(s)DSLD:302994
- CATALOAntioxidants Complex Ultimate FormulaTrans-Resveratrol · 95%, Yeast Fermented25 mgper 1 Capsule(s)DSLD:302998
- CATALOAntioxidants Complex Ultimate FormulaTrans-Resveratrol · 95% (yeast fermented)50 mgper 2 Capsule(s)DSLD:303008
- CellucorNO3 Ultimate Blue Raspberry30 mgper 10.5 Gram(s)DSLD:82977
- CellucorNO3 Ultimate Fruit Punch30 mgper 10.5 Gram(s)DSLD:82979
- CellucorNO3 Ultimate Watermelon30 mgper 10.5 Gram(s)DSLD:82981
- Century SystemsHeart Miracle50 mgper 6 Capsule(s)DSLD:3262
- CodeageBrain Focus Vitamins+ EternalPolygonum cuspidatum Root Extract150 mgper 2 Capsule(s)DSLD:333405
- CodeageGLP-Advantage+Polygonum cuspidatum Root Extract5 mgper 2 Capsule(s)DSLD:333409
- CodeageGLP-Harmony Companion+Polygonum cuspidatum Root Extract10 mgper 2 Capsule(s)DSLD:333410
- CodeageLiposomal NAD+ UltraJapanese Knotweed Root Extract · std. to 98% trans-resveratrol180 mgper 3 Capsule(s)DSLD:333428
- CodeageLiposomal Urolithin AJapanese Knotweed Extract · std. to 98%150 mgper 2 Capsule(s)DSLD:333435
- CodeageMultivitamin Performance Elite MaxPolygonum cuspidatum5 mgper 3 Capsule(s)DSLD:333440
- CodeageMultivitamin Recovery Elite MaxPolygonum cuspidatum5 mgper 3 Capsule(s)DSLD:333441
- Cognetix LabsProvasilPolygonum cuspidatum Root Extract · Resveratrol (Form: as Polygonum cuspidatum root extract PlantPart: root Genus: Polygonum Species: cuspidatum)25 mgper 1 Tablet(s)DSLD:239432
- Cognetix LabsProvasilJapanese Knotweed Root Extract25 mgper 1 Tablet(s)DSLD:274326
- Core Med ScienceLiposomal Curcumin-Resveratrol75 mgper 6 mLDSLD:259500
- Country LifeResveratrol Plus100 mgper 1 Capsule(s)DSLD:326838
- Country LifeResveratrol Plus100 mgper 1 Capsule(s)DSLD:327618
- CurEase100% Trans Resveratrol Powderpure Trans-Resveratrol Note: (100%) (2.1 oz.)60 Gram(s)per 0.125 tspDSLD:79632
- CurEasePure 100% Trans Resveratrol 500 mgTrans Resveratrol Note: 100%500 mgper 1 Capsule(s)DSLD:79627
- CurEaseTrans Resveratrol 1600 With Acai Berry AntioxidantPolygonum cuspidatum · Resveratrol (Form: Polygonum cuspidatum PlantPart: root Genus: Polygonum Species: cuspidatum, standardized to 50% Trans Resveratrol)1,000 mgper 1 Capsule(s)DSLD:79967
- DaVinci Benefits LineEstro BenefitsPolygonum cuspidatum Root Extract50 mgper 2 Capsule(s)DSLD:318956
- DaVinci LaboratoriesBioDIM ComplexJapanese Knotweed Root Extract50 mgper 2 Capsule(s)DSLD:322154
- DaVinci LaboratoriesMetabolic MultiPolygonum cuspidatum25 mgper 6 Capsule(s)DSLD:313228
- DaVinci LaboratoriesProstate HealthTrans-Resveratrol5 mgper 2 Capsule(s)DSLD:330914
- DaVinci LaboratoriesResveratrol-50Polygonum cuspidatum extract · yielding200 mgper 1 Capsule(s)DSLD:304032
- DaVinci LaboratoriesResveratrol-50Polygonum cuspidatum extract · yielding200 mgper 1 Capsule(s)DSLD:314614
- DaVinci LaboratoriesSpectra Infinite NutritionPolygonum cuspidatum · yielding200 mgper 19.5 Gram(s)DSLD:322202
- DaVinci Laboratories Of VermontBeauty & Brains25 mgper 3 Capsule(s)DSLD:21811
- DaVinci Laboratories Of VermontGenessentials BHResveratrol (Polygonum cuspidatum) Extract Genus: Polygonum Species: cuspidatum Note: yielding40 mgper 5 Capsule(s)DSLD:22611
- DaVinci Laboratories Of VermontOsteoActivResveratrol (Polygonum cuspidatum) Extract Genus: Polygonum Species: cuspidatum Note: yielding40 mgper 5 Capsule(s)DSLD:23394
- DCResveratrol 200 mgTiger Cane · Resveratrol (Form: from Tiger Cane)200 mgper 1 Tablet(s)DSLD:244711
- DCResveratrol 200 mgTiger Cane200 mgper 1 Tablet(s)DSLD:265970
- DCResveratrol 200 mgTiger Cane200 mgper 1 Tablet(s)DSLD:265971
- DCResveratrol 200 mgTiger Cane200 mgper 1 Tablet(s)DSLD:265972
- DCResveratrol 200 mgTiger Cane200 mgper 1 Tablet(s)DSLD:266681
- DCResveratrol 200 mgTiger Cane200 mgper 1 Tablet(s)DSLD:266682
- DCResveratrol 50 mg Japanese KnotweedJapanese Knotweed50 mgper 1 Softgel(s)DSLD:265974
- DCResveratrol 50 mg Japanese KnotweedJapanese Knotweed50 mgper 1 Softgel(s)DSLD:265975
- DCTrans Resveratrol 200 mgJapanese Knotweed200 mgper 1 Vegetable Capsule(s)DSLD:331323
- DCTrans Resveratrol 50 mgJapanese Knotweed50 mgper 1 Vegetable Capsule(s)DSLD:309918
- DEKE & LAIFEAnti-Aging PrimePolygonum cuspidatum150 mgper 3 Capsule(s)DSLD:277626
- Designs for HealthArthroSoothe10 mgper 2 Capsule(s)DSLD:22263
- Designs for HealthArthroSoothe Supreme10 mgper 4 Capsule(s)DSLD:23511
- Designs for HealthFemGuard + Balance20 mgper 4 Capsule(s)DSLD:23332
- Designs for HealthFemGuard + BalancePolygonum cuspidatum20 mgper 4 Capsule(s)DSLD:276158
- Designs for HealthInflammatone5 mgper 2 Capsule(s)DSLD:23211
- Designs for HealthInflammatone5 mgper 2 Capsule(s)DSLD:23213
- Designs for HealthMitochondrial NRG100 mgper 2 Capsule(s)DSLD:22943
- Designs for HealthResveratrol Synergy200 mgper 1 Capsule(s)DSLD:22801
- Designs for HealthUltimate Antiox Full Spectrum5 mgper 3 Capsule(s)DSLD:23273
- DEVATuba Prime MultivitaminPolygonum cuspidatum Root Extract1 mgper 2 Tablet(s)DSLD:304308
- Doctor's BestHigh Potency Trans-Resveratrol 600 mgJapanese Knotweed · 98% pure trans-resveratrol600 mgper 1 Veggie Capsule(s)DSLD:302680
- Doctor's BestTrans-Resveratrol 100 With ResVinol100 mgper 1 Veggie Capsule(s)DSLD:62632
- Doctor's BestTrans-Resveratrol 200 With ResVinol200 mgper 1 Veggie Capsule(s)DSLD:62634
- Doctors' PreferredLiver+ Revive & RestoreJapanese Knotweed Root Extract8 mgper 2 Vegan Capsule(s)DSLD:309898
- Doctors' PreferredLiver+ Revive & RestoreJapanese Knotweed Root Extract8 mgper 2 Vegan Capsule(s)DSLD:322435
- DoNotAge.orgPure ResveratrolTotal e30g1 Gram(s)per 2 Capsule(s)DSLD:315495
- Double Wood SupplementsResveratrolPolygonum cuspidatum500 mgper 2 Capsule(s)DSLD:255631
- Douglas LaboratoriesMethylated Resveratrol PlusTrans-Resveratrol · Resveratrol (Form: as Trans-Resveratrol)100 mgper 1 Vegetarian Capsule(s)DSLD:232282
- Douglas LaboratoriesMethylated Resveratrol PlusTrans-Resveratrol · resVida Resveratrol (Form: as Trans-Resveratrol)100 mgper 1 Vegetarian Capsule(s)DSLD:274083
- Douglas LaboratoriesResveratrolTrans-Resveratrol200 mgper 1 Vegetarian Capsule(s)DSLD:274095
- Douglas LaboratoriesUltra Preventive VisionTrans-Resveratrol · Resveratrol (Form: as Trans-Resveratrol)10 mgper 4 Vegetarian Capsule(s)DSLD:245419
- Dr. Clark Research Association Dr. Clark ZentrumClark All-in-One10 mgper 20 Gram(s)DSLD:255085
- Dr. David WilliamsAdvanced Phytonutrient ShieldJapanese Knotweed4 mgper 1 Capsule(s)DSLD:296854
- Dr. Emil NutritionResveratrol Plus 500 mgGiant Knotweed500 mgper 2 Capsule(s)DSLD:321810
- Dr. MercolaOrganic ResveratrolJapanese Knotweed Root Extract · Organic100 mgper 1 Capsule(s)DSLD:308854
- Dr. MercolaPurple Defense with ResveratrolPolygonum cuspidatum Root Extract50 mgper 1 Capsule(s)DSLD:327203
- Dr. MercolaPurple Defense with ResveratrolPolygonum cuspidatum Root Extract50 mgper 1 Capsule(s)DSLD:327648
- Dr. Rico PerezResveratrol 250 mgPolygonum cuspidatum extract250 mgper 1 Tablet(s)DSLD:321034
- Dr. Seth's Vitamin VibrationsPower Estro BalancePolygonum cuspidatum Root Extract50 mgper 2 Capsule(s)DSLD:315796
- Dr. SinatraHeart Healthy Multivitamin Complete10 mgper 2 Tablet(s)DSLD:302875
- Dr. SinatraHeart Healthy Multivitamin CompleteJapanese Knotweed Root Extract10 mgper 2 Tablet(s)DSLD:323220
- Dr. SinatraOmega Q Plus 100 Resveratrol30 mgper 2 Softgel(s)DSLD:201865
- Dr. SinatraOmega Q Plus 100 Resveratrol30 mgper 2 Softgel(s)DSLD:201866
- Dr. SinatraOmega Q Plus 100 Resveratrol30 mgper 2 Softgel(s)DSLD:230550
- Dr. SinatraOmega Q Plus 100 Resveratrol30 mgper 2 Softgel(s)DSLD:230544
- Dr. SinatraOmega Q Plus 100 Resveratrol30 mgper 2 Softgel(s)DSLD:256782
- Dr. SinatraOmega Q Plus 100 Resveratrol30 mgper 2 Softgel(s)DSLD:256783
- Dr. SinatraOmega Q Plus 100 Resveratrol30 mgper 2 Softgel(s)DSLD:323223
- Dr. SinatraOmega Q Plus Max30 mgper 2 Softgel(s)DSLD:230521
- Dr. SinatraOmega Q Plus Max30 mgper 2 Softgel(s)DSLD:261302
- Dr. SinatraOmega Q Plus MAX30 mgper 2 Softgel(s)DSLD:286048
- Dr. SinatraOmega Q Plus MAX30 mgper 2 Softgel(s)DSLD:326172
- Dr. SinatraOmega Q Plus MAX30 mgper 2 Softgel(s)DSLD:323224
- Dr. SinatraOmega Q Plus PRO90 mgper 3 Softgel(s)DSLD:326173
- Dr. SinatraOmega Q Plus PRO90 mgper 3 Softgel(s)DSLD:323225
- Dr. SinatraOmega Q Plus Resveratrol30 mgper 2 Softgel(s)DSLD:230524
- Dr. SinatraOmega Q Plus Resveratrol30 mgper 2 Softgel(s)DSLD:315467
- Dr. SinatraOmega Q Plus Resveratrol30 mgper 2 Softgel(s)DSLD:326174
- Dr. SinatraOmega Q Plus Resveratrol30 mgper 2 Softgel(s)DSLD:323226
- Dr. SinatraOmega Q Plus Resveratrol and Turmeric30 mgper 2 Softgel(s)DSLD:315469
- Dr. SinatraOmega Q Plus Resveratrol and Turmeric30 mgper 2 Softgel(s)DSLD:315468
- Dr. SinatraOmega Q Plus Resveratrol And Turmeric30 mgper 2 Softgel(s)DSLD:179536
- Dr. SinatraOmega Q Plus Ultra30 mgper 2 Softgel(s)DSLD:326175
- Dr. SinatraOmega Q Plus Ultra30 mgper 2 Softgel(s)DSLD:323227
- Dr. SinatraSeanol Longevity Plus30 mgper 2 Capsule(s)DSLD:230510
- Dr. TobiasMenopause ReliefPolygonum cuspidatum Root Extract1 mgper 2 Capsule(s)DSLD:319426
- Dr. WhitakerTriveratrol PlusJapanese Knotweed · Trans Resveratrol (Form: from Japanese Knotweed PlantPart: root)100 mgper 2 Capsule(s)DSLD:61964
- dr.boMenopause SupportPolygonum cuspidatum Root Extract1 mgper 2 Capsule(s)DSLD:328681
- DrFormulasBlood Sugar Support2.5 mgper 1 Packet(s)DSLD:295246
- DrFormulasMenopause SupportPolygonum cuspidatum extract · Trans-Resveratrol (Form: from Polygonum cuspidatum extract PlantPart: root Genus: Polygonum Species: cuspidatum)1 mgper 2 Capsule(s)DSLD:203812
- DrVita.comSix Daily Advanced Multi-VitaminPolygonum cuspidatum extract · Resveratrol (Form: from Polygonum cuspidatum extract (Form: standaridized to 50% Resveratrol) PlantPart: root Genus: Polygonum Species: cuspidatum)25 mgper 6 Capsule(s)DSLD:79238
- elonMenopause SupportPolygonum cuspidatum Root Extract1 mgper 2 Capsule(s)DSLD:293481
- Emerald LabsAnti-Aging Cellular ComplexPolygonum cuspidatum · standardized from 50% polygonum cuspidatum75 mgper 2 Capsule(s)DSLD:302537
- Emerald LabsBlood Sugar HealthPolygonum cuspidatum · Polygonum cuspidatum 50%50 mgper 1 Capsule(s)DSLD:302541
- Emerald LabsResveratrol 250 mgPolygonum cuspidatum · 50%250 mgper 1 Capsule(s)DSLD:302739
- EmmaEmmaPolygonum cuspidatum Root Extract125 mgper 2 Capsule(s)DSLD:312631
- Endurance Products CompanyResveratrol 100 mgresVida Trans-Resveratrol · Resveratrol (Form: from resVida Trans-Resveratrol)100 mgper 1 Tablet(s)DSLD:259545
- Esmond NaturalNMN Plus150 mgper 2 Capsule(s)DSLD:315909
- ETST Earth Science TechPain ManagementTrans-Resveratrol Note: 50% extract2.5 mgper 1 Capsule(s)DSLD:70546
- Everyday HealthResveratrol+Japanese Knotweed100 mgper 1 Capsule(s)DSLD:306120
- Evlution NutritionResveratrol 250 mgPolygonum cuspidatum Root Extract · resveratrol extract, providing500 mgper 2 Capsule(s)DSLD:326406
- eXplicit SupplementsResveratrol 600 mgJapanese Knotweed Root Extract · 90% Extract600 mgper 1 Veggie Capsule(s)DSLD:310043
- EZ MeltsResveratrol 150 mg Red Grape99% powdered extract150 mgper 2 Tablet(s)DSLD:260921
- Fairhaven HealthFH PRO for WomenPolygonum cuspidatum root extract50 mgper 6 Capsule(s)DSLD:260632
- Feel Great Vitamin Co.Super Fruit RedsPolygonum cuspidatum extract · Trans-Resveratrol (Form: from Polygonum cuspidatum extract PlantPart: root Genus: Polygonum Species: cuspidatum)20 mgper 2 Capsule(s)DSLD:243752
- Finest NutritionResveratrol 200 mgPolygonum Cuspidaum · Resveratrol (Form: From Polygonum Cuspidaum CorrectedName: Polygonum Cuspidatum) PlantPart: Root Genus: Polygonum Species: Cuspidatum200 mgper 2 Softgel(s)DSLD:26678
- FN Formutech NutritionFit Women37.5 mgper 3 Capsule(s)DSLD:259064
- ForeverForever VisionPolygonum cuspidatum · Resveratrol (Form: Polygonum cuspidatum PlantPart: root Genus: Polygonum Species: cuspidatum) Note: 20%5 mgper 2 Tablet(s)DSLD:70433
- Formutech NutritionCarve Water Loss37.5 mgper 5 Capsule(s)DSLD:322299
- FortifeyeFortifeye Advanced Retina Formula99%40 mgper 2 Capsule(s)DSLD:263414
- Fortifeye Performance NutritionComplete Sport20 mgper 2 Tablet(s)DSLD:263416
- FortifyHeart Support30 mgper 6 Capsule(s)DSLD:283916
- Foster RegalResveratrol 50 mgJapanese Knotweed50 mgper 1 Softgel(s)DSLD:260168
- Fresh NutritionResveratrol750 mgper 3 Capsule(s)DSLD:242078
- FSRevive150 mgper 3 Capsule(s)DSLD:219370
- Fully FloraWomans Hormone SupportPolygonum cuspidatum Root Extract1 mgper 2 Capsule(s)DSLD:295303
- FuturebioticsCholesta-LoPolygonum cuspidatum10 mgper 3 Tablet(s)DSLD:259048
- FuturebioticsCholesta-LoPolygonum cuspidatum10 mgper 3 Tablet(s)DSLD:261049
- FuturebioticsPressur-LoPolygonum cuspidatum30 mgper 6 Tablet(s)DSLD:259170
- FuturebioticsPressur-LoPolygonum cuspidatum30 mgper 6 Tablet(s)DSLD:325714
- Genceutic NaturalsWild & Pure Resveratrol + 500 mg Trans-ResveratrolJapanese Knotweed (Polygonum cuspidatum) (root) extract · Resveratrol (Form: from Japanese Knotweed (Polygonum cuspidatum) (root) extract (Form: standardized to 98% Trans-Resveratrol) PlantPart: root Genus: Polygonum Species: cuspidatum, and Muscadine Grape PlantPart: skin and seed Genus: Vitis Species: rotundifolia)500 mgper 1 Capsule(s)DSLD:191115
- Genestra BrandsResveratrol 250Japanese Knotweed · Resveratrol (Form: from Japanese Knotweed PlantPart: root)250 mgper 1 Capsule(s)DSLD:55990
- Genoma NutritionalsGlycosciaPolygonum cuspidatum · Trans-Resveratrol (Form: from Polygonum cuspidatum PlantPart: root Genus: Polygonum Species: cuspidatum)50 mgper 1 Capsule(s)DSLD:47772
- GenuinePurityLiposomal Trans-ResveratrolPolygonum cuspidatum Root Extract500 mgper 2 VCapsule(s)DSLD:336119
- GenuinePurityLongevity+Polygonum cuspidatum Root Extract · 99%100 mgper 1 Delayed Release Capsule(s)DSLD:336120
- GNC AMP Advanced Muscle PerformanceN.O. Charger & Circulatory Pump30 mgper 2 Light Yellow Caplet(s)DSLD:312704
- GNC AMP Advanced Muscle PerformanceN.O. Charger & Circulatory Pump30 mgper 2 Light Yellow Caplet(s)DSLD:317649
- GNC Beyond RawBeyond Raw Infinite Test30 mgper 4 Tablet(s)DSLD:79573
- GNC Beyond RawInfinite Test30 mgper 4 Tablet(s)DSLD:221112
- GNC Mega Men50 Plus1 mgper 2 Caplet(s)DSLD:304603
- GNC Mega Men50 Plus1 mgper 2 Caplet(s)DSLD:304604
- GNC Mega MenAntioxidant & Circulation30 mgper 1 Capsule(s)DSLD:221158
- GNC Mega MenAntioxidant & Circulation30 mgper 1 Capsule(s)DSLD:31998
- GNC Mega MenBlood Flow & Circulation30 mgper 1 Dark-Green Capsule(s)DSLD:33605
- GNC Mega MenBlood Flow & Circulation30 mgper 1 Dark Green Capsule(s)DSLD:66429
- GNC Mega MenBlood Flow & Circulation30 mgper 1 Dark Green Capsule(s)DSLD:69275
- GNC Mega MenCirculation & Metabolism Support30 mgper 1 White Capsule(s)DSLD:27473
- GNC Mega MenCirculatory Health30 mgper 1 White Capsule(s)DSLD:259818
- GNC Mega MenCirculatory Health30 mgper 1 Dark Green Capsule(s)DSLD:304640
- GNC Mega MenCirculatory Health30 mgper 1 Red Capsule(s)DSLD:315092
- GNC Mega MenCirculatory Health30 mgper 1 Red Capsule(s)DSLD:315819
- GNC Mega MenCirculatory Health30 mgper 1 White Capsule(s)DSLD:315841
- GNC Mega MenHealthy Aging Antioxidant Support30 mgper 1 Capsule(s)DSLD:69698
- GNC Mega MenMega Men 50 Plus Multivitamin1 mgper 2 Beige Caplet(s)DSLD:259831
- GNC Mega MenUltra Testosterone30 mgper 4 Capsule(s)DSLD:308324
- GNC Mega MenUltra Testosterone30 mgper 4 Capsule(s)DSLD:315853
- GNC Men'sHealthy Testosterone30 mgper 2 Caplet(s)DSLD:304333
- GNC Men'sStaminol Rapid Surge30 mgper 1 Caplet(s)DSLD:1640
- GNC Preventive NutritionCellular Antioxidant Formula30 mgper 2 Caplet(s)DSLD:82403
- GNC Preventive NutritionEnhanced Sleep Formulaamount not statedper 2 Capsule(s)DSLD:27312
- GNC Preventive NutritionEnhanced Sleep Formula30 mgper 2 Capsule(s)DSLD:70152
- GNC Preventive NutritionEye Health Formula30 mgper 2 Sofgel Capsule(s)DSLD:243680
- GNC Preventive NutritionEye Health Formula30 mgper 2 Softgel Capsule(s)DSLD:304446
- GNC Preventive NutritionHealthy Blood Pressure Formula30 mgper 3 Capsule(s)DSLD:315307
- GNC Preventive NutritionresVida 30 mg30 mgper 1 Capsule(s)DSLD:7088
- GNC Pro PerformanceAMP Pump XXX Fruit Punch30 mgper 14.82 Gram(s)DSLD:74583
- GNC Pro PerformanceAmplified Creatine XXX Blue Raspberry30 mgper 62.5 Gram(s)DSLD:18538
- GNC Pro Performance AMPAmplified Creatine XXX Fruit Punch30 mgper 31.5 Gram(s)DSLD:74753
- GNC Pro Performance AMPAmplified Creatine XXX Pink Lemonade30 mgper 31.5 Gram(s)DSLD:176055
- GNC Pro Performance AMPAmplified N.O. Charger & Circulatory Pump30 mgper 2 Yellow Caplet(s)DSLD:67290
- GNC Triple StrengthFish Oil +ResveratrolPolygonum cuspidatum root extract · Resveratrol (Form: from Polygonum cuspidatum root extract PlantPart: root Genus: Polygonum Species: cuspidatum)125 mgper 1 Softgel(s)DSLD:1071
- GNC Triple StrengthKrill Oil 1000 +Heart Support30 mgper 2 Softgel(s)DSLD:36103
- GNC Women'sAntioxidant & Circulation30 mgper 1 Capsule(s)DSLD:243683
- GNC Women'sHealthy Aging Antioxidant FormulaTrans-Resveratrol30 mgper 1 Yellow Filled Capsule(s)DSLD:331491
- GNC Women'sMultivitamin ActiveFallopia japonica2 mgper 1 Caplet(s)DSLD:259789
- GNC Women's Ultra MegaAntioxidant & Circulation30 mgper 1 Capsule(s)DSLD:69503
- GNC Women's Ultra MegaCirculation & Metabolism Support30 mgper 1 White Capsule(s)DSLD:33543
- GNC Women's Ultra MegaHealthy Aging Antioxidant Formula30 mgper 1 Capsule(s)DSLD:57501
- Good StateRaspberry KetonesTrans-Resveratrol Note: 98%50 mgper 1 Vegetarian Capsule(s)DSLD:229700
- Gottfried InstituteHormone Balancing EssentialsTrans-Resveratrol Note: These ingredients are complexed with Time-Sorb(R), a time-release matrix.50 mgper 1 Packet(s)DSLD:45504
- Greens First FemaleSeraMense plus Probiotics ChocolateJapanese Knotweed Root Extract50 mgper 15.41 Gram(s)DSLD:214123
- Greens First FemaleSeraMense plus Probiotics GreensJapanese Knotweed Root Extract50 mgper 10.41 Gram(s)DSLD:214295
- Groovy BeeLiposomal Curcumin + ResveratrolJapanese Knotweed · japanese giant knotweed75 mgper 6 mLDSLD:317750
- Hard Rock SupplementsTerminate250 mgper 2 Capsule(s)DSLD:313008
- Health Products DistributorsUltimate Protector+Polygonum cuspidatum root extract135 mgper 2 Veggie Capsule(s)DSLD:254881
- Health Thru Nutrition NaturallyResveratrol 100 mg100 mgper 1 Softgel(s)DSLD:177674
- Healths HarmonyMenopause ReliefPolygonum cuspidatum extract1 mgper 2 Capsule(s)DSLD:277505
- Healths HarmonySuper AntioxidantsPolygonum cuspidatum Root Extract20 mgper 2 Capsule(s)DSLD:318371
- Healthy BlendGenesis250 mgper 4 Gram(s)DSLD:271671
- Healthy Choice NaturalsAcai AdvantageTrans-Resveratrol Note: 50% extract20 mgper 2 Capsule(s)DSLD:71905
- Healthy Choice NaturalsGreen Coffee Bean Supreme10 mgper 2 Capsule(s)DSLD:72022
- Healthy ItemsLiposomal Can-HelpLiposomal75 mgper 15 mLDSLD:259070
- Healthy ItemsLiposomal Can-Help Complex100 mgper 1 TbspDSLD:231116
- Healthy ItemsProsta-Plex PlusJapanese Knotweed extract10 mgper 3 Softgel(s)DSLD:259072
- Healthy Items Liposomal NutritionalsLiposomal Age-Less250 mgper 0.5 Ounce(s)DSLD:11445
- Healthy OriginsResveratrol 300 mgTrans-Resveratrol · Veri-te (Form: Trans-Resveratrol Note: 98%)300 mgper 1 Vegetarian Capsule(s)DSLD:269453
- Healthy Transformation by Bariatric AdvantageEssential Multi PackPolygonum cuspidatum Root Extract5 mgper 1 Packet(s)DSLD:323328
- HealthyCellHeart & Vascular Health StrawberryPolygonum cuspidatum Root Extract30 mgper 25 mLDSLD:336365
- Her OwnBeautyPolygonum cuspidatum Root Extract25 mgper 1 Capsule(s)DSLD:307910
- HerbadietNatural Resveratrol PowderGrape Skin Extract, Natural, Powder · Standardized to contain minimum 98% natural trans-resveratrol100 mgper 100 mgDSLD:293482
- HerbadietResveratrol ComplexGrape250 mgper 2 Capsule(s)DSLD:258125
- HerbadietResveratrol PlusJapanese Knotweed125 mgper 1 Capsule(s)DSLD:293493
- HerbadietTrans-ResveratrolGrape50 mgper 1 Capsule(s)DSLD:258199
- Herbalife NutritionCell Activator0.9 mgper 1 Capsule(s)DSLD:250681
- HerbaMeHeart VitalityPolygonum cuspidatum extract · from 60mg of polygonum cuspidatum 50% Extract30 mgper 2 Capsule(s)DSLD:293443
- HerbaMeHeart Vitalityfrom30 mgper 6 Capsule(s)DSLD:304588
- Herbs SRAEstrogen BlockerJapanese Knotweed · 98%160 mgper 2 Capsule(s)DSLD:316170
- HerbTonicsFoli-Tonic100 mgper 1 Vegetable Capsule(s)DSLD:287055
- High Performance NutritionS(9)Polygonum cuspidatum extract600 mgper 1 Vegetarian Capsule(s)DSLD:271190
- HMS NutritionResveratrolpure Trans-Resveratrol · Resveratrol (Form: std. to 50% pure Trans-Resveratrol (Form: from Polygonum cuspidatum root extract PlantPart: root Genus: Polygonum Species: cuspidatum))1,200 mgper 2 Capsule(s)DSLD:229921
- HoltraCeuticalsAge WellPolygonum cuspidatum100 mgper 2 Capsule(s)DSLD:270813
- HoltraCeuticalsAntiox MaxPolygonum cuspidatum root extract18.5 mgper 2 Capsule(s)DSLD:271576
- HoltraCeuticalsGH StimPolygonum cuspidatum Root Extract8 mgper 1 Capsule(s)DSLD:271518
- HoltraCeuticalsMito ImmunePolygonum cuspidatum10 mgper 2 Capsule(s)DSLD:271549
- Home Aide Diagnostics, Inc.Co-Balamin99%400 mgper 1 Capsule(s)DSLD:263552
- Human NSuperbeets Memory + Focus Blueberry Pomegranate FlavorResveratrol150 mgper 1 Chew(s)DSLD:291811
- HyalogicResveratrol with Grape Seed ExtractPolygonum cuspidatum20 mgper 1 Capsule(s)DSLD:201545
- HyalogicResveratrol with Grape Seed ExtractPolygonum cuspidatum20 mgper 1 Capsule(s)DSLD:247786
- Igennus Healthcare NutritionMicronutrient Capsule50 mgper 1 Capsule(s)DSLD:249484
- ILN Iron Labs NutritionPCT Xtreme6 mgper 2 Capsule(s)DSLD:286926
- ImmunotecMulti + ResveratrolPolygonum cuspidatum root extract · Trans-Resveratrol (Form: as Polygonum cuspidatum root extract PlantPart: root Genus: Polygonum Species: cuspidatum)50 mgper 2 Capsule(s)DSLD:240030
- Indiana Botanic GardensHearty HeartPolygonum cuspidatum root extract · Trans-Resveratrol (Form: from Polygonum cuspidatum root extract PlantPart: root Genus: Polygonum Species: cuspidatum)150 mgper 2 Capsule(s)DSLD:46998
- Indiana Botanic GardensHearty HeartPolygonum cuspidatum extract · Trans-Resveratrol (Form: from Polygonum cuspidatum extract PlantPart: root Genus: Polygonum Species: cuspidatum)150 mgper 2 Capsule(s)DSLD:78114
- Indiana Botanic GardensOral Health Pro-TecPolygonum cuspidatum extract · Trans-Resveratrol (Form: from Polygonum cuspidatum extract PlantPart: root Genus: Polygonum Species: cuspidatum)50 mgper 2 Capsule(s)DSLD:78116
- Indiana Botanic GardensResveratrol 100 mgPolygonum cuspidatum extract · Resveratrol (Form: from Polygonum cuspidatum extract PlantPart: root Genus: Polygonum Species: cuspidatum)100 mgper 1 Softgel(s)DSLD:46906
- Indiana Botanic GardensResveratrol 100 mgPolygonum cuspidatum root extract · Trans-Resveratrol (Form: from Polygonum cuspidatum root extract PlantPart: root Genus: Polygonum Species: cuspidatum)200 mgper 1 Capsule(s)DSLD:77196
- Indiana Botanic GardensResveratrol 50 mgPolygonum cuspidatum extract · Resveratrol (Form: from Polygonum cuspidatum extract PlantPart: root Genus: Polygonum Species: cuspidatum)100 mgper 1 Softgel(s)DSLD:77798
- InessaBiosoothePolygonum cuspidatum root extract100 mgper 2 Capsule(s)DSLD:318802
- Infiniti Creations100% Pure Raspberry Ketones100 mgper 1 Capsule(s)DSLD:238988
- InstaflexInstaflex AdvancedJapanese Knotweed Root Extract · Resveratrol (Form: from Japanese Knotweed root extract PlantPart: root)100 mgper 1 Capsule(s)DSLD:249953
- InstaflexInstaflex AdvancedJapanese Knotweed Root Extract100 mgper 1 Capsule(s)DSLD:282611
- Irwin NaturalsCollagen BeautyJapanese Knotweed Root Extract10 mgper 6 Liquid Softgel(s)DSLD:292067
- Irwin NaturalsCoQ10-PlusJapanese Knotweed Root Extract10 mgper 2 Liquid Softgel(s)DSLD:292126
- Irwin NaturalsInflamma-LessJapanese Knotweed Root Extract9 mgper 2 Liquid Soft-Gel(s)DSLD:323285
- IsagenixAgeless Essentials With Product BPolygonum cuspidatum · Resveratrol (Form: from Polygonum cuspidatum Genus: Polygonum Species: cuspidatum)125 mgper 1 Packet(s)DSLD:62366
- IsagenixCytoActivesPolygonum cuspidatum · Resveratrol (Form: from Polygonum cuspidatum Genus: Polygonum Species: cuspidatum)50 mgper 2 Softgel(s)DSLD:238840
- IVL Institute for Vibrant LivingAll Day Energy Green Zing25 mgper 9.5 Gram(s)DSLD:12146
- IVL Institute For Vibrant LivingBio-Renew Refreshing Orange FlavorPolygonum cuspidatum radix and rhizome extract · Resveratrol (Form: from Polygonum cuspidatum radix and rhizome extract PlantPart: radix and rhizome Genus: Polygonum Species: cuspidatum)20 mgper 13.2 Gram(s)DSLD:24850
- IVL Institute For Vibrant LivingOmega Max Gold Lemon FlavorTrans-Resveratrol · Resveratrol (Form: 95% Trans-Resveratrol)40 mgper 2 Softgel(s)DSLD:60821
- IVL Institute For Vibrant LivingOmega Max SoftgelsTrans-Res · Resveratrol (Form: 95% Trans-Res)200 mgper 2 Softgel(s)DSLD:15547
- iwiBeautyPolygonum cuspidatum extract20 mgper 2 Softgel(s)DSLD:247652
- Jarrow FormulasGlucose OptimizerPolygonum cuspidatum25 mgper 2 Tablet(s)DSLD:307595
- Jarrow FormulasResveratrolPolygonum cuspidatum100 mgper 1 Capsule(s)DSLD:307724
- Jarrow FormulasResveratrolPolygonum cuspidatum100 mgper 1 Capsule(s)DSLD:307725
- Jarrow FormulasResveratrol SynergyTiger Cane200 mgper 1 Tablet(s)DSLD:307726
- Justified LaboratoriesBlood Balance MaxJapanese Knotweed Root Extract10 mgper 2 Capsule(s)DSLD:276014
- Justified LaboratoriesBlood Balance MaxJapanese Knotweed Root Extract10 mgper 1 Capsule(s)DSLD:315890
- Justified LaboratoriesGlucofort MaxJapanese Knotweed Root Extract10 mgper 1 Capsule(s)DSLD:276409
- Justified LaboratoriesGlucofort MaxJapanese Knotweed Root Extract10 mgper 1 Capsule(s)DSLD:341031
- Justified LaboratoriesGlucotrust MaxJapanese Knotweed Root Extract10 mgper 1 Capsule(s)DSLD:315926
- Justified LaboratoriesPure Synapse XT MaxJapanese Knotweed Root Extract10 mgper 1 Capsule(s)DSLD:276448
- Justified LaboratoriesResveratrol MaxJapanese Knotweed Root Extract10 mgper 1 Capsule(s)DSLD:316001
- Justified LaboratoriesSweet Relief Glycogen Support ExtremeJapanese Knotweed Root Extract10 mgper 2 Capsule(s)DSLD:341387
- Justified LaboratoriesVisiClear MaxJapanese Knotweed extract10 mgper 1 Capsule(s)DSLD:276462
- JuvenonYouthful MemoryPolygonum cuspidatum root extract · Resveratrol (Form: from Polygonum cuspidatum root extract PlantPart: root Genus: Polygonum Species: cuspidatum)30 mgper 2 Vegetable Capsule(s)DSLD:50105
- KirkmanAdvanced Adult Multi-Vitamin/Mineral25 mgper 2 Capsule(s)DSLD:23871
- LAIFEAnti-AgingPolygonum cuspidatum135 mgper 3 Capsule(s)DSLD:277624
- LAIFEAnti-Aging ProPolygonum cuspidatum150 mgper 3 Vegetarian Capsule(s)DSLD:301424
- Lee Haney's Nutritional Support SystemsAge Management Pack500mg of polygonum cuspidatum 50% extract · Trans-Resveratrol (Form: from 500mg of polygonum cuspidatum 50% extract)250 mgper 9 Capsule(s)DSLD:12985
- Lee Haney's Nutritional Support SystemsAge Management ResveratrolResveratrol Note: 250 milligrams of elemental Trans-Resveratrol from 500 mg's of polygonum cuspidatum 50% standardized extract.250 mgper 2 Capsule(s)DSLD:656
- Leviathan WellnessFortitudePolygonum cuspidatum · std. to 50% Trans-Resveratrol200 mgper 4 Capsule(s)DSLD:322128
- LG SciencesForm-XTResveratrol Note: (trans) (95%)25 mgper 1 Tablet(s)DSLD:219396
- LifeHeart Strong Q10 with Fish Oil & Resveratrol30 mgper 1 Softgel(s)DSLD:76771
- LifeSuper AntioxidantsPolygonum cuspidatum · Trans-Resveratrol (Form: std. Polygonum cuspidatum Genus: Polygonum Species: cuspidatum)150 mgper 2 Vegetarian Capsule(s)DSLD:54185
- Life Extension7-Keto DHEA Metabolite 100 mgJapanese Knotweed (root) extract1 mgper 1 Vegetarian Capsule(s)DSLD:328272
- Life ExtensionAnti-Alcohol ComplexJapanese Knotweed Root Extract5 mgper 1 Capsule(s)DSLD:328280
- Life ExtensionAnti-Alcohol With HepatoProtection ComplexJapanese Knotweed · Trans-Resveratrol (Form: from Japanese Knotweed PlantPart: root, and Red Grape (fruit) extracts PlantPart: fruit)5 mgper 1 Capsule(s)DSLD:74526
- Life ExtensionCR Mimetic Longevity FormulaJapanese Knotweed extract · Trans-Resveratrol (Form: from Japanese Knotweed extract PlantPart: root)250 mgper 2 Vegetarian Capsule(s)DSLD:61991
- Life ExtensionDHEA CompleteGrape fruit extract1 mgper 1 Vegetarian Capsule(s)DSLD:328414
- Life ExtensionGrapeseed Extract 100 mgGrape fruit extract20 mgper 1 Capsule(s)DSLD:328471
- Life ExtensionGrapeseed Extract With Resveratrol & PterostilbeneGlycosides · Trans-Resveratrol (Form: from Japanese Knotweed PlantPart: root, and whole Red Grape extracts, also supplying Glycosides (Form: Polydatin))20 mgper 1 Vegetarian Capsule(s)DSLD:60875
- Life ExtensionOptimized NAD+ Cell Regenerator with ResveratrolJapanese Knotweed extract · Trans-Resveratrol (Form: from Japanese Knotweed extract PlantPart: root)100 mgper 1 Vegetarian Capsule(s)DSLD:182477
- Life ExtensionOptimized NAD+ Cell Regenerator with ResveratrolJapanese Knotweed extract · Trans-Resveratrol (Form: from Japanese Knotweed extract PlantPart: root)100 mgper 1 Vegetarian Capsule(s)DSLD:182479
- Life ExtensionOptimized ResveratrolJapanese Knotweed · Trans-Resveratrol (Form: from Japanese Knotweed PlantPart: root)250 mgper 1 Vegetarian Capsule(s)DSLD:60689
- Life ExtensionOptimized Resveratrol 250 mg With Synergistic Grape-Berry ActivesGlycosides · Trans-Resveratrol (Form: from Japanese Knotweed PlantPart: root, also supplying Glycosides (Form: Polydatin))250 mgper 1 Vegetarian Capsule(s)DSLD:61935
- Life ExtensionOptimized Resveratrol With NAD + Cell RegeneratorJapanese Knotweed · Trans-Resveratrol (Form: from Japanese Knotweed (Form: also supplying Glycosides (Form: Polydatin)) PlantPart: root)250 mgper 1 Vegetarian Capsule(s)DSLD:62801
- Life ExtensionOptimized Resveratrol with Nicotinamide RibosideJapanese Knotweed · Trans-Resveratrol (Form: from Japanese Knotweed PlantPart: root)250 mgper 1 Vegetarian Capsule(s)DSLD:60754
- Life ExtensionResveratrol With Pterostilbene 100 mgGlycosides · Trans-Resveratrol (Form: from Japanese Knotweed PlantPart: root, and whole Red Grape extracts, also supplying Glycosides (Form: Polydatin))100 mgper 1 Vegetarian Capsule(s)DSLD:60874
- Life ExtensionResveratrol With Pterostilbene 20 mgGlycosides · Trans-Resveratrol (Form: from Japanese Knotweed PlantPart: root, and whole Red Grape extracts, also supplying Glycosides (Form: Polydatin))20 mgper 1 Vegetarian Capsule(s)DSLD:60882
- Life ExtensionTriple Action Cruciferous Vegetable Extract and ResveratrolGrape fruit extract20 mgper 1 Vegetarian Capsule(s)DSLD:328750
- Life ExtensionWhole Grape ExtractGlycosides · Trans-Resveratrol (Form: from Japanese Knotweed PlantPart: root, and whole Red Grape extracts, also supplying Glycosides (Form: Polydatin))25 mgper 1 Vegetarian Capsule(s)DSLD:64473
- Life PriorityV-Guard 2133 mgper 3 Capsule(s)DSLD:320761
- LifeLinkilLuminol Reservatrol Formula 250250 mgper 1 Capsule(s)DSLD:11849
- LifeSeasons Recode With The Bredesen ProtocolType 3 ToxicPolygonum cuspidatum25 mgper 4 Capsule(s)DSLD:310530
- LifeSeasons TherapeuticsAgeless Skin CarePolygonum cuspidatum100 mgper 3 Capsule(s)DSLD:310456
- LifeSeasons TherapeuticsPuri-TPolygonum cuspidatum25 mgper 2 Capsule(s)DSLD:310516
- LifeTIMELiquid Collagen with Co-Q10 and Resveratrol Natural Orange/Vanilla Flavor 2,000 mgTrans-Resveratrol · Resveratrol (Form: as Trans-Resveratrol (Form: from Japanese Knotweed PlantPart: root Genus: Polygonum Species: cuspidatum Note: extract))100 mgper 1 TbspDSLD:47684
- Liposomal NutritionalsLiposomal ResveratrolTrans-Resveratrol166 mgper 1 tspDSLD:183355
- Logos NutritionalsEve's HarmonyPolygonum cuspidatum Root Extract1 mgper 2 Capsule(s)DSLD:335709
- Logos NutritionalsFitcose 1C50%90 mgper 1 Capsule(s)DSLD:335711
- LumidayRadiance WithinJapanese Knotweed (root) extract30 mgper 2 Capsule(s)DSLD:288636
- M3 Supplement CompanyUltimate GCB20% extract5 mgper 1 Capsule(s)DSLD:338331
- MannatechBounceBackJapanese Knotweed1.2 mgper 2 Capsule(s)DSLD:34833
- Maxi HealthMaxi Resveratrol with Coenzyme Q10from100 mgper 1 Capsule(s)DSLD:304204
- MBi NutraceuticalsBio-Naturalvite50 mgper 2 Tablet(s)DSLD:231525
- MBi NutraceuticalsBio-Pro10 mgper 21 Gram(s)DSLD:231537
- MBi NutraceuticalsDerma-Vites75 mgper 1 Capsule(s)DSLD:231568
- MDLogicMenopause CompletePolygonum cuspidatum Root Extract20 mgper 2 Capsule(s)DSLD:299140
- MedOpMaxiVision Ocular Formula5 mgper 2 Vegetable Capsule(s)DSLD:27736
- MedOpMaxiVision Whole Body Formula5 mgper 4 Vegetarian Capsule(s)DSLD:26327
- MelaleucaProvexCVPolygonum cuspidatum Root Extract60 mgper 2 Capsule(s)DSLD:277009
- MelaleucaVitality 6 Essentials + Heart30 mgper 1 Packet(s)DSLD:13664
- MelaleucaVitality Total30 mgper 1 Packet(s)DSLD:13621
- Mental RefreshmentResveratrol 1000 mgPolygonum cuspidatum1,000 mgper 2 Capsule(s)DSLD:247676
- Metabolic MaintenanceResveratrol 200 mg with Piperine200 mgper 1 Capsule(s)DSLD:274117
- Metabolic MaintenanceResveratrol With PiperinePolygonum cuspidatum root extract · Resveratrol (Form: from 400 mg Polygonum cuspidatum root extract (Form: standardized to 50% Resveratrol) PlantPart: root Genus: Polygonum Species: cuspidatum )200 mgper 1 Capsule(s)DSLD:25118
- MetagenicsEstroFactorsPolygonum cuspidatum root extract · Resveratrol (Form: from Polygonum cuspidatum root extract PlantPart: root Genus: Polygonum Species: cuspidatum)2 mgper 3 Tablet(s)DSLD:26818
- MetagenicsEstroFactorsPolygonum cuspidatum root extract · Resveratrol (Form: from Polygonum cuspidatum root extract PlantPart: root Genus: Polygonum Species: cuspidatum)2 mgper 3 Tablet(s)DSLD:26822
- MetagenicsHealthy Transformation Advanced NutritionPolygonum cuspidatum root extract · Resveratrol (Form: from Polygonum cuspidatum root extract PlantPart: root Genus: Polygonum Species: cuspidatum)5 mgper 1 Packet(s)DSLD:216863
- MetagenicsPhytoMulti CapsulesPolygonum cuspidatum Root Extract10 mgper 1 Capsule(s)DSLD:260880
- MetagenicsPhytoMulti CapsulesPolygonum cuspidatum Root Extract10 mgper 1 Capsule(s)DSLD:295854
- MetagenicsPhytoMulti TabletsPolygonum cuspidatum root extract · Resveratrol (Form: from Polygonum cuspidatum root extract PlantPart: root Genus: Polygonum Species: cuspidatum)10 mgper 1 Tablet(s)DSLD:216600
- MetagenicsPhytoMulti TabletsPolygonum cuspidatum root extract · Resveratrol (Form: from Polygonum cuspidatum root extract PlantPart: root Genus: Polygonum Species: cuspidatum)10 mgper 1 Tablet(s)DSLD:216607
- MetagenicsPhytoMulti with Iron TabletsPolygonum cuspidatum root extract10 mgper 1 Tablet(s)DSLD:295855
- MetagenicsWellness EssentialsPolygonum cuspidatum root extract · Resveratrol (Form: from Polygonum cuspidatum root extract PlantPart: root Genus: Polygonum Species: cuspidatum)5 mgper 1 Packet(s)DSLD:216514
- MetagenicsWellness EssentialsPolygonum cuspidatum root extract5 mgper 1 Packet(s)DSLD:266536
- MetagenicsWellness Essentials ActivePolygonum cuspidatum root extract · Resveratrol (Form: from Polygonum cuspidatum root extract PlantPart: root Genus: Polygonum Species: cuspidatum)5 mgper 1 Packet(s)DSLD:216577
- MetagenicsWellness Essentials ActivePolygonum cuspidatum root extract5 mgper 1 Packet(s)DSLD:266551
- MetagenicsWellness Essentials Brain HealthPolygonum cuspidatum root extract · Resveratrol (Form: from Polygonum cuspidatum root extract PlantPart: root Genus: Polygonum Species: cuspidatum)5 mgper 1 Packet(s)DSLD:211103
- MetagenicsWellness Essentials Healthy BalancePolygonum cuspidatum root extract · Resveratrol (Form: from Polygonum cuspidatum root extract PlantPart: root Genus: Polygonum Species: cuspidatum)5 mgper 1 Packet(s)DSLD:216519
- MetagenicsWellness Essentials Men's VitalityPolygonum cuspidatum root extract · Resveratrol (Form: from Polygonum cuspidatum root extract PlantPart: root Genus: Polygonum Species: cuspidatum)5 mgper 1 Packet(s)DSLD:216518
- MetagenicsWellness Essentials Men's VitalityPolygonum cuspidatum root extract · Resveratrol (Form: from Polygonum cuspidatum root extract PlantPart: root Genus: Polygonum Species: cuspidatum)5 mgper 1 Packet(s)DSLD:267878
- MetagenicsWellness Essentials WomenPolygonum cuspidatum root extract · Resveratrol (Form: from Polygonum cuspidatum root extract PlantPart: root Genus: Polygonum Species: cuspidatum)10 mgper 1 Packet(s)DSLD:216516
- MetagenicsWellness Essentials WomenPolygonum cuspidatum root extract · Resveratrol (Form: from Polygonum cuspidatum root extract PlantPart: root Genus: Polygonum Species: cuspidatum)10 mgper 1 Packet(s)DSLD:267978
- MetagenicsWellness Essentials Women's PrimePolygonum cuspidatum root extract · Resveratrol (Form: from Polygonum cuspidatum root extract PlantPart: root Genus: Polygonum Species: cuspidatum)5 mgper 1 Packet(s)DSLD:216515
- MilaMiAmorWrinkles Away with Resveratrol10 mgper 2 Capsule(s)DSLD:331962
- Mimi's MiracleMulti50 mgper 3 Capsule(s)DSLD:230167
- MomentousEssential MultiPolygonum cuspidatum10 mgper 4 Capsule(s)DSLD:321459
- MomentousMultivitaminPolygonum cuspidatum10 mgper 4 Capsule(s)DSLD:317536
- Morphogen NutritionMorphoprimeTrans-Resveratrol · Resveratrol (Form: as Trans-Resveratrol)150 mgper 6 Capsule(s)DSLD:212817
- Moss NutritionCV Select25 mgper 2 Capsule(s)DSLD:187437
- Moss NutritionCV Select25 mgper 2 Capsule(s)DSLD:187446
- Moss NutritionGlycemic SelectPolygonum cuspidatum Root Extract10 mgper 6 Capsule(s)DSLD:334930
- Moss NutritionResveratrol SelectPolygonum cuspidatum225 mgper 1 Capsule(s)DSLD:334950
- NasaBe'AhavaResveratrol 1000 mgPolygonum cuspidatum · 8% potency/equivalent to 40mg1,000 mgper 2 Capsule(s)DSLD:321991
- NatrolResveratrol Plus 100 mgPolygonum cuspidatum · Resveratrol (Form: from Polygonum cuspidatum PlantPart: root Genus: Polygonum Species: cuspidatum)100 mgper 1 Tablet(s)DSLD:78079
- Natural ClinicianClinical Advanced Joint Care45 mgper 2 Capsule(s)DSLD:18631
- Natural ClinicianClinical Cholesterol/Anti-Homocysteine Support20 mgper 2 Capsule(s)DSLD:18607
- Natural FactorsResveratrolRich Regular Strength Resveratrol Concentrate250 mgper 1 Capsule(s)DSLD:38158
- Natural FactorsResveratrolRich Super Strength Resveratrol Concentrate500 mgper 1 Capsule(s)DSLD:52866
- Natural Healthy ConceptsCell-ImmunePolygonum cuspidatum · trans-Resveratrol (Form: from Polygonum cuspidatum PlantPart: roots Genus: Polygonum Species: cuspidatum)10 mgper 2 Capsule(s)DSLD:230732
- Nature's AnswerWild & Pure Resveratrol + 500 mg Trans-ResveratrolJapanese Knotweed (Polygonum cuspidatum) (root) extract500 mgper 1 Capsule(s)DSLD:264286
- Nature's BountyHealthy HairPolygonum cuspidatum extract · Resveratrol (Form: from Polygonum cuspidatum extract PlantPart: root Genus: Polygonum Species: cuspidatum)10 mgper 2 Capsule(s)DSLD:240149
- Nature's Bounty Optimal SolutionsKeratin FormulaPolygonum cuspidatum extract · Resveratrol (Form: from Polygonum cuspidatum extract PlantPart: root Genus: Polygonum Species: cuspidatum)10 mgper 2 Capsule(s)DSLD:49568
- Nature's CraftMenopause SupportPolygonum cuspidatum Root Extract1 mgper 2 Capsule(s)DSLD:296777
- Nature's CraftResveratrolPolygonum cuspidatum · complex containing 50% trans-resveratrol1,200 mgper 2 Veggie Capsule(s)DSLD:296720
- Nature's LabOne Daily MultivitaminJapanese Knotweed · Trans-Resveratrol (Form: from Japanese Knotweed PlantPart: root Genus: Polygonum Species: cuspidatum)3.2 mgper 1 Capsule(s)DSLD:205404
- Nature's LabOne Daily MultivitaminJapanese Knotweed · Trans-Resveratrol (Form: from Japanese Knotweed PlantPart: root Genus: Polygonum Species: cuspidatum)3.2 mgper 1 Capsule(s)DSLD:205516
- Nature's LabSix Daily Advanced MultivitaminPolygonum cuspidatum extract · Resveratrol (Form: from Polygonum cuspidatum extract (Form: standaridized to 50% Resveratrol) PlantPart: root Genus: Polygonum Species: cuspidatum)25 mgper 6 Capsule(s)DSLD:207064
- Nature's LabSuper Antioxidant SupportPolygonum cuspidatum20 mgper 2 Vegetarian Capsule(s)DSLD:334728
- Nature's NutritionAdvanced Heart Health 1648 mg15 mgper 1 Capsule(s)DSLD:271187
- Nature's WayAlive! Daily Energy Complete MultivitaminJapanese Knotweed Root Extract700 mcgper 1 Tablet(s)DSLD:327855
- Nature's WayAlive! Energy 50+ Complete MultivitaminJapanese Knotweed extract900 mcgper 1 Tablet(s)DSLD:267674
- NatureCityTrueResveratrolTrans-Resveratrol · 98% trans-Resveratrol75 mgper 1 Capsule(s)DSLD:283384
- Natures PlusSource of Life Gold TabletsGrape seed concentrate50 mgper 3 Tablet(s)DSLD:248867
- NaturesPlusGHT MaleGrape · Trans Resveratrol Complex (Form: from Grape PlantPart: seed Genus: Vitis Species: vinifera, Polygonum cuspidatum Genus: Polygonum Species: cuspidatum)100 mgper 3 Capsule(s)DSLD:250538
- NaturesPlusHeartBeatPolygonum cuspidatum standardized root extract · Resveratrol (Form: from Polygonum cuspidatum standardized root extract PlantPart: root Genus: Polygonum Species: cuspidatum)25 mgper 3 Heart-Shaped Tablet(s)DSLD:249811
- NaturesPlusSource of Life Gold Drink Mix Delicious Tropical Fruit Flavor50 mgper 18 Gram(s)DSLD:298608
- NaturesPlusSource of Life Gold Mini-TabsGrape Seed Extract50 mgper 6 Tablet(s)DSLD:266114
- NaturesPlusSource of Life Gold TabletsGrape Seed Extract50 mgper 3 Tablet(s)DSLD:266116
- NaturesPlusVitamin D3 5000 IU (125 mcg) with ResveratrolPolygonum cuspidatum Root Extract · alcohol-free25 mgper 1 Extended Release Tablet(s)DSLD:298637
- NaturesPlus AgeLossBlood Pressure SupportGrape whole fruit extract · PentaTrol Brand 5-Tier Trans-Resveratrol (Form: from Polygonum cuspidatum Genus: Polygonum Species: cuspidatum, Grape whole fruit extract PlantPart: whole fruit) Note: 146 glasses of red wine100 mgper 3 Tablet(s)DSLD:249509
- NaturesPlus Source of LifeGold Liquid Delicious Tropical Fruit FlavorGrape seed concentrate25 mgper 29.57 mLDSLD:319169
- NBX WellnessSoothe Support ProPolygonum cuspidatum Root Extract50 mgper 1 Capsule(s)DSLD:327705
- NeoCellResveratrol Antioxidant{Resveratrol} Oligomers · Trans-Resveratrol Note: In a base of (Form: Vitis vinifera Genus: Vitis Species: vinifera Note: naturally containing trans-e viniferin, oligo stilbenes , Resveratrol Monomers, {Resveratrol} Oligomers, Muscadine Grape seed powder PlantPart: seed, Oligomeric Proanthocyanidin (Form: from Grape seed extract PlantPart: seed Genus: Vitis Species: vinifera-PC 95) (Alt. Name: OPC), Quercetin flavonols, Pomegranate extract (Form: 70% Ellagic Acid)) Genus: Vitis Species: vinifera Note: In a base of100 mgper 5 Capsule(s)DSLD:35294
- NeoLifeTreGrape skin extract500 mcgper 1 Fluid Ounce(s)DSLD:303239
- NeurobiologixMito Cell PQQPolygonum cuspidatum Root Extract100 mgper 0.5 Capsule(s)DSLD:327691
- NeurobiologixPEA Soothe SupportPolygonum cuspidatum Root Extract50 mgper 1 Capsule(s)DSLD:327698
- New SunAdvanced IN-F PlusPolygonum cuspidatum root extract10 mgper 1 Veg Capsule(s)DSLD:313653
- New SunAdvanced ProstateJapanese Knotweed extract · natural Trans-Resveratrol (Form: from Japanese Knotweed extract PlantPart: root Genus: Polygonum Species: cuspidatum)10 mgper 2 Softgel(s)DSLD:244747
- New VitalityRuby RedsJapanese Knotweed Root Extract10 mgper 10.31 Gram(s)DSLD:277274
- NewtonEverettResveratrol with Grape Seed Extract 260 mgResveratrol Note: root250 mgper 1 Softgel(s)DSLD:213206
- NewtonEverettStriagen-DSPolygonum cuspidatum extract · Resveratrol (Form: Polygonum cuspidatum extract PlantPart: root Genus: Polygonum Species: cuspidatum) Note: 50%10 mgper 2 Capsule(s)DSLD:213227
- NewtonEverettSuperFlex-3 AdvancedTrans-Resveratrol Note: 50% extract2.5 mgper 1 Packet(s)DSLD:213177
- NooCubeBrain Productivity99%14.3 mgper 2 Capsule(s)DSLD:269068
- Nora RossResveratrol Plusamount not statedper 1 Capsule(s)DSLD:319539
- NOWADAM CapsulesJapanese Knotweed extract10 mgper 3 Veg Capsule(s)DSLD:313553
- NOWADAM TabletsJapanese Knotweed extract5 mgper 1 Tablet(s)DSLD:313556
- NOWADAM TabletsJapanese Knotweed extract5 mgper 1 Tablet(s)DSLD:314833
- NOWClinical Strength Prostate HealthJapanese Knotweed extract · natural Trans-Resveratrol (Form: from Japanese Knotweed extract PlantPart: root Genus: Polygonum Species: cuspidatum)10 mgper 3 Softgel(s)DSLD:314105
- NOWD-FlamePolygonum cuspidatum root extract · Resveratrol (Form: from Polygonum cuspidatum root extract PlantPart: root Genus: Polygonum Species: cuspidatum)10 mgper 1 Veg Capsule(s)DSLD:245748
- NuMedicaLiposomal CoQ10 PQQ 5 mgPolygonum cuspidatum Root Extract10 mgper 6 mLDSLD:323552
- NusaPureMenopause ComplexPolygonum cuspidatum Root Extract1 mgper 2 Capsule(s)DSLD:307345
- NusaPureResveratrol 500 mgPolygonum cuspidatum extract500 mgper 2 Capsule(s)DSLD:246928
- NutraBioResveratrolPolygonum cuspidatum Root Extract500 mgper 1 Vegetarian Capsule(s)DSLD:278729
- NutraBioTrans-Resveratrol250 mgper 0.5 Gram(s)DSLD:51149
- NutraBioTrans-Resveratrol 100 Milligrams100 mgper 1 Vegetable Capsule(s)DSLD:51150
- NutraBioTrans-Resveratrol 100 Milligrams100 mgper 1 Vegetable Capsule(s)DSLD:51151
- NutraBioTrans-Resveratrol 100 Milligrams100 mgper 1 Vegetable Capsule(s)DSLD:79851
- NutraBioTrans-Resveratrol 250 mg250 mgper 1 Vegetable Capsule(s)DSLD:248251
- NutraBioTrans-Resveratrol 250 Milligrams250 mgper 1 Vegetable Capsule(s)DSLD:51154
- NutraChampsResveratrolPolygonum cuspidatum root extract · Trans-Resveratrol (Form: Polygonum cuspidatum root extract PlantPart: root Genus: Polygonum Species: cuspidatum, std. to 50% Trans-Resveratrol)1,200 mgper 2 Capsule(s)DSLD:228981
- NutraChampsResveratrolPolygonum cuspidatum Root Extract · standardized to contain 50% resveratrol1,200 mgper 2 Capsule(s)DSLD:338144
- NutracraftMenoMaxPolygonum cuspidatum extract · Trans-Resveratrol (Form: from Polygonum cuspidatum extract PlantPart: root Genus: Polygonum Species: cuspidatum)1 mgper 2 Capsule(s)DSLD:246532
- NutraMedixResveratrolJapanese Knotweed Root Extract200 mgper 1 Capsule(s)DSLD:334052
- NutraOneShredOnePolygonum cuspidatum · Resveratrol (Form: Polygonum cuspidatum Genus: Polygonum Species: cuspidatum) Note: 50%50 mgper 3 Capsule(s)DSLD:172508
- NutraPro (Neutraceutical Corp.)Healthy Heart15 mgper 3 Capsule(s)DSLD:253174
- Nutri-WestTotal VeggieResveratrol extract Note: 20%7 mgper 1 Tablet(s)DSLD:29076
- NutriCologyGlucevia Complex with Chromiumpure Trans-Resveratrol · Resveratrol (Form: as 98% pure Trans-Resveratrol)250 mgper 2 Capsule(s)DSLD:235557
- NutriCologyQuatreActiv Folate Plus with Enhanced Antioxidant SupportPolygonum cuspidatum extract · Trans-Resveratrol (Form: from Polygonum cuspidatum extract Genus: Polygonum Species: cuspidatum)25 mgper 1 Capsule(s)DSLD:199593
- NutricostCognitive Complex50 mgper 2 Capsule(s)DSLD:77114
- NutricostResveratrol 500 mgJapanese Knotweed · 50% Trans-Resveratrol500 mgper 1 Capsule(s)DSLD:269797
- Nutrients for HealthRejuvenate Plus for WomenPolygonum cuspidatum Root Extract1 mgper 2 Capsule(s)DSLD:316941
- Nutrients for HealthResveratrol 250 mgResveratrol · trans-Resveratrol (Form: from 500 mg of 50% Resveratrol (Form: Polygonum cuspidatum root extract PlantPart: root Genus: Polygonum Species: cuspidatum))250 mgper 1 Capsule(s)DSLD:229550
- O OrgeuosQuercetin 1000 mgPolygonum cuspidatum Root Extract600 mgper 2 Capsule(s)DSLD:325829
- OL Olympian LabsAgelessResveratrol Note: 20%275 mgper 3 Softgel(s)DSLD:175962
- OL Olympian Labs The Optimal BlendAgelessResveratrol Note: 20%183 mgper 2 Softgel(s)DSLD:39019
- OL Olympian Labs The Optimal BlendHeart Health FormulaResveratrol Note: (20%) (yielding)183 mgper 2 Softgel(s)DSLD:53713
- OLLYMighty MojoJapanese Knotweed Root Extract30 mgper 1 Capsule(s)DSLD:316118
- Olympus LabsSup3r Pct50%200 mgper 4 Capsule(s)DSLD:278267
- ON Optimum NutritionPro Pre Fruit Fusion75 mgper 18 Gram(s)DSLD:179674
- ON Optimum NutritionPro Pre Grape Candy75 mgper 18 Gram(s)DSLD:179684
- ON Optimum NutritionPro Pre Juicy Watermelon75 mgper 18 Gram(s)DSLD:179692
- ON Optimum NutritionPro Pre Strawberry Burst75 mgper 18 Gram(s)DSLD:179691
- OnnitTotal MitochondriaResveratrol · MicroActive Resveratrol (Form: standardized to 30% Resveratrol)167 mgper 1 Capsule(s)DSLD:208906
- Oregon HealthMulti-Guard50 mgper 2 Capsule(s)DSLD:180726
- Oregon HealthMulti-Guard50 mgper 2 Capsule(s)DSLD:180741
- Ormus MineralsBlood Sugar Stabilizer20%amount not statedper 4 Capsule(s)DSLD:269136
- Ortho Molecular ProductsAlpha Base Premier PacksPolygonum cuspidatum · trans-Resveratrol (Form: from Polygonum cuspidatum PlantPart: roots Genus: Polygonum Species: cuspidatum)50 mgper 1 Packet(s)DSLD:176591
- Ortho Molecular ProductsAlpha Base Premier PacksPolygonum cuspidatum · trans-Resveratrol (Form: from Polygonum cuspidatum PlantPart: roots Genus: Polygonum Species: cuspidatum)50 mgper 1 Packet(s)DSLD:176632
- Ortho Molecular ProductsFemarinPolygonum cuspidatum · trans-Resveratrol (Form: from Polygonum cuspidatum PlantPart: roots Genus: Polygonum Species: cuspidatum)4 mgper 1 Capsule(s)DSLD:175149
- Ortho Molecular ProductsMitocorePolygonum cuspidatum · trans-Resveratrol (Form: from Polygonum cuspidatum PlantPart: roots Genus: Polygonum Species: cuspidatum)10 mgper 2 Capsule(s)DSLD:174394
- Ortho Molecular ProductsMitocorePolygonum cuspidatum · trans-Resveratrol (Form: from Polygonum cuspidatum PlantPart: roots Genus: Polygonum Species: cuspidatum)10 mgper 2 Capsule(s)DSLD:174406
- Ortho Molecular ProductsMitocorePolygonum cuspidatum · trans-Resveratrol (Form: from Polygonum cuspidatum PlantPart: roots Genus: Polygonum Species: cuspidatum)10 mgper 2 Capsule(s)DSLD:277576
- Ortho Molecular ProductsMitocore LemonPolygonum cuspidatum10 mgper 29.6 Gram(s)DSLD:313466
- Ortho Molecular ProductsMitocore StrawberryPolygonum cuspidatum10 mgper 29.6 Gram(s)DSLD:313467
- Ortho Molecular ProductsResvoxitrolPolygonum cuspidatum100 mgper 2 Capsule(s)DSLD:294151
- Pathway To HealingBasic Nutrient Support Tablet5 mgper 5 Tablet(s)DSLD:14984
- Patient One 1 MediNutritionalsRejuvenate OnePolygonum cuspidatum root extract · Trans-Resveratrol (Form: from Polygonum cuspidatum root extract PlantPart: root Genus: Polygonum Species: cuspidatum)100 mgper 2 Capsule(s)DSLD:47951
- PCOS Nutrition Center Resveratrol ProtectJapanese Knotweed200 mgper 1 Capsule(s)DSLD:274567
- Peak Pure & NaturalPeak Chelation+ResveratrolTrans-Resveratrol150 mgper 3 Capsule(s)DSLD:333605
- Perfect SupplementsPerfect ResGrape ResveratrolPolygonum cuspidatum200 mgper 2 Capsule(s)DSLD:288120
- PharmaFreak PfEstro-X Freak efJapanese Knotweed Root Extract100 mgper 2 Capsule(s)DSLD:272232
- Pharmaxa LabsProvasilJapanese Knotweed Root Extract25 mgper 1 Tablet(s)DSLD:306938
- Premier Research LabsPremier ResveratrolGiant Knotweed extract180 mgper 5 mLDSLD:269341
- Primal BlueprintMaster FormulaPolygonum cuspidatum100 mgper 6 Capsule(s)DSLD:286797
- Primal BlueprintPrimal Damage ControlJapanese Knotweed50 mgper 1 Capsule(s)DSLD:286796
- ProCapsMen's Elite 100 with Maximum Essential Omega-3 500 mgPolygonum cuspidatum root extract100 mgper 1 Packet(s)DSLD:331583
- ProCapsMen's Founder'sPolygonum cuspidatum (root) extract200 mgper 1 Packet(s)DSLD:331584
- ProCapsResveratrol 100Polygonum cuspidatum Root Extract100 mgper 1 Capsule(s)DSLD:331592
- ProCapsUltimate Anti-Oxidant ExtractsPolygonum cuspidatum Root Extract20 mgper 2 Capsule(s)DSLD:331605
- ProCapsWomen's Elite 100 with Maximum Essential Omega-3 500 mgPolygonum cuspidatum Root Extract100 mgper 1 Packet(s)DSLD:331635
- ProCapsWomen's Founder'sPolygonum cuspidatum Root Extract200 mgper 1 Packet(s)DSLD:331636
- ProCaps LaboratoriesAndrew's Five FavoritesPolygonum cuspidatum root extract · Resveratrol (Form: from Polygonum cuspidatum root extract PlantPart: root Genus: Polygonum Species: cuspidatum)200 mgper 2 Capsule(s)DSLD:248401
- ProCaps LaboratoriesAndrew's Five FavoritesPolygonum cuspidatum root extract200 mgper 3 Capsule(s)DSLD:320058
- ProCaps LaboratoriesAndrew's Five FavoritesPolygonum cuspidatum root extract200 mgper 3 Capsule(s)DSLD:331512
- ProCaps LaboratoriesAndrew's Five FavoritesPolygonum cuspidatum (root) extract · Resveratrol (Form: from Polygonum cuspidatum (root) extract PlantPart: root Genus: Polygonum Species: cuspidatum)100 mgper 3 Capsule(s)DSLD:4673
- ProCaps LaboratoriesFruit Full Anti-Oxidant ExtractsPolygonum cuspidatum Root Extract20 mgper 1 Capsule(s)DSLD:320117
- ProCaps LaboratoriesFruit Full Anti-Oxidant Extracts Bulk PowderPolygonum cuspidatum Root Extract20 mgper 471 mgDSLD:320116
- ProCaps LaboratoriesMen's Elite 100Polygonum cuspidatum (root) extract100 mgper 1 Packet(s)DSLD:320159
- ProCaps LaboratoriesMen's Elite 100 with Maximum Essential Omega-3 1,000 mgPolygonum cuspidatum Root Extract100 mgper 1 Packet(s)DSLD:320160
- ProCaps LaboratoriesMen's Elite 100 with Maximum Essential Omega-3 500 mgPolygonum cuspidatum root extract100 mgper 1 Packet(s)DSLD:320161
- ProCaps LaboratoriesMen's Elite 200Polygonum cuspidatum (root) extract200 mgper 1 Packet(s)DSLD:320162
- ProCaps LaboratoriesMen's Founder'sPolygonum cuspidatum (root) extract200 mgper 1 Packet(s)DSLD:320163
- ProCaps LaboratoriesMen's Life Rx Elite Plus Maximum Essential Omega-3Polygonum cuspidatum (root) extract · Resveratrol (Form: from Polygonum cuspidatum (root) extract PlantPart: root Genus: Polygonum Species: cuspidatum)100 mgper 8 Capsule(s)DSLD:29935
- ProCaps LaboratoriesMen's Life Rx UltimatePolygonum cuspidatum (root) extract · Resveratrol (Form: from Polygonum cuspidatum (root) extract PlantPart: root Genus: Polygonum Species: cuspidatum)100 mgper 8 Capsule(s)DSLD:4718
- ProCaps LaboratoriesMillion ORAC Standardized ExtractsPolygonum cuspidatum (root) extract · Resveratrol (Form: from Polygonum cuspidatum (root) extract PlantPart: root Genus: Polygonum Species: cuspidatum)20 mgper 1 Capsule(s)DSLD:275275
- ProCaps LaboratoriesMillion ORAC Standardized ExtractsPolygonum cuspidatum (root) extract · Resveratrol (Form: from Polygonum cuspidatum (root) extract PlantPart: root Genus: Polygonum Species: cuspidatum)20 mgper 1 Capsule(s)DSLD:29548
- ProCaps LaboratoriesResveratrol 100 Green Tea EGCG 100 Pomegranate Extract 40:40Polygonum cuspidatum (root) extract · Resveratrol (Form: from Polygonum cuspidatum (root) extract PlantPart: root Genus: Polygonum Species: cuspidatum)100 mgper 1 Capsule(s)DSLD:57368
- ProCaps LaboratoriesResveratrol 100 with EGCG 100Polygonum cuspidatum Root Extract100 mgper 1 Capsule(s)DSLD:320267
- ProCaps LaboratoriesResveratrol 100 with Green Tea 100, Grape Seed 100, and Pomegranate 100Polygonum cuspidatum Root Extract100 mgper 1 Capsule(s)DSLD:320269
- ProCaps LaboratoriesResveratrol 100 With Pomegranate 40:40Polygonum cuspidatum (root) extract · Resveratrol (Form: from Polygonum cuspidatum (root) extract PlantPart: root Genus: Polygonum Species: cuspidatum)100 mgper 1 Capsule(s)DSLD:69420
- ProCaps LaboratoriesResveratrol 200Polygonum cuspidatum Root Extract200 mgper 1 Capsule(s)DSLD:320268
- ProCaps LaboratoriesResveratrol- 50 mg EGCG - 100 mgPolygonum cuspidatum (root) extract · Resveratrol (Form: from Polygonum cuspidatum (root) extract PlantPart: root Genus: Polygonum Species: cuspidatum)50 mgper 1 Capsule(s)DSLD:4670
- ProCaps LaboratoriesResveratrol-100Polygonum cuspidatum (root) extract · Resveratrol (Form: from Polygonum cuspidatum (root) extract PlantPart: root Genus: Polygonum Species: cuspidatum)100 mgper 1 Capsule(s)DSLD:29468
- ProCaps LaboratoriesResveratrol-100 With Pomegranate 40:40Polygonum cuspidatum (root) extract · Resveratrol (Form: from Polygonum cuspidatum (root) extract PlantPart: root Genus: Polygonum Species: cuspidatum)100 mgper 1 Capsule(s)DSLD:29554
- ProCaps LaboratoriesWomen's Elite 100Polygonum cuspidatum Root Extract100 mgper 1 Packet(s)DSLD:320314
- ProCaps LaboratoriesWomen's Elite 100 with Maximum Essential Omega-3 1,000 mgPolygonum cuspidatum Root Extract100 mgper 1 Packet(s)DSLD:320315
- ProCaps LaboratoriesWomen's Elite 100 with Maximum Essential Omega-3 500 mgPolygonum cuspidatum Root Extract100 mgper 1 Packet(s)DSLD:320316
- ProCaps LaboratoriesWomen's Elite 200Polygonum cuspidatum Root Extract200 mgper 1 Packet(s)DSLD:320317
- ProCaps LaboratoriesWomen's Founder'sPolygonum cuspidatum Root Extract200 mgper 1 Packet(s)DSLD:320318
- ProCaps LaboratoriesWomen's Life Rx ElitePolygonum cuspidatum (root) extract · Resveratrol (Form: from Polygonum cuspidatum (root) extract PlantPart: root Genus: Polygonum Species: cuspidatum)100 mgper 6 Capsule(s)DSLD:29931
- ProCaps LaboratoriesWomen's Life Rx ElitePolygonum cuspidatum (root) extract · Resveratrol (Form: from Polygonum cuspidatum (root) extract PlantPart: root Genus: Polygonum Species: cuspidatum)100 mgper 6 Capsule(s)DSLD:4728
- ProCaps LaboratoriesWomen's Life Rx Elite Plus Maximum Essential Omega-3Polygonum cuspidatum (root) extract · Resveratrol (Form: from Polygonum cuspidatum (root) extract PlantPart: root Genus: Polygonum Species: cuspidatum)100 mgper 8 Capsule(s)DSLD:29945
- ProCaps LaboratoriesWomen's Life Rx UltimatePolygonum cuspidatum (root) extract · Resveratrol (Form: from Polygonum cuspidatum (root) extract PlantPart: root Genus: Polygonum Species: cuspidatum)100 mgper 8 Capsule(s)DSLD:4707
- ProCaps LaboratoriesWorld HealthPolygonum cuspidatum (root) extract40 mgper 2 Capsule(s)DSLD:331639
- ProEnzolFemale Balance5 mgper 1 Vegan Capsule(s)DSLD:244160
- Progressive Professional from Progressive LaboratoriesBP NaturalJapanese Knotweed13 mgper 2 Capsule(s)DSLD:261205
- Progressive Professional from Progressive LaboratoriesPro-Antho ForteJapanese Knotweed10 mgper 1 Vegetable Capsule(s)DSLD:263132
- Progressive Professional from Progressive LaboratoriesTrans Resveratrol with QuercetinJapanese Knotweed · Profile Proven125 mgper 1 Vegetable Capsule(s)DSLD:263232
- Protocol For Life BalanceClinical Strength Prostate-BJapanese Knotweed Root Extract10 mgper 3 Softgel(s)DSLD:337791
- Protocol For Life BalanceD-FlamePolygonum cuspidatum root extract · Resveratrol (Form: from Polygonum cuspidatum root extract PlantPart: root Genus: Polygonum Species: cuspidatum)10 mgper 1 Veg Capsule(s)DSLD:77418
- Protocol For Life BalanceOrtho Multi For MenJapanese Knotweed extract · natural Trans-Resveratrol (Form: from Japanese Knotweed extract PlantPart: root Genus: Polygonum Species: cuspidatum)10 mgper 3 Veg Capsule(s)DSLD:73527
- Pure AdvantageMRP Chocolate12 mgper 69 Gram(s)DSLD:180795
- Pure AdvantageMRP Vanilla12 mgper 69 Gram(s)DSLD:180822
- Pure EncapsulationsBalanced ImmuneJapanese Knotweed Root Extract100 mgper 1 Capsule(s)DSLD:299032
- Pure EncapsulationsDaily Pure Pack LongevityJapanese Knotweed (Polygonum cuspidatum) extract150 mgper 3 Capsule(s)DSLD:261870
- Pure EncapsulationsDaily Pure Pack Menopause SupportresVida25 mgper 1 Packet(s)DSLD:261872
- Pure EncapsulationsEndoLOXTrans-Resveratrol · resVida Resveratrol (Form: as Trans-Resveratrol)12.5 mgper 1 Capsule(s)DSLD:185288
- Pure EncapsulationsMemory ProJapanese Knotweed (Polygonum cuspidatum) extract · Trans-Resveratrol (Form: from Japanese Knotweed (Polygonum cuspidatum) extract PlantPart: root Genus: Polygonum Species: cuspidatum)20 mgper 3 Capsule(s)DSLD:277771
- Pure EncapsulationsMemory ProJapanese Knotweed (Polygonum cuspidatum) extract · Trans-Resveratrol (Form: from Japanese Knotweed (Polygonum cuspidatum) extract PlantPart: root Genus: Polygonum Species: cuspidatum)20 mgper 3 Capsule(s)DSLD:277772
- Pure EncapsulationsMenoViveTrans-Resveratrol · resVida Resveratrol (Form: as Trans-Resveratrol)12.5 mgper 1 Capsule(s)DSLD:277775
- Pure EncapsulationsMetabolic XtraTrans-Resveratrol · resVida Resveratrol (Form: as Trans-Resveratrol)20 mgper 1 Capsule(s)DSLD:246350
- Pure EncapsulationsMetabolic XtraTrans-Resveratrol20 mgper 1 Capsule(s)DSLD:287431
- Pure EncapsulationsMetabolic XtraTrans-Resveratrol20 mgper 1 Capsule(s)DSLD:294024
- Pure EncapsulationsMitochondria-ATPJapanese Knotweed (Polygonum cuspidatum) extract · Trans-Resveratrol (Form: from Japanese Knotweed (Polygonum cuspidatum) extract PlantPart: root Genus: Polygonum Species: cuspidatum)25 mgper 2 Capsule(s)DSLD:185118
- Pure EncapsulationsMitochondria-ATPJapanese Knotweed (Polygonum cuspidatum) extract · Trans-Resveratrol (Form: from Japanese Knotweed (Polygonum cuspidatum) extract PlantPart: root Genus: Polygonum Species: cuspidatum)25 mgper 2 Capsule(s)DSLD:219690
- Pure EncapsulationsMitochondria-ATPJapanese Knotweed extract30 mgper 2 Capsule(s)DSLD:294028
- Pure EncapsulationsMitochondria-ATPJapanese Knotweed Root Extract30 mgper 2 Capsule(s)DSLD:299751
- Pure EncapsulationsNR Longevity150 mgper 2 Capsule(s)DSLD:313541
- Pure EncapsulationsNrf2 DetoxTrans-Resveratrol · resVida Resveratrol (Form: as Trans-Resveratrol)15 mgper 1 Capsule(s)DSLD:277961
- Pure EncapsulationsNrf2 DetoxResveratrol15 mgper 1 Capsule(s)DSLD:299077
- Pure EncapsulationsRENUALJapanese Knotweed (Polygonum cuspidatum) extract · Trans-Resveratrol (Form: from Japanese Knotweed (Polygonum cuspidatum) extract PlantPart: root Genus: Polygonum Species: cuspidatum)150 mgper 2 Caplique(R) Capsule(s)DSLD:278350
- Pure EncapsulationsResCu-SRMicroActive Resveratrol · Trans-Resveratrol (Form: from MicroActive Resveratrol Note: sustained-release complex)100 mgper 1 Capsule(s)DSLD:187546
- Pure EncapsulationsResveratrolJapanese Knotweed (Polygonum cuspidatum) extract · Trans-Resveratrol (Form: from Japanese Knotweed (Polygonum cuspidatum) extract PlantPart: root Genus: Polygonum Species: cuspidatum)40 mgper 1 Capsule(s)DSLD:278351
- Pure EncapsulationsResveratrolJapanese Knotweed (Polygonum cuspidatum) extract · Trans-Resveratrol (Form: from Japanese Knotweed (Polygonum cuspidatum) extract PlantPart: root Genus: Polygonum Species: cuspidatum)40 mgper 1 Capsule(s)DSLD:278352
- Pure EncapsulationsResveratrol ExtraJapanese Knotweed (Polygonum cuspidatum) extract · Trans-Resveratrol (Form: from Japanese Knotweed (Polygonum cuspidatum) extract PlantPart: root Genus: Polygonum Species: cuspidatum)100 mgper 1 Capsule(s)DSLD:187549
- Pure EncapsulationsResveratrol ExtraJapanese Knotweed (Polygonum cuspidatum) extract · Trans-Resveratrol (Form: from Japanese Knotweed (Polygonum cuspidatum) extract PlantPart: root Genus: Polygonum Species: cuspidatum)100 mgper 1 Capsule(s)DSLD:187551
- Pure EncapsulationsResveratrol VESIsorbresVida100 mgper 2 Caplique Capsule(s)DSLD:294053
- Pure EncapsulationsRevitalAge UltraTrans-Resveratrol · resVida Resveratrol (Form: as Trans-Resveratrol)30 mgper 3 Capsule(s)DSLD:247312
- Pure EncapsulationsRevitalAge UltraTrans-Resveratrol30 mgper 3 Capsule(s)DSLD:287467
- Pure EncapsulationsRevitalAge UltraJapanese Knotweed extract30 mgper 3 Capsule(s)DSLD:294054
- Pure EncapsulationsRevitalAge UltraJapanese Knotweed Root Extract30 mgper 3 Capsule(s)DSLD:299752
- Pure EncapsulationsUltra Pure PackJapanese Knotweed extract · Trans-Resveratrol (Form: as Japanese Knotweed extract PlantPart: root Genus: Polygonum Species: cuspidatum)100 mgper 7 Capsule(s)DSLD:247017
- Pure PrescriptionsResveratrol 100 mgRed Wine Polyphenols · Resveratrol Proprietary extract (Form: 25% Trans-Resveratrol, 20% Red Wine Polyphenols Note: non-GMO)100 mgper 1 Capsule(s)DSLD:228218
- Pure SynergySuperPure Resveratrolamount not statedper 1 Capsule(s)DSLD:246625
- Pure VeganAntioxidant Formula100 mgper 3 Capsule(s)DSLD:231543
- PureBulk.comResveratrol Pure250 mgper 250 mgDSLD:23246
- PureMax Labs YummyViteHeart Health15 mgper 1 Capsule(s)DSLD:315442
- PureMax Labs YummyViteMenopause Support Herbal FormulaPolygonum cuspidatum Root Extract1 mgper 2 Capsule(s)DSLD:318899
- PureMax Labs YummyViteSuper AntioxidantsPolygonum cuspidatum Root Extract20 mgper 2 Vegetable Capsule(s)DSLD:318904
- Purest VantageTrans-Resveratrol 600 mgPolygonum cuspidatum extract · Standardized to 50%600 mgper 2 Capsule(s)DSLD:276280
- PurHEALTHResveratrol 1500 mgPolygonum cuspidatum1,500 mgper 3 Capsule(s)DSLD:200356
- Puritan's PrideGrape Seed Extract 60 mgPolygonum cuspidatum30 mcgper 2 Capsule(s)DSLD:286265
- Puritan's PrideQ-Sorb Co Q-10, Resveratrol & GrapeseedPolygonum cuspidatum100 mgper 1 Softgel(s)DSLD:286016
- Puritan's PrideResveratrol & PycnogenolPolygonum cuspidatum root extract100 mgper 1 Softgel(s)DSLD:286000
- Puritan's PrideResveratrol 100 mgPolygonum cuspidatum root extract100 mgper 1 Softgel(s)DSLD:318319
- Puritan's PrideResveratrol 100 mgPolygonum cuspidatum root extract100 mgper 1 Softgel(s)DSLD:318347
- Puritan's PrideResveratrol 250 mg plus Red Wine Extract 10 mgPolygonum cuspidatum Root Extract250 mgper 1 Softgel(s)DSLD:318320
- Puritan's PrideResveratrol 500 mgPolygonum cuspidatum500 mgper 1 Capsule(s)DSLD:285997
- Puritan's PrideResveratrol 500 mgPolygonum cuspidatum Root Extract500 mgper 1 Capsule(s)DSLD:285998
- Puritan's PrideUltra Man MaxPolygonum cuspidatum25 mgper 2 Caplet(s)DSLD:318336
- Puritan's PrideUltra Woman Collagen SupportPolygonum cuspidatum100 mgper 2 Capsule(s)DSLD:250630
- Puritan's Pride PremiumResveratrol 100 mgPolygonum cuspidatum root extract100 mgper 1 Softgel(s)DSLD:286001
- Puritan's Pride PremiumResveratrol 50 mgPolygonum cuspidatum extract · Resveratrol (Form: from Polygonum cuspidatum extract PlantPart: root Genus: Polygonum Species: cuspidatum)50 mgper 1 Softgel(s)DSLD:26002
- Purity ProductsChris Kilham's Green Tea CRPolygonum cuspidatum (root) extract · Trans-Resveratrol (Form: from Polygonum cuspidatum (root) extract PlantPart: root Genus: Polygonum Species: cuspidatum)10 mgper 2 Vegetarian Capsule(s)DSLD:243419
- Purity ProductsChris Kilham's Green Tea CR PhytosomePolygonum cuspidatum · Trans-Resveratrol (Form: from Polygonum cuspidatum PlantPart: root Genus: Polygonum Species: cuspidatum)40 mgper 2 Vegetarian Capsule(s)DSLD:243420
- Purity ProductsCoQ10 Daily Melt with ResveratrolresVida Resveratrol · trans-Resveratrol (Form: from resVida Resveratrol)30 mgper 2 Fast Dissolving Tablet(s)DSLD:243507
- Purity ProductsCoQ10 Daily Super BoostPolygonum cuspidatum Root Extract10 mgper 2 Vegetarian Capsule(s)DSLD:243672
- Purity ProductsMagResPolygonum cuspidatum (root) extract · Trans-Resveratrol (Form: from Polygonum cuspidatum (root) extract PlantPart: root Genus: Polygonum Species: cuspidatum)25 mgper 2 Vegetarian Capsule(s)DSLD:243835
- Purity ProductsMagRes + ProbioticPolygonum cuspidatum (root) extract · Trans-Resveratrol (Form: from Polygonum cuspidatum (root) extract PlantPart: root Genus: Polygonum Species: cuspidatum)40 mgper 3 Vegetarian Capsule(s)DSLD:243836
- Purity ProductsNiteVitesPolygonum cuspidatum root extract · Trans-Resveratrol (Form: from Polygonum cuspidatum root extract PlantPart: root Genus: Polygonum Species: cuspidatum)10 mgper 3 Tablet(s)DSLD:243871
- Purity ProductsNiteVites Extra StrengthPolygonum cuspidatum root extract · Trans-Resveratrol (Form: from Polygonum cuspidatum root extract PlantPart: root Genus: Polygonum Species: cuspidatum)10 mgper 3 Tablet(s)DSLD:243904
- Purity ProductsPerfect PurplesPolygonum cuspidatum root extract · Trans-Resveratrol (Form: from Polygonum cuspidatum root extract PlantPart: root Genus: Polygonum Species: cuspidatum)5 mgper 9 Gram(s)DSLD:244039
- Purity ProductsUbiquinol DailyresVida High-Potency Resveratrol · trans-Resveratrol (Form: from resVida High-Potency Resveratrol)30 mgper 2 Capsule(s)DSLD:244255
- Purity ProductsWomen's Perfect MultiJapanese Knotweed Root Extract · Resveratrol (Form: from Japanese Knotweed root extract PlantPart: root)40 mgper 4 Tablet(s)DSLD:244321
- Quality Of LifeResveratrol-SRResveratrol · sustained-release complex150 mgper 1 Vegicap(s)DSLD:299348
- Quicksilver ScientificDr. Shade's The OneJapanese Knotweed Root Extract · Resveratrol (Form: from Japanese Knotweed root extract PlantPart: root)15 mgper 1 Teaspoon(s)DSLD:248523
- Rainbow NutrientsNAD+Polygonum cuspidatum root extract · 20:1, equivalent to 6,000 mg of raw polygonum cuspidatum root300 mgper 2 Capsule(s)DSLD:333646
- Raw Forest FoodsEstrogen Detox50 mgper 4 Capsule(s)DSLD:309784
- Real HealthProstate CompleteTrans-Resveratrol · Resveratrol (Form: Trans-Resveratrol) Note: provided by8 mgper 1 Softgel Capsule(s)DSLD:245034
- Real HealthProstate Complete with Saw PalmettoTrans-Resveratrol · Resveratrol (Form: Trans-Resveratrol) Note: provided by8 mgper 1 Softgel Capsule(s)DSLD:214064
- Rejuvenation ScienceMaximum Vitality20 mgper 2 Tablet(s)DSLD:206219
- RejuviCareAge Defying Hair, Skin & Nails Renewal FormulaPolygonum cuspidatum root extract · Resveratrol (Form: from Polygonum cuspidatum root extract PlantPart: root Genus: Polygonum Species: cuspidatum)10 mgper 2 Caplet(s)DSLD:46455
- Renue By ScienceLipo Resveratrol125 mgper 1 Vegetarian Capsule(s)DSLD:286891
- Renue By ScienceLipo Trans-ResveratrolGreater than 98%125 mgper 1 Vegetarian Capsule(s)DSLD:318997
- Renue By ScienceNAD+ w/ Resveratrol Lipo Gel50 mgper 2 mLDSLD:286898
- Renue By ScienceNMN w/ Resveratrol Lipo Gel40 mgper 2 mLDSLD:319025
- Renue By SciencePure Resveratrol500 mgper 0.5 Gram(s)DSLD:286908
- Renue By SciencePure Trans-Resveratrolgreater than 98%500 mgper 0.5 Gram(s)DSLD:319007
- Renue By ScienceResveratrol w/ Curcumin Lipo Gel125 mgper 2 mLDSLD:319026
- Reserveage BeautyResveratrol Gummies Grape FlavoredJapanese Knotweed Rhizome Extract100 mgper 2 Gummy(ies)DSLD:327283
- Rise-N-ShineAntioxidants ExtremePolygonum cuspidatum Root Extract10 mgper 1 Capsule(s)DSLD:297105
- Rise-N-ShineMenopause SupportPolygonum cuspidatum Root Extract0.5 mgper 1 Capsule(s)DSLD:297089
- Rise-N-ShineWrinkle Vitaminsfrom5 mgper 1 Capsule(s)DSLD:297130
- RM Red Mountain Weight LossResveratrol98%200 mgper 1 Capsule(s)DSLD:268270
- RoexEssentially AllPolygonum cuspidatum10 mgper 3 Tablet(s)DSLD:279331
- RunFit NutritionRunner's Sleep RecoveryPolygonum cuspidatum · std. to 50% Trans-Resveratrol20 mgper 2 Capsule(s)DSLD:286063
- RVB 300RVB 300Polygonum cuspidatum100 mgper 1 Capsule(s)DSLD:277502
- Seeking HealthOptimal Liposomal Curcumin with Resveratrol75 mgper 3 mLDSLD:210975
- SeniorLife HealthWomen's Natural BalancePolygonum cuspidatum extract1 mgper 2 Capsule(s)DSLD:256566
- ShakleeCoQHeartPolygonum cuspidatum640 mcgper 1 Capsule(s)DSLD:5033
- ShakleeCoQHeart with Q-TrolPolygonum cuspidatum2 mgper 1 Softgel(s)DSLD:210137
- ShakleeCoQHeart with Q-TrolPolygonum cuspidatum2 mgper 1 Softgel(s)DSLD:301188
- ShakleeKosher VivixTrans-Resveratrol PlantPart: root Genus: Polygonum Species: cuspidatum Note: standardized to a minimum of 98% purity100 mgper 1 tspDSLD:5054
- ShakleeTriple Strength CoQHeart With Q-Trol2 mgper 1 Softgel(s)DSLD:17531
- ShakleeVivix Cellular Anti-Aging TonicPolygonum cuspidatum · Trans-Resveratrol (Form: Polygonum cuspidatum PlantPart: root Genus: Polygonum Species: cuspidatum) Note: standardized to a minimum of 98% purity100 mgper 1 tspDSLD:2936
- SigmaCeuticalKnee, Hip & Joint Complex2.5 mgper 1 Capsule(s)DSLD:255964
- SigmaCeuticalSuper AntioxidantsPolygonum cuspidatum Root Extract20 mgper 2 Capsule(s)DSLD:321755
- SolgarResveratrol 100 mg100 mgper 1 Vegetable Capsule(s)DSLD:201611
- SolgarResveratrol 250 mg with Red Wine ExtractTrans-Resveratrol Note: from250 mgper 1 Softgel(s)DSLD:218658
- SolgarResveratrol 250 mg with Red Wine ExtractTrans-Resveratrol Note: from250 mgper 1 Softgel(s)DSLD:218664
- SolgarResveratrol 500 mgTrans-Resveratrol Note: from500 mgper 1 Vegetable Capsule(s)DSLD:44483
- Source NaturalsAgeless MindPolygonum cuspidatum root extract · natural Trans-Resveratrol (Form: from Polygonum cuspidatum root extract PlantPart: root Genus: Polygonum Species: cuspidatum)66 mgper 1 Tablet(s)DSLD:181668
- Source NaturalsAgeless MindPolygonum cuspidatum root extract · natural Trans-Resveratrol (Form: from Polygonum cuspidatum root extract PlantPart: root Genus: Polygonum Species: cuspidatum)66 mgper 1 Tablet(s)DSLD:181678
- Source NaturalsAgeless MindPolygonum cuspidatum root extract · natural Trans-Resveratrol (Form: from Polygonum cuspidatum root extract PlantPart: root Genus: Polygonum Species: cuspidatum)66 mgper 1 Tablet(s)DSLD:181686
- Source NaturalsBlood Pressure ResponsePolygonum cuspidatum · Total Resveratrol (Form: from Polygonum cuspidatum Genus: Polygonum Species: cuspidatum)24 mgper 3 Tablet(s)DSLD:214394
- Source NaturalsBlood Pressure ResponsePolygonum cuspidatum · Total Resveratrol (Form: from Polygonum cuspidatum Genus: Polygonum Species: cuspidatum)24 mgper 3 Tablet(s)DSLD:214396
- Source NaturalsBlood Pressure ResponsePolygonum cuspidatum · Total Resveratrol (Form: from Polygonum cuspidatum Genus: Polygonum Species: cuspidatum)24 mgper 3 Tablet(s)DSLD:214397
- Source NaturalsBlood Pressure ResponsePolygonum cuspidatum · Total Resveratrol (Form: from Polygonum cuspidatum Genus: Polygonum Species: cuspidatum)24 mgper 5 Tablet(s)DSLD:214719
- Source NaturalsDiet-PhenPolygonum cuspidatum root extract · Resveratrol (Form: from Polygonum cuspidatum root extract PlantPart: root Genus: Polygonum Species: cuspidatum)6 mgper 1 Tablet(s)DSLD:213980
- Source NaturalsDiet-PhenPolygonum cuspidatum Root Extract · Resveratrol (Form: from Polygonum cuspidatum root extract PlantPart: root Genus: Polygonum Species: cuspidatum)6 mgper 1 Tablet(s)DSLD:213985
- Source NaturalsDiet-PhenPolygonum cuspidatum root extract · Resveratrol (Form: from Polygonum cuspidatum root extract PlantPart: root Genus: Polygonum Species: cuspidatum)6 mgper 1 Tablet(s)DSLD:213987
- Source NaturalsHeart SciencePolygonum cuspidatum Root Extract40 mgper 3 Tablet(s)DSLD:274660
- Source NaturalsInflama TrimPolygonum cuspidatum root extract5 mgper 2 Tablet(s)DSLD:295891
- Source NaturalsInflama-RestPolygonum cuspidatum extract100 mgper 4 Tablet(s)DSLD:274674
- Source NaturalsInflama-RestPolygonum cuspidatum Root Extract100 mgper 4 Tablet(s)DSLD:295892
- Source NaturalsLife Force MultiplePolygonum cuspidatum root ext. · natural Trans-Resveratrol (Form: from Polygonum cuspidatum root ext. PlantPart: root Genus: Polygonum Species: cuspidatum )20 mgper 2 Tablet(s)DSLD:272910
- Source NaturalsLife Force MultiplePolygonum cuspidatum root ext. · natural Trans-Resveratrol (Form: from Polygonum cuspidatum root ext. PlantPart: root Genus: Polygonum Species: cuspidatum )20 mgper 2 Tablet(s)DSLD:273038
- Source NaturalsLife Force MultiplePolygonum cuspidatum root extract · natural Trans-Resveratrol (Form: from Polygonum cuspidatum root extract PlantPart: root Genus: Polygonum Species: cuspidatum)20 mgper 2 Tablet(s)DSLD:273040
- Source NaturalsLife Force MultiplePolygonum cuspidatum root ext. · natural Trans-Resveratrol (Form: from Polygonum cuspidatum root ext. PlantPart: root Genus: Polygonum Species: cuspidatum )20 mgper 4 Capsule(s)DSLD:273202
- Source NaturalsLife Force MultiplePolygonum cuspidatum root extract20 mgper 4 Capsule(s)DSLD:273219
- Source NaturalsLife Force MultiplePolygonum cuspidatum root ext. · natural Trans-Resveratrol (Form: from Polygonum cuspidatum root ext. PlantPart: root Genus: Polygonum Species: cuspidatum )20 mgper 4 Capsule(s)DSLD:274820
- Source NaturalsLife Force MultiplePolygonum cuspidatum root ext. · natural Trans-Resveratrol (Form: from Polygonum cuspidatum root ext. PlantPart: root Genus: Polygonum Species: cuspidatum )20 mgper 4 Capsule(s)DSLD:274819
- Source NaturalsLife Force MultiplePolygonum cuspidatum Root Extract · Natural20 mgper 2 Tablet(s)DSLD:295961
- Source NaturalsLife Force MultiplePolygonum cuspidatum root ext. · natural Trans-Resveratrol (Form: from Polygonum cuspidatum root ext. PlantPart: root Genus: Polygonum Species: cuspidatum )20 mgper 2 Tablet(s)DSLD:75453
- Source NaturalsLife Force Multiple No IronPolygonum cuspidatum root extract · natural Trans-Resveratrol (Form: from Polygonum cuspidatum root extract PlantPart: root Genus: Polygonum Species: cuspidatum)20 mgper 2 Tablet(s)DSLD:274836
- Source NaturalsScreen Time Stamina30 mgper 3 Tablet(s)DSLD:75647
- Source NaturalsScreen Time StaminaPolygonum cuspidatum root extract · natural Trans-Resveratrol (Form: from Polygonum cuspidatum root extract PlantPart: root Genus: Polygonum Species: cuspidatum)30 mgper 3 Tablet(s)DSLD:75652
- Source NaturalsScreen Time StaminaPolygonum cuspidatum root extract · natural Trans-Resveratrol (Form: from Polygonum cuspidatum root extract PlantPart: root Genus: Polygonum Species: cuspidatum)30 mgper 3 Tablet(s)DSLD:75655
- Source NaturalsTelomeronPolygonum cuspidatum root extract100 mgper 4DSLD:275456
- Source NaturalsTop 10 HealersPolygonum cuspidatum root extract · natural Trans-Resveratrol (Form: from Polygonum cuspidatum root extract PlantPart: root Genus: Polygonum Species: cuspidatum)200 mgper 1 Tablet(s)DSLD:78353
- Source NaturalsTop 10 HealersPolygonum cuspidatum root extract · natural Trans-Resveratrol (Form: from Polygonum cuspidatum root extract PlantPart: root Genus: Polygonum Species: cuspidatum)200 mgper 1 Tablet(s)DSLD:78358
- Source NaturalsVegan True Vegan Force MultiplePolygonum cuspidatum root ext. · natural Trans-Resveratrol (Form: from Polygonum cuspidatum root ext. PlantPart: root Genus: Polygonum Species: cuspidatum )20 mgper 2 Tablet(s)DSLD:79153
- Spring ValleyResveratrol 250 mg Plus Red Wine ExtractPolygonum cuspidatum extract · Resveratrol (Form: from Polygonum cuspidatum extract PlantPart: root Genus: Polygonum Species: cuspidatum)250 mgper 1 Softgel(s)DSLD:65048
- Stop Aging NowMax-Q10 UltraJapanese Knotweedamount not statedper 1 Softgel(s)DSLD:206818
- Stop Aging NowRED-Q10Japanese Knotweed50 mgper 2 Veggie Capsule(s)DSLD:278479
- SunergeticPterostilbeneJapanese Knotweed extract200 mgper 2 Vegetable Capsule(s)DSLD:276830
- Sunfood SuperfoodsLiposomal Immune Boost100 mgper 1 Ounce(s)DSLD:218589
- Sunshine NaturalsResveratrol with Co Q10 & Hawthorne BerriesResveratrol Note: 50%200 mgper 1 Capsule(s)DSLD:49804
- Super NutritionActive Women's MultivitaminPolygonum cuspidatum Root Extract4 mgper 3 Tablet(s)DSLD:338998
- Superior SourceResveratrol 100 mg3, 5, 4'-Trihydroxy-Trans-Stilbene100 mgper 1 MicroLingual(R) Tablet(s)DSLD:212743
- SuperSmartAntiOxidant SynergyPolygonum cuspidatum · 98%50 mgper 2 Capsule(s)DSLD:332332
- SuperSmartNatural Skin Formula62.5 mgper 1 Capsule(s)DSLD:332464
- SuperSmartResveratrolcomprising40 mgper 1 Capsule(s)DSLD:332730
- SuperSmartResveratrol Synergyfrom100 mgper 1 Capsule(s)DSLD:332731
- SuperSmartTrans-Resveratrol200 mgper 1 Capsule(s)DSLD:332754
- Supplement SpotHealthy Skin10 mgper 2 Capsule(s)DSLD:264598
- Supplement SpotResvertatrolfrom250 mgper 1 Vegetable Capsule(s)DSLD:328360
- SwansonHair Revitalizing FormulaPolygonum cuspidatum Root Extract2.5 mgper 1 Tablet(s)DSLD:337831
- SwansonHawthorn, Resveratrol, Cayenne & Garlic150 mgper 1 Veggie Capsule(s)DSLD:308596
- SwansonIndole-3-Carbinol with ResveratrolPolygonum cuspidatum Root Extract · 200:1 standardized Polygonum cuspidatum Root Extract5 mgper 1 Capsule(s)DSLD:308606
- SwansonPure HeartPolygonum cuspidatum Root Extract150 mgper 1 Veggie Capsule(s)DSLD:185236
- SwansonResveratrol 250 mgPolygonum cuspidatum Root Extract250 mgper 1 Capsule(s)DSLD:308735
- SwansonResveratrol 50 mgPolygonum cuspidatum Root Extract50 mgper 1 Capsule(s)DSLD:188866
- SwansonResveratrol Complex30 mgper 1 Capsule(s)DSLD:337776
- Swiss BioEnergeticsB3 Nicotinamide100 mgper 2 Capsule(s)DSLD:284222
- Swiss BioEnergeticsUltra-Resveratrol 150 mg150 mgper 1 Capsule(s)DSLD:284380
- Swole AFEscobar Tropical ParadisePolygonum cuspidatum · 50%25 mgper 5.5 Gram(s)DSLD:262194
- Systemic FormulaseNRG LQ Quantum Cellular ATP Energyamount not statedper 0.5 Dropper(s)DSLD:22506
- T.S. SupplementsRezVera40 mgper 1 Capsule(s)DSLD:37637
- Terra OriginReds Superfoods Kiwi StrawberryJapanese Knotweed Root Extract10 mgper 8.3 Gram(s)DSLD:242093
- Terra OriginResveratrol PlusJapanese Knotweed Root Extract100 mgper 1 Capsule(s)DSLD:248007
- Terra OriginYouthful SkinJapanese Knotweed Root Extract · Resveratrol (Form: from Japanese Knotweed root extract PlantPart: root)100 mgper 1 Capsule(s)DSLD:242134
- Terra OriginYouthful SkinJapanese Knotweed Root Extract · Resveratrol (Form: from Japanese Knotweed root extract PlantPart: root)100 mgper 1 Capsule(s)DSLD:276231
- The Genius BrandGenius EternalPolygonum cuspidatum Root Extract100 mgper 2 Veggie Capsule(s)DSLD:321104
- The Health GuardianCardio for Life Grape Flavor50 mgper 1 Level Scoop(s)DSLD:260033
- The Vitamin ShoppeUltimate Woman GoldPolygonum cuspidatum extract100 mgper 3 Tablet(s)DSLD:204324
- The Vitamin ShoppeUltimate Woman GoldPolygonum cuspidatum extract100 mgper 3 Tablet(s)DSLD:204329
- ThorneL-Arginine Plus50 mgper 3 Capsule(s)DSLD:336346
- ThornePolyResveratrol-SR100 mgper 2 Capsule(s)DSLD:284255
- ThornePolyResveratrol-SR100 mgper 2 Capsule(s)DSLD:336336
- ThorneSynaQuell125 mgper 7.8 Gram(s)DSLD:337875
- TN Trusted NutrientsResveratrol500 mgper 2 Capsule(s)DSLD:214398
- tnvitaminsResveratrol 100 mgPolygonum cuspidatum100 mgper 1 Capsule(s)DSLD:217625
- Totally ProductsWrinkle Remove with Resveratrol10 mgper 2 Capsule(s)DSLD:294196
- Trace Minerals ResearchLiquid Multi Vitamin-Mineral25 mgper 2 TbspDSLD:4609
- True HealthDr. Cutler's Ultimate Res350 mgper 1 Capsule(s)DSLD:16824
- TRUNATUREGrape Seed & Resveratrol75 mgper 1 Tablet(s)DSLD:277493
- TRUNATUREGrape Seed & Resveratrol30 mgper 1 Tablet(s)DSLD:81694
- TRUNATUREMaximum Strength Resveratrol 250 mgTrans-Resveratrol250 mgper 1 Softgel(s)DSLD:25840
- TRUNATUREResveratrol Plus 250 mgPolygonum cuspidatum · Resveratrol (Form: Trans-Resveratrol, standardized from Polygonum cuspidatum PlantPart: root Genus: Polygonum Species: cuspidatum)250 mgper 1 Vegetarian Capsule(s)DSLD:239464
- Trusted NutrientsResveratrol500 mgper 2 Capsule(s)DSLD:266193
- VERSOCell Being250 mgper 2 Capsule(s)DSLD:333268
- ViandaRudofilPolygonum cuspidatum extract40 mgper 3 Capsule(s)DSLD:176322
- Vibrant HealthPlant-Based Vitamin CKnotweed root extract2 mgper 2 Capsule(s)DSLD:323211
- ViMultiCoffee-SlimResveratrol extract Note: 10%5 mgper 1 Capsule(s)DSLD:52884
- VincoMultiMen'sResveratrol Note: 50%10 mgper 1 Tablet(s)DSLD:206495
- VincoMultiWomen'sResveratrol Note: 50%10 mgper 1 Tablet(s)DSLD:206503
- Vinco'sResveratrol with Red Wine ExtractPolygonum cuspidatum · Trans-Resveratrol (Form: from 500 mg of Polygonum cuspidatum PlantPart: root Genus: Polygonum Species: cuspidatum Note: 50% standardized extract)250 mgper 1 Softgel(s)DSLD:33985
- Vita LogicInflama FreeJapanese Knotweed · Trans-Resveratrol (Form: from Japanese Knotweed)8 mgper 2 Vegetarian Capsule(s)DSLD:248177
- VitabasePain RXPolygonum cuspidatum · Resveratrol (Form: 15- 20% Polygonum cuspidatum Genus: Polygonum Species: cuspidatum)5 mgper 2 Capsule(s)DSLD:6209
- VitabaseResveratrol High Quality 50 mgpolygonum cuspidatum · Resveratrol (Form: from polygonum cuspidatum)50 mgper 1 Vegetarian Capsule(s)DSLD:6691
- VitabaseSuper Fruit Formula20 mgper 1 Capsule(s)DSLD:6706
- VitabaseSuper Fruit Formula20 mgper 1 Capsule(s)DSLD:6707
- VitabaseWrinkle Free Skin FormulaPolygonum cuspidatum extract · Resveratrol (Form: from 20 mg of 50% Polygonum cuspidatum extract Genus: Polygonum Species: cuspidatum)10 mgper 2 Capsule(s)DSLD:6772
- VitaCeutical LabsCardio Support SoftgelsPolygonum cuspidatum · Resveratrol (Form: from Polygonum Cuspidatum)25 mgper 1 Softgel(s)DSLD:6276
- VitacostSynergy 3000 Multi-VitaminPolygonum cuspidatum extract · Resveratrol (Form: from Polygonum cuspidatum extract (Form: standaridized to 50% Resveratrol) PlantPart: root Genus: Polygonum Species: cuspidatum)25 mgper 6 Capsule(s)DSLD:45624
- Vitacost SynergyOnce Daily Multi-VitaminJapanese Knotweed extract · Trans-Resveratrol (Form: from Japanese Knotweed extract) PlantPart: root10 mgper 1 Capsule(s)DSLD:207788
- Vital NutrientsHormone BalancePolygonum cuspidatum · Standardized to 50% Resveratrol10 mgper 1 Vegetarian Capsule(s)DSLD:305053
- VitalsExtra High Potency ResveratrolPolygonum cuspidatum · complex containing 50% trans-resveratrol600 mgper 1 Capsule(s)DSLD:316153
- Vitamin Research ProductsExtension Resveratrol 300 mgJapanese Knotweed (Polygonum cuspidatum) root extract · Trans-Resveratrol (Form: from Japanese Knotweed (Polygonum cuspidatum) Root Extract PlantPart: root Genus: Polygonum Species: cuspidatum)300 mgper 1 Capsule(s)DSLD:33997
- Vitamin Research ProductsKandidaPlexJapanese Knotweed (Polygonum cuspidatum) root extract · Trans-Resveratrol (Form: from Japanese Knotweed (Polygonum cuspidatum) Root Extract PlantPart: root Genus: Polygonum Species: cuspidatum)10 mgper 1 Capsule(s)DSLD:34001
- Vitamin WorldDouble Strength Youth Guard Resveratrol 100 mgPolygonum cuspidatum100 mgper 1 Softgel(s)DSLD:1484
- Vitamin WorldMaximum Strength Resveratrol Youth Guard 500 mg500 mgper 1 Capsule(s)DSLD:1290
- Vitamin WorldUltra Man Max Daily MultiPolygonum cuspidatum25 mgper 2 Caplet(s)DSLD:21154
- Vitamin WorldUltra Man Max Daily MultiPolygonum cuspidatum25 mgper 2 Caplet(s)DSLD:21270
- Vitamin WorldUltra Man Max Daily MultiPolygonum cuspidatum · Resveratrol (Form: from Polygonum cuspidatum PlantPart: root Genus: Polygonum Species: cuspidatum)25 mgper 2 Caplet(s)DSLD:240125
- Vitamin WorldUltra Woman Collagen SupportPolygonum cuspidatum · Resveratrol (Form: from Polygonum cuspidatum PlantPart: root Genus: Polygonum Species: cuspidatum)100 mgper 2 Capsule(s)DSLD:20464
- Vitamin WorldUltra Woman Max Daily MultiPolygonum cuspidatum extract · Resveratrol (Form: from Polygonum cuspidatum extract PlantPart: root Genus: Polygonum Species: cuspidatum)25 mgper 2 Caplet(s)DSLD:240146
- Vitamin WorldUltra Woman Max Daily MultiPolygonum cuspidatum extract · Resveratrol (Form: from Polygonum cuspidatum extract PlantPart: root Genus: Polygonum Species: cuspidatum)25 mgper 2 Caplet(s)DSLD:64853
- Vitamin WorldYouth Guard Resveratrol 250 mg Plus Red Wine Extract 10 mgPolygonum cuspidatum extract · Resveratrol (Form: from Polygonum cuspidatum extract PlantPart: root Genus: Polygonum Species: cuspidatum)250 mgper 1 Softgel(s)DSLD:65933
- VitaMonkEstroTraxTrans-Resveratrol Note: 98% standardized100 mgper 2 Capsule(s)DSLD:242132
- VitaMonkResveratrol & PterostilbeneJapanese Knotweed · Trans-Resveratrol (Form: from Japanese Knotweed PlantPart: root Genus: Polygonum Species: cuspidatum Note: std. min 50%)600 mgper 1 Capsule(s)DSLD:242167
- Vite MDAge Defying Skincare VitaminResveratrol 50% Extract Note: provides 2 mgs. Trans Resveratrol400 mgper 1 Capsule(s)DSLD:2499
- Viva VitaminsGreater-GreensResveratrol Note: root25 mgper 9.5 Gram(s)DSLD:238714
- WarriorForceWarrior Shield Antioxidant300 mgper 2 VeganCap(s)(TM)DSLD:28622
- Wellthy NutraceuticalsCleanseJapanese Knotweed1 mgper 2 Capsule(s)DSLD:248176
- Whitaker NutritionPhytoNutrient EssentialsJapanese Knotweed · Resveratrol (Form: from Japanese Knotweed PlantPart: root)4 mgper 1 Capsule(s)DSLD:230643
- Whitaker NutritionPhytoNutrient EssentialsJapanese Knotweed4 mgper 1 Capsule(s)DSLD:288248
- Whitaker NutritionTriveratrol GoldJapanese Knotweed · Trans Resveratrol (Form: from Japanese Knotweed PlantPart: root) (Alt. Name: ResVinol)100 mgper 2 Capsule(s)DSLD:230604
- Whitaker NutritionTriveratrol GoldJapanese Knotweed · Trans Resveratrol (Form: from Japanese Knotweed PlantPart: root) (Alt. Name: ResVinol)100 mgper 2 Capsule(s)DSLD:288244
- Whitaker NutritionTriveratrol PlusJapanese Knotweed · Trans Resveratrol (Form: from Japanese Knotweed PlantPart: root) (Alt. Name: ResVinol)100 mgper 2 Capsule(s)DSLD:201654
- WholeHealthExtra Strength Resveratrol 325 mgPolygonum cuspidatum root extract · Trans-Resveratrol (Form: from Polygonum cuspidatum root extract PlantPart: root Genus: Polygonum Species: cuspidatum Note: 50%)325 mgper 1 Capsule(s)DSLD:248505
- WholeHealthExtra Strength Resveratrol 325 mgPolygonum cuspidatum root extract325 mgper 1 Capsule(s)DSLD:248507
- Wholly LiquidDeFlam250 mgper 15 mLDSLD:272100
- Wholly YouNMN Plus50 mgper 1 Capsule(s)DSLD:275744
- Williams NutritionAdvanced Phytonutrient ShieldJapanese Knotweed4 mgper 1 Capsule(s)DSLD:267406
- Williams NutritionAdvanced Phytonutrient ShieldJapanese Knotweed Root Extract4 mgper 1 Capsule(s)DSLD:287811
- WindmillMulti Vitamin With Minerals & Green Tea2 mgper 2 Tablet(s)DSLD:7201
- Windmill Rx Premium VitaminsAdvanced Diabetic Multivitamin Formula2 mgper 2 Caplet(s)DSLD:7435
- Windmill Rx Premium VitaminsMen's 50+ Multi Vitamin & Mineral Formula2 mgper 2 Caplet(s)DSLD:7398
- Windmill Rx Premium VitaminsMen's Multi Vitamin & Mineral Formula2 mgper 2 Caplet(s)DSLD:7418
- Windmill Rx Premium VitaminsTotal Cardio Health Formula2 mgper 1 Capsule(s)DSLD:7425
- Windmill Rx Premium VitaminsWomen's 50+ Multi Vitamin & Mineral Formula2 mgper 2 Caplet(s)DSLD:7428
- Windmill Rx Premium VitaminsWomen's Multi Vitamin & Mineral Formula2 mgper 2 Caplet(s)DSLD:7431
- WiseLife NaturalsKeto XR50 mgper 1 Capsule(s)DSLD:258693
- Wonder LaboratoriesResveratrol 200 mgTiger Cane200 mgper 1 Tablet(s)DSLD:262052
- Wonder LaboratoriesResveratrol 200 mgTiger Cane200 mgper 1 Tablet(s)DSLD:262403
- Wonder LaboratoriesResveratrol 50 mgJapanese Knotweed50 mgper 1 Softgel(s)DSLD:215603
- Wonder LaboratoriesResveratrol 50 mg Japanese KnotweedJapanese Knotweed50 mgper 1 Softgel(s)DSLD:260492
- Wonder LaboratoriesTrans Resveratrol 200 mgJapanese Knotweed200 mgper 1 Vegetable Capsule(s)DSLD:325887
- Wonder LaboratoriesTrans-Resveratrol Japanese Knotweed 50 mgJapanese Knotweed50 mgper 1 Vegetable Capsule(s)DSLD:315245
- XtendlifeCardio-KlenzJapanese Knotweed · Trans-Resveratrol (Form: from Japanese Knotweed PlantPart: root)25 mgper 6 Tablet(s)DSLD:17014
- XtendlifeCardio-SupportJapanese Knotweed · Trans-Resveratrol (Form: from Japanese Knotweed PlantPart: root)25 mgper 6 Tablet(s)DSLD:82166
- XtendlifeNeuro-Natural GeneralJapanese Knotweed · Trans-Resveratrol (Form: from Japanese Knotweed PlantPart: root)25 mgper 3 Tablet(s)DSLD:82170
- XtendlifeNeuro-Natural SerenityJapanese Knotweed · Trans-Resveratrol (Form: from Japanese Knotweed PlantPart: root)15 mgper 3 Tablet(s)DSLD:82185
- XtendlifeNeuro-Natural SleepJapanese Knotweed · Trans-Resveratrol (Form: from Japanese Knotweed PlantPart: root)15 mgper 3 Tablet(s)DSLD:82194
- XtendlifeNR6Japanese Knotweed100 mgper 1 Capsule(s)DSLD:318037
- XtendlifeTotal Balance Children'sJapanese Knotweed5 mgper 3 Tablet(s)DSLD:318023
- XtendlifeTotal Balance Men'sJapanese Knotweed7 mgper 4 Tablet(s)DSLD:331308
- XtendlifeTotal Balance Men's PremiumJapanese Knotweed25 mgper 7 Tablet(s)DSLD:331309
- XtendlifeTotal Balance Unisex PremiumJapanese Knotweed25 mgper 6 Tablet(s)DSLD:283408
- XtendlifeTotal Balance Women'sJapanese Knotweed7 mgper 4 Tablet(s)DSLD:331311
- XtendlifeTotal Balance Women's PremiumJapanese Knotweed25 mgper 7 Tablet(s)DSLD:331312
- XYMOGENActivNutrients PerformancePolygonum cuspidatum extract10 mgper 4 Capsule(s)DSLD:294616
- XYMOGENFemquilPolygonum cuspidatum20 mgper 2 Capsule(s)DSLD:303685
- XYMOGENMemorAllPolygonum cuspidatum Root Extract1 mgper 1 Capsule(s)DSLD:288087
- XYMOGENMemorAllPolygonum cuspidatum Root Extract1 mgper 1 Capsule(s)DSLD:303750
- XYMOGENResveratin PlusPolygonum cuspidatum Root Extract75 mgper 1 Capsule(s)DSLD:335560
- XYMOGENXenoProtXPolygonum cuspidatum Root Extract18.5 mgper 2 Capsule(s)DSLD:303861
- XyngularAxionPolygonum cuspidatum root extract · Resveratrol (Form: from Polygonum cuspidatum root extract PlantPart: root Genus: Polygonum Species: cuspidatum)5 mgper 2 Tablet(s)DSLD:206023
- YoungevityBeyond Tangy Tangerine 2.0Polygonum cuspidatum root extract · Trans-Resveratrol (Form: from Polygonum cuspidatum root extract PlantPart: root Genus: Polygonum Species: cuspidatum)50 mgper 4 Tablet(s)DSLD:209214
- youtheoryHeart Collagen + ResveratrolPure Trans-Resveratrol200 mgper 6 Tablet(s)DSLD:256976
- youtheoryResveratrolTrans-Resveratrol · resVida Resveratrol (Form: as Trans-Resveratrol)100 mgper 4 Tablet(s)DSLD:253007
- youtheoryResveratrolTrans-Resveratrol · resVida Resveratrol (Form: as Trans-Resveratrol)100 mgper 4 Tablet(s)DSLD:253012
- youtheoryResveratrolJapanese Knotweed (root) extract · Trans-Resveratrol (Form: as Japanese Knotweed (root) extract PlantPart: Root)250 mgper 4 Tablet(s)DSLD:253013
- youtheoryResveratrolJapanese Knotweed (root) extract · Trans-Resveratrol (Form: as Japanese Knotweed (root) extract PlantPart: Root)250 mgper 4 Tablet(s)DSLD:253014
- Zenith LabsBlood Sugar PremierPolygonum cuspidatum Root Extract10 mgper 2 Capsule(s)DSLD:326179
- Zenith LabsLongevity ActivatorPolygonum cuspidatum Root Extract25 mgper 1 Capsule(s)DSLD:326184
- ZHOUResveratrolPolygonum cuspidatum1,000 mgper 2 Vegetable Capsule(s)DSLD:250102
Label record: NIH Office of Dietary Supplements · CC0
Registered, and not reported
- Source
- ClinicalTrials.gov
- Intervention
- resveratrol
- Status
- Completed, terminated or suspended
- Results posted
- No
Trials without posted results
139 trials
139 registered trials without posted results · Overdue (FDAAA 801): 114 · Showing 120 of 139
114 past the window6 within it, or no actual date
- NCT05377242completed2026-06-22a university or hospital
- NCT07569744completed2026-06-01a university or hospital
- NCT06790771completed2026-03-15a university or hospital
- NCT06521333completed2025-12-30a university or hospital
- NCT07301515completed2025-11-10a university or hospital
- NCT06250283completed2025-10-30a university or hospital
- NCT06954649completed2025-02-24a government bodypast the reporting window
- NCT06914934completed2025-01-20a university or hospitalpast the reporting window
- NCT06763809completed2024-12-12industrypast the reporting window
- NCT04421079completed2024-12-02a university or hospitalpast the reporting window
- NCT05062486completed2024-11-07a university or hospitalpast the reporting window
- NCT05896878terminated— Product terminated2024-08-10a university or hospitalpast the reporting window
Show the remaining 127
- NCT04166396completed2024-07-30a university or hospitalpast the reporting window
- NCT03933163completed2024-03-28a university or hospitalpast the reporting window
- NCT05601180completed2024-01-15industrypast the reporting window
- NCT05653895completed2023-12-30a university or hospitalpast the reporting window
- NCT06131918completed2023-12-22a university or hospitalpast the reporting window
- NCT05982860completed2023-08-31a university or hospitalpast the reporting window
- NCT06383442completed2023-07-31a university or hospitalpast the reporting window
- NCT05981053completed2023-04-28industrypast the reporting window
- NCT06078163completed2023-03-04a university or hospitalpast the reporting window
- NCT05761327completed2023-02-18a university or hospitalpast the reporting window
- NCT06095635completed2023-01-10a university or hospitalpast the reporting window
- NCT05172947completed2022-12-01a university or hospitalpast the reporting window
- NCT04654689completed2022-11-12a university or hospitalpast the reporting window
- NCT04661267completed2022-10-31industrypast the reporting window
- NCT03819517completed2022-08-30a university or hospitalpast the reporting window
- NCT02502253completed2022-06-01a university or hospitalpast the reporting window
- NCT04886297completed2022-05-30a university or hospitalpast the reporting window
- NCT02905799completed2022-02-09a university or hospitalpast the reporting window
- NCT04867252completed2021-08-03a university or hospitalpast the reporting window
- NCT03563365terminated— Lack of Funding2021-03-02a university or hospitalpast the reporting window
- NCT04542993terminated— Difficulty accruing patients2021-02-05a university or hospitalpast the reporting window
- NCT04456829completed2020-11-10industrypast the reporting window
- NCT04666753completed2020-09-29industrypast the reporting window
- NCT01842399terminated— The protocol experienced slow accrual.2020-07-31NIHpast the reporting window
- NCT04723849completed2020-03-31a university or hospitalpast the reporting window
- NCT05306002completed2020-03-22a government bodypast the reporting window
- NCT04386499completed2020-03-11a university or hospitalpast the reporting window
- NCT04314739completed2019-12-19a university or hospitalpast the reporting window
- NCT03525379completed2019-10-08a university or hospitalpast the reporting window
- NCT03728777completed2019-10-01a university or hospitalpast the reporting window
- NCT02336633completed2019-10a university or hospitalpast the reporting window
- NCT03448094completed2019-07-13a university or hospitalpast the reporting window
- NCT04689412completed2019-03-31a university or hospitalpast the reporting window
- NCT02565979completed2019-03a university or hospitalpast the reporting window
- NCT02219906completed2019-02-07a university or hospitalpast the reporting window
- NCT03482401completed2018-12-01a government bodypast the reporting window
- NCT03446625completed2018-10-01a university or hospitalpast the reporting window
- NCT03349619completed2018-07-31a university or hospitalpast the reporting window
- NCT07634302completed2018-07-13a government bodypast the reporting window
- NCT04756310completed2018-04industrypast the reporting window
- NCT02909699completed2018-03-31a university or hospitalpast the reporting window
- NCT03683108completed2018-03a university or hospitalpast the reporting window
- NCT02549924terminated— no financial support2018-01-01a university or hospitalpast the reporting window
- NCT06961279completed2017-12-15a university or hospitalpast the reporting window
- NCT03509688completed2017-12a university or hospitalpast the reporting window
- NCT04258306completed2017-11-20a university or hospitalpast the reporting window
- NCT02245932completed2017-11a university or hospitalpast the reporting window
- NCT02314208completed2017-09-27a government bodypast the reporting window
- NCT02419092completed2017-09a university or hospitalpast the reporting window
- NCT03352895completed2017-07a university or hospitalpast the reporting window
- NCT02129595completed2017-04a university or hospitalpast the reporting window
- NCT03062163completed2017-02-06a university or hospitalpast the reporting window
- NCT02704494completed2017-02a university or hospitalpast the reporting window
- NCT02216552completed2017-01-01a university or hospitalpast the reporting window
- NCT02621554completed2017-01a university or hospitalpast the reporting window
- NCT03546530completed2017-01a university or hospitalpast the reporting window
- NCT03541993completed2016-12-22a university or hospitalpast the reporting window
- NCT02625376terminated2016-10-26a university or hospitalpast the reporting window
- NCT01219244completed2016-07a university or hospitalpast the reporting window
- NCT02244879completed2016-02a university or hospitalpast the reporting window
- NCT03546075completed2015-12-18a university or hospitalpast the reporting window
- NCT01716637completed2015-10a university or hospitalpast the reporting window
- NCT01720511completed2015-10a university or hospitalpast the reporting window
- NCT02616822completed2015-09a university or hospitalpast the reporting window
- NCT01714102completed2015-08a university or hospitalpast the reporting window
- NCT01489319terminated— The PI left Indiana University. The findings served as preliminary data for a recently awarded NIH R01 grant.2015-06a university or hospitalpast the reporting window
- NCT02415114completed2015-06industrypast the reporting window
- NCT02944097completed2015-05a university or hospitalpast the reporting window
- NCT03100019completed2015-04-30a university or hospitalpast the reporting window
- NCT01881347completed2015-03-01a university or hospitalpast the reporting window
- NCT01564381completed2015-03a university or hospitalpast the reporting window
- NCT01464801completed2015-02a university or hospitalpast the reporting window
- NCT02062190completed2015-01a university or hospitalpast the reporting window
- NCT02137421completed2014-08a university or hospitalpast the reporting window
- NCT02381145completed2014-05a university or hospitalpast the reporting window
- NCT01446276completed2014-04a university or hospitalpast the reporting window
- NCT01964846completed2014-03a university or hospitalpast the reporting window
- NCT02409537completed2014-03a university or hospitalpast the reporting window
- NCT02433925completed2014-01a university or hospitalpast the reporting window
- NCT01635114completed2013-12a university or hospitalpast the reporting window
- NCT02130440completed2013-12a university or hospitalpast the reporting window
- NCT01185067completed2013-11-04a university or hospitalpast the reporting window
- NCT01302639completed2013-10a university or hospitalpast the reporting window
- NCT01476592completed2013-10a university or hospitalpast the reporting window
- NCT01451918completed2013-09a university or hospitalpast the reporting window
- NCT01832584completed2013-09industrypast the reporting window
- NCT01412645completed2013-08a university or hospitalpast the reporting window
- NCT01593605completed2013-06a university or hospitalpast the reporting window
- NCT01782911completed2013-02-01a university or hospitalpast the reporting window
- NCT02030977completed2013-02a university or hospitalpast the reporting window
- NCT01126229completed2012-12a university or hospitalpast the reporting window
- NCT01364961completed2012-12a university or hospitalpast the reporting window
- NCT01794351completed2012-12a university or hospitalpast the reporting window
- NCT01747252completed2012-10industrypast the reporting window
- NCT02247596completed2012-10a university or hospitalpast the reporting window
- NCT01339884completed2012-08a university or hospitalpast the reporting window
- NCT01717820completed2012-08a university or hospitalpast the reporting window
- NCT01752868completed2012-08a university or hospitalpast the reporting window
- NCT01158417terminated— FDA clinical hold requiring IND submission, product not available in the market anymore2012-07-08a university or hospitalpast the reporting window
- NCT01321268terminated— sponsor stopped study due to recruitment problems2012-07industrypast the reporting window
- NCT01370889completed2012-07NIHpast the reporting window
- NCT01492114completed2012-02a university or hospitalpast the reporting window
- NCT01150955completed2011-11a university or hospitalpast the reporting window
- NCT01324089completed2011-11a university or hospitalpast the reporting window
- NCT01751750completed2011-09US federal agencypast the reporting window
- NCT01615445completed2011-08a university or hospitalpast the reporting window
- NCT01768507completed2011-03a university or hospitalpast the reporting window
- NCT01173640completed2011-02a university or hospitalpast the reporting window
Papers screened
2,736 papers
- Compound
- resveratrol
- Screened
- 2,736
- Admitted
- 24
- Discarded
- 1,570
- Not read
- 1,142
- Showing
- 200 of 2,736
Produced a finding24 papers
- PMID:324921382026-10-11
- PMID:333726792026-10-11
- PMID:344149042026-10-11
- PMID:353689302026-09-30
- PMID:354319942026-09-30
- PMID:377673992026-09-30
- PMID:405650042026-09-29
and 17 more.
Read and discarded1,570 papers
- PMID:28662290record read only — no claim pass ran (ADR-0092 §2)2026-10-12
- PMID:29034918record read only — no claim pass ran (ADR-0092 §2)2026-10-12
- PMID:26993301record read only — no claim pass ran (ADR-0092 §2)2026-10-12
- PMID:28012964record read only — no claim pass ran (ADR-0092 §2)2026-10-12
- PMID:28063505record read only — no claim pass ran (ADR-0092 §2)2026-10-12
- PMID:28315369record read only — no claim pass ran (ADR-0092 §2)2026-10-12
- PMID:28346848record read only — no claim pass ran (ADR-0092 §2)2026-10-12
- PMID:28672425record read only — no claim pass ran (ADR-0092 §2)2026-10-12
- PMID:28675763record read only — no claim pass ran (ADR-0092 §2)2026-10-12
- PMID:28796895record read only — no claim pass ran (ADR-0092 §2)2026-10-12
- PMID:28843911record read only — no claim pass ran (ADR-0092 §2)2026-10-12
- PMID:28945938record read only — no claim pass ran (ADR-0092 §2)2026-10-12
and 1,558 more.
Not read yet1,142 papers
- PMID:190884392026-10-12
- PMID:192394172026-10-12
- PMID:180464092026-10-12
- PMID:176302012026-10-07
- PMID:157853172026-09-29
- PMID:180960942026-09-29
- PMID:191674812026-09-29
- PMID:218523392026-09-29
- PMID:224398732026-09-29
- PMID:237368272026-09-29
- PMID:252522932026-09-29
- PMID:253454712026-09-29
and 1,130 more.
Measured, not recorded
- Compound
- resveratrol
- Endpoints measured
- 1,451 endpoints
- Recorded as a finding
- No
Show what was measured
rat sensitivity to pain following intracerebral resveratrol treatment
decreases
Novel observations point to the hypothesis that intracerebral resveratrol treatment diminishes the sensitivity of rats to pain, and that the said analgesic action of resveratrol is a central mechanism mediated by the inhibition of cycloxygenases I and II.
PMID:18092939 · one of two readings recorded this
sensitivity of rats to pain
Novel observations point to the hypothesis that intracerebral resveratrol treatment diminishes the sensitivity of rats to pain, and that the said analgesic action of resveratrol is a central mechanism mediated by the inhibition of cycloxygenases I and II.
PMID:18092939 · one of two readings recorded this
anticancer mechanisms (proapoptotic, antiproliferation, anti-inflammation)
The major mechanisms of actions through which resveratrol works include proapoptotic, antiproliferation, and anti-inflammation.
PMID:22432802 · one of two readings recorded this
tolerability and absorption in pharmacokinetic human studies
Pharmacokinetic human studies suggest good tolerability in healthy subjects, although they have low absorptive characteristics.
PMID:22432802 · one of two readings recorded this
GLUT4 expression in streptozotocin-induced diabetic rats
increases
Studies on rats with streptozotocin-induced diabetes have demonstrated that the expression of the insulin-dependent glucose transporter, GLUT4, is increased after resveratrol ingestion.
PMID:24841877 · one of two readings recorded this
mitochondrial fatty-acid oxidation (FAO) capacity in CPT2- and VLCAD-deficient patient fibroblasts
increases, +50% to +360%
By contrast, in all fibroblasts from patients with the mild, myopathic form, of the diseases, RSV induced increases in FAO capacities, ranging from +50% to +360%, resulting in restoration of normal FAO levels in most cases.
PMID:27136581 · one of two readings recorded this
body mass index/body weight, fat mass/fat volume/abdominal fat distribution, and inflammatory markers in overweight/obese adults (systematic review of 9 RCTs, vote-counted not pooled)
no effect
Not recorded as a finding: a review that discusses its trials without pooling them
Seven studies indicated no significant change in body mass index or body weight (P > 0.05), and three studies showed no improvements in fat mass, fat volume, or abdominal fat distribution (P > 0.05).
PMID:27379440 · one of two readings recorded this
body mass index / body weight
no effect
Seven studies indicated no significant change in body mass index or body weight (P > 0.05), and three studies showed no improvements in fat mass, fat volume, or abdominal fat distribution (P > 0.05).
PMID:27379440 · one of two readings recorded this
body mass index or body weight
no effect
Seven studies indicated no significant change in body mass index or body weight (P > 0.05), and three studies showed no improvements in fat mass, fat volume, or abdominal fat distribution (P > 0.05).
PMID:27379440 · one of two readings recorded this
fat mass / fat volume / abdominal fat distribution
no effect
Seven studies indicated no significant change in body mass index or body weight (P > 0.05), and three studies showed no improvements in fat mass, fat volume, or abdominal fat distribution (P > 0.05).
PMID:27379440 · one of two readings recorded this
fat mass, fat volume, or abdominal fat distribution
no effect
Seven studies indicated no significant change in body mass index or body weight (P > 0.05), and three studies showed no improvements in fat mass, fat volume, or abdominal fat distribution (P > 0.05).
PMID:27379440 · one of two readings recorded this
inflammatory markers
unclear
Four studies included measurements of inflammatory markers, with three of these finding resveratrol supplementation to have a significant positive effect (P > 0.05).
PMID:27379440 · both readings recorded this
cardiovascular prevention (endothelial dysfunction, hypertension, dyslipidemia, metabolic diseases)
decreases
Polyphenols and especially resveratrol largely contribute to CV prevention mainly through antioxidant properties
PMID:28521683 · one of two readings recorded this
Perivascular adipose tissue function
increases
Interestingly, resveratrol also improves PVAT function
PMID:28672425 · one of two readings recorded this
effectiveness against brain changes associated with aging
unclear
In comparison to resveratrol, pterostilbene appears to be more effective in combatting brain changes associated with aging.
PMID:29168580 · one of two readings recorded this
neuroprotective or therapeutic effects in mild cognitive impairment or Alzheimer's disease
no effect
The findings of available intervention trials of resveratrol in individuals with mild cognitive impairment or AD do not provide evidence of neuroprotective or therapeutic effects.
PMID:29168580 · one of two readings recorded this
protection against dementia syndromes (Alzheimer's disease, vascular dementia) in cellular and mammalian models
decreases
Numerous investigations in cellular and mammalian models have associated resveratrol and pterostilbene with protection against dementia syndromes such as Alzheimer's disease (AD) and vascular dementia.
PMID:29168580 · one of two readings recorded this
mediators of intestinal immunity
decreases
resveratrol may down-regulate mediators of intestinal immunity in rodent models
PMID:29191255 · one of two readings recorded this
metabolic stability and pharmacological activity, pterostilbene versus resveratrol
increases
Pterostilbene was found to be more metabolically stable and usually exhibited stronger pharmacological activities than that of resveratrol
PMID:29315886 · one of two readings recorded this
oral bioefficacy of resveratrol and pterostilbene
decreases
the bioefficacy of these compounds is greatly reduced when consumed orally due to their poor aqueous solubility, which leads to poor bioavailability
PMID:29322567 · one of two readings recorded this
differentially expressed genes linked to resveratrol treatment (cell cycle, proliferation, apoptosis)
Differentially expressed genes commonly linked to resveratrol treatment were linked to cell cycle, proliferation, and apoptosis.
PMID:29476886 · one of two readings recorded this
inhibitory activity against tumor cell lines including blood malignancies
decreases
Resveratrol has potent inhibitory activity in vitro against various tumor types, including cell lines derived from virtually all blood malignancies
PMID:30005817 · one of two readings recorded this
body weight and fat mass, glucose homeostasis, blood pressure, triglycerides, cholesterol, inflammation, oxidative stress, gut microbiota composition, narrated across cited rodent and human studies
unclear
In humans, however, most of the research published until now shows a lack of effect on body adiposity and body weight.
PMID:30400297 · one of two readings recorded this
efficacy in management of diabetes, cardiovascular and neurological diseases (clinical trials)
unclear
Following the pre-clinical studies, clinical trials on the same reveal the efficacy of resveratrol in the effective management of these diseases
PMID:30551481 · one of two readings recorded this
anti-inflammatory and anti-angiogenic effects of the combination of resveratrol and leuprolide acetate
decreases
Moreover, their combination decreased the activity of each therapeutical agent, mostly the anti-inflammatory and anti-angiogenic effects.
PMID:30781885 · one of two readings recorded this
cholesterol biosynthesis and HMGCR enzyme activity in human endometrial stromal cells
decreases
The results of this study indicated that resveratrol potentiated the inhibitory effects of simvastatin on cholesterol biosynthesis and the activity of the HMGCR enzyme.
PMID:30781885 · one of two readings recorded this
dysmenorrhea pain scores
decreases
They added 30 mg of resveratrol to the standard hormone therapy and concluded that the pain scores significantly reduced after two months of treatment
PMID:30781885 · one of two readings recorded this
endometrial aromatase and COX-2 inhibition
increases
The authors concluded that the inhibition of aromatase and COX-2 was increased in the group with combined therapy.
PMID:30781885 · one of two readings recorded this
endometriosis-related symptoms (median pain scores)
no effect
resveratrol did not prove any additional effects to placebo for the treatment of endometriosis-related symptoms because the differences between median pain scores in the two groups were insignificant
PMID:30781885 · one of two readings recorded this
estrogenic activity of resveratrol in an endometrial xenograft mouse model
modulates
They concluded that resveratrol functions in low doses as an estrogen agonist and in high doses as an estrogen antagonist.
PMID:30781885 · one of two readings recorded this
histological scores of endometriotic lesions
decreases
Histological scores were also decreased in the treated groups compared.
PMID:30781885 · one of two readings recorded this
MDA (lipid peroxidation) in peritoneal plasma and implants
decreases
after supplementing with resveratrol in a dose-dependent manner, the increased levels were suppressed
PMID:30781885 · one of two readings recorded this
mean areas and volumes of endometriotic implants
decreases
The mean areas and volumes of the implants decreased after treatment with both resveratrol and leuprolide acetate.
PMID:30781885 · one of two readings recorded this
plasma and peritoneal interleukin-6, interleukin-8 and TNF-α
decreases
Plasmatic and peritoneal levels of interleukin-6, interleukin-8, and TNF-α were reduced in the group that received only one therapeutical agent (1 and 2)
PMID:30781885 · one of two readings recorded this
quantity and dimensions of endometriotic lesions
decreases
Their study concluded that the oral gavage of resveratrol could reduce the quantity and dimensions of endometriotic lesions.
PMID:30781885 · one of two readings recorded this
serum and peritoneal MCP-1 and VEGF
decreases
Serum and peritoneal levels of MCP-1 and VEGF also appeared to be significantly lower in both groups
PMID:30781885 · one of two readings recorded this
survivin mRNA expression in human endometriotic stromal cells
decreases
A study of Taguchi et al. demonstrated that resveratrol alone could reduce significantly surviving mRNA expression, but did not induce apoptosis in human endometriotic stromal cells.
PMID:30781885 · one of two readings recorded this
volume of endometriotic lesions
decreases
Their study indicated that resveratrol significantly reduced the volume of endometriotic lesions.
PMID:30781885 · one of two readings recorded this
Notch signaling pathway activity / spinal cord injury outcome
decreases
Resveratrol can inhibit Notch signaling pathway to curtail SCI.
PMID:30797976 · one of two readings recorded this
Notch signaling pathway inhibition and spinal cord injury outcomes (mechanistic review, no original data)
decreases
Not recorded as a finding: a review that discusses its trials without pooling them
Resveratrol can inhibit Notch signaling pathway to curtail SCI.
PMID:30797976 · one of two readings recorded this
Notch signaling pathway inhibition and spinal cord injury outcomes
decreases
Resveratrol can inhibit Notch signaling pathway to curtail SCI.
PMID:30797976 · one of two readings recorded this
spinal cord injury outcome via Notch signaling pathway inhibition (mechanisms reviewed, no primary data or pooled estimate)
decreases
Not recorded as a finding: a review that discusses its trials without pooling them
Resveratrol can inhibit Notch signaling pathway to curtail SCI.
PMID:30797976 · one of two readings recorded this
blood pressure in hypertensive and pre-hypertensive patients
decreases, resveratrol plays an important role in reducing blood pressure, n = 229
Not recorded as a finding: a review that discusses its trials without pooling them
Data from five studies with a total of 229 hypertensive and pre-hypertensive patients (men and women) showed that resveratrol plays an important role in reducing blood pressure.
PMID:30813878 · one of two readings recorded this
blood pressure (systolic/diastolic not specified), across five studies of resveratrol dose and duration in hypertensive/pre-hypertensive patients
decreases, resveratrol plays an important role in reducing blood pressure, described as dose- and duration-dependent, across five pooled-narrative studies, n = 229
Not recorded as a finding: a review that discusses its trials without pooling them
Data from five studies with a total of 229 hypertensive and pre-hypertensive patients (men and women) showed that resveratrol plays an important role in reducing blood pressure.
PMID:30813878 · one of two readings recorded this
blood pressure
decreases, resveratrol plays an important role in reducing blood pressure, described as dose- and duration-dependent, n = 229
Data from five studies with a total of 229 hypertensive and pre-hypertensive patients (men and women) showed that resveratrol plays an important role in reducing blood pressure.
PMID:30813878 · one of two readings recorded this
systolic blood pressure in hypertensive patients and blood glucose in patients with diabetes mellitus, narrated across clinical trials
decreases
Not recorded as a finding: a review that discusses its trials without pooling them
In clinical trials, resveratrol moderately diminished systolic blood pressure in hypertensive patients, as well as blood glucose in patients with diabetes mellitus.
PMID:30934670 · one of two readings recorded this
pro-inflammatory cytokine accumulation and inflammatory cell production
decreases
the anti-inflammatory properties of Resveratrol have been highly studied on animal models, cell lines and human subjects and proven to be very effective in reducing inflammatory cell production and pro-inflammatory cytokine accumulation
PMID:30968773 · one of two readings recorded this
maternal and fetal outcomes after gestational resveratrol exposure in animal models of pregnancy complications
Maternal and fetal outcomes differed not only based on the model of complicated pregnancy assessed but also as a result of species.
PMID:31029765 · one of two readings recorded this
Aggregatibacter actinomycetemcomitans, Porphyromonas gingivalis and Tannerella forsythia concentrations in ligatures
no effect
Cirano et al., on the other hand, found no differences for Aggregatibacter Actinomycetemcomitans, Porphyromonas gingivalis, and Tannerella forsythia concentrations in ligatures extracted from rats after resveratrol administration.
PMID:31035477 · one of two readings recorded this
alveolar bone loss (ABL), cementoenamel-junction-to-bone-crest distance in methylene-blue-stained specimens, morphometry
decreases
Not recorded as a finding: this platform holds no node for the endpoint
This result indicates a significant effect in the reduction of the alveolar bone loss with the use of resveratrol.
PMID:31035477 · one of two readings recorded this
alveolar bone loss (ABL) reduction, range across studies
decreases
An average bone loss reduction with resveratrol ranged from 7.09% to 61.52% (Table 2).
PMID:31035477 · one of two readings recorded this
alveolar bone loss (ABL)
decreases
the pooled weighted mean difference was of −0.09 (τ2 = 0.0041; p < 0.01), which may be in a 95% CI from −0.14 to −0.04.
PMID:31035477 · one of two readings recorded this
alveolar bone loss (ABL)
no effect
In one study, resveratrol was combined with curcumin. No synergism was observed for ABL or gingival IFN-γ.
PMID:31035477 · one of two readings recorded this
alveolar bone loss, cement-enamel junction to bone crest distance (morphometry in methylene blue stained specimens)
decreases
Not recorded as a finding: this platform holds no node for the endpoint
This result indicates a significant effect in the reduction of the alveolar bone loss with the use of resveratrol.
PMID:31035477 · one of two readings recorded this
gingival IFN-γ
no effect
In one study, resveratrol was combined with curcumin. No synergism was observed for ABL or gingival IFN-γ.
PMID:31035477 · one of two readings recorded this
mean periodontal pocket depth
decreases
In this study, four weeks of daily intake of capsules containing 480 mg of resveratrol decreased the mean pocket depth in diabetic patients with chronic periodontitis compared to patients consuming a placebo.
PMID:31035477 · one of two readings recorded this
periodontal disease (PD) progression
decreases
Four studies evaluated the effects of resveratrol on PD associated with other conditions such as arthritis, smoke inhalation, and diabetes. All articles indicated an improvement of PD after resveratrol administration.
PMID:31035477 · one of two readings recorded this
endothelial nitric oxide synthase (eNOS) enzymatic activity and nitric oxide production in endothelial cells
increases
Not recorded as a finding: a review that discusses its trials without pooling them
Resveratrol increases the production of nitric oxide (NO) in endothelial cells by upregulating the expression of endothelial NO synthase (eNOS), stimulating eNOS enzymatic activity, and preventing eNOS uncoupling.
PMID:31052341 · one of two readings recorded this
fatty acid synthesis (FASN, PI3K/AKT/mTOR pathway), cholesterol synthesis (HMGCR, SREBP), sphingolipid/eicosanoid metabolism (COX, LOX, CYP1A1/1B1), lipid peroxidation, in cancer cell lines and animal tumour models
decreases
RES significantly reduced lipid synthesis through the downregulation of FASN in many cancer cell lines.
PMID:31159437 · one of two readings recorded this
AGE/RAGE production and downstream oxidative stress, inflammatory response, cellular immune reactions, insulin response, and atherosclerosis (29 studies narratively reviewed, not pooled)
decreases
Not recorded as a finding: a review that discusses its trials without pooling them
Except one, all studies showed suppressing effects for RSV on the production of AGEs or receptor for advanced glycation end products (RAGE) and its detrimental consequences including oxidative stress, inflammatory response, cellular immune reactions, insulin response, and atherosclerosis.
PMID:31185146 · one of two readings recorded this
AGE/RAGE production and downstream oxidative stress, inflammatory response, cellular immune reactions, insulin response, and atherosclerosis (systematic review, 29 studies, not pooled)
decreases
Not recorded as a finding: a review that discusses its trials without pooling them
Except one, all studies showed suppressing effects for RSV on the production of AGEs or receptor for advanced glycation end products (RAGE) and its detrimental consequences including oxidative stress, inflammatory response, cellular immune reactions, insulin response, and atherosclerosis.
PMID:31185146 · one of two readings recorded this
AGE/RAGE production and downstream oxidative stress, inflammatory response, cellular immune reactions, insulin response, atherosclerosis
decreases
Except one, all studies showed suppressing effects for RSV on the production of AGEs or receptor for advanced glycation end products (RAGE) and its detrimental consequences including oxidative stress, inflammatory response, cellular immune reactions, insulin response, and atherosclerosis.
PMID:31185146 · both readings recorded this
abdominal fat
decreases
Obese (fa/fa) and lean (Fa/fa) Zucker rats standard diet | 10 mg/kg/day by oral gavage | 8 weeks | Abdominal fat ↓ |
PMID:31316465 · one of two readings recorded this
adipocyte size and proportion of small adipocytes
modulates
Obese men | 150 mg/day | 30 days | Adipocyte size↓ Small adipocytes ↑ |
PMID:31316465 · one of two readings recorded this
BMI, WC, fat mass and triglycerides
decreases
consumption of an orlistat-resveratrol combination for 6 months could dramatically decrease BMI, WC, fat mass, and triglycerides levels in obese subjects compared with those in placebo group subjects
PMID:31316465 · one of two readings recorded this
body and visceral adipose weight, blood glucose and lipids; gut microbiota
modulates
Kunming mice | 200 mg/kg/day | 12 weeks | Body and visceral adipose weight ↓Blood glucose and lipid levels ↓ | Bacteroidetes/Firmicutes ratios, Lactobacillus, and Bifidobacterium ↑ Enterococcus faecalis ↓ |
PMID:31316465 · one of two readings recorded this
body weight and adiposity
decreases
FVB/N mice high-fat diet | 30 mg/kg/day in the diet | 60 days | Body weight and adiposity ↓ |
PMID:31316465 · one of two readings recorded this
body weight and epididymal WAT weight
decreases
ApoE deficient mice atherogenic diet | 0.02% in the diet | 12 weeks | Body weight and epididymal WAT weight ↓ |
PMID:31316465 · one of two readings recorded this
body weight and fat accumulation
decreases
Wistar rats standard chow diet plus cafeteria diet | 200 mg/kg/day in the milk | 22 days | Body weight and fat accumulation ↓ |
PMID:31316465 · one of two readings recorded this
body weight and fat mass; adipocyte size; UCP1 and PGC-1α in BAT
modulates
C57BL/6J mice high-fat diet | 200 or 400 mg/kg/day in the diet | 15 weeks | Body weight and fat mass ↓ Adipocyte size ↓ UCP1 and PGC-1α in BAT ↑ |
PMID:31316465 · one of two readings recorded this
body weight and fat mass (animal, short intervention)
no effect
One study treated C57BL/6J male mice that were fed a high-fat diet for only 3 weeks with oral resveratrol (30 mg/kg/day) and did not observe a significant decrease in body weight or fat mass
PMID:31316465 · one of two readings recorded this
body weight and fat mass (no changes)
no effect
C57BL/6J mice high-fat diet | 30 mg/kg/day by oral gavage | 3 weeks | No changes |
PMID:31316465 · one of two readings recorded this
body weight and fat mass
no effect
a study in which 29 non-obese, postmenopausal women with normal glucose tolerance were administered resveratrol supplementation (75 mg/day) or placebo for 12 weeks and found no changes in body and fat weight or gene expression in WAT
PMID:31316465 · one of two readings recorded this
body weight and fat (no changes)
no effect
Wistar rats high-fat high-sucrose diet | 15 mg/kg/day in the diet | 6 weeks | No changes |
PMID:31316465 · one of two readings recorded this
body weight and fat weight (no changes)
no effect
C57BL/6J mice high-fat diet | 0.2 or 0.4% in the diet | 15 weeks | No changes |
PMID:31316465 · one of two readings recorded this
body weight and VAT weight
decreases
Kunming mice high-fat diet | 200 mg/kg/day in the diet | 12 weeks | Body weight and VAT weight ↓ |
PMID:31316465 · one of two readings recorded this
body weight, BMI, WC; ALT, NF-κB, cytokeratin-18
decreases
NAFLD patients | 500 mg/day | 12 weeks | Body weight, BMI, and WC ↓ ALT, NF-κb, and cytokeratin-18 ↓ |
PMID:31316465 · one of two readings recorded this
body weight, BMI, WC, fat mass; AUC of insulin; insulinogenic index
decreases
Patients with metabolic syndrome | 1,500 mg/day | 90 days | Body weight, BMI, WC, and fat mass ↓ AUC of insulin and insulinogenic index ↓ |
PMID:31316465 · one of two readings recorded this
body weight, BMI, WC, fat mass; TG and leptin
decreases
Obese subjects | Orlistat + resveratrol (120 + 100 mg/day) | 6 months | Weight body, BMI, WC, and fat mass ↓ TG and leptin ↓ |
PMID:31316465 · one of two readings recorded this
body weight, fat mass and energy expenditure (no changes)
no effect
Healthy obese men | 1,500 mg/day | 4 weeks | No changes |
PMID:31316465 · one of two readings recorded this
body weight gain, adipose weight, TG, LDL-C, glucose; gut microbiota
modulates
C57BL/6 mice | 50, 75, and 100 mg/kg | 3 months | Body weight gain, adipose tissue weight ↓ TG, LDL-C, glucose ↓ | Deferribacteraceae ↑ Coriobacteriaceae and Desulfovibrionaceae ↓ |
PMID:31316465 · one of two readings recorded this
body weight gain and epididymal WAT weight
decreases
Obese Zucker fa/fa rats standard diet | 15 mg/kg/day by an orogastric catheter | 6 weeks | Body weight gain and epididymal WAT weight ↓ |
PMID:31316465 · one of two readings recorded this
body weight gain and fat content (rats on obesogenic diet)
no effect
resveratrol supplementation appeared to have no effect on reducing body weight gain and fat content in rats fed an obesogenic diet (15 mg/kg/day for 6 weeks)
PMID:31316465 · one of two readings recorded this
body weight gain and fat deposition; gut microbiota
modulates
C57Bl/6J mice | 200 mg/kg/day | 8 weeks | Body weight gain and fat deposition ↓ | Lactococcus, Clostridium XI, Oscillibacter, and Hydrogenoanaerobacterium ↓ |
PMID:31316465 · one of two readings recorded this
body weight gain and serum insulin; gut microbiota
modulates
Wistar rats | Quercetin+resveratrol (30 + 15 mg/kg/day) | 6 weeks | Body weight gain ↓ Serum insulin levels ↓ | Firmicutes/Bacteroidetes ratio, Erysipelotrichaceae, Bacillus, Eubacterium cylindroides ↓ |
PMID:31316465 · one of two readings recorded this
body weight gain and WAT weight
decreases
C57BL/6C mice high-fat diet | 1, 10, or 30 mg/kg/day by oral gavage | 10 weeks | Body weight gain and WAT weight ↓ |
PMID:31316465 · one of two readings recorded this
body weight gain, VAT weight and adipocyte size
decreases
C57BL/6J mice high-fat diet | 0.4% in the diet | 10 weeks | Body weight gain and VAT weight ↓ Adipocyte size ↓ |
PMID:31316465 · one of two readings recorded this
body weight gain, VAT weight, serum lipids, IL-6, TNF-α, MCP-1; gut microbiota
modulates
Wistar rats | Quercetin+resveratrol (30 + 15 mg/kg/day) | 10 weeks | Body weight gain and VAT weight ↓ Serum lipids, IL-6, TNF-α, and MCP-1 ↓ | Bacteroidales_S24-7_group, Christensenellaceae, Akkermansia, Ruminococcaceae_UCG-014, and Ruminococcaceae_UCG-005 ↑ Firmicutes, Desulfovibrionaceae, Acidaminococcaceae, Coriobacteriacea, Bilophila, and Lachnoclostridium ↓ |
PMID:31316465 · one of two readings recorded this
body weight gain
decreases
OLETF rats standard diet | 0.5% in the diet | 4 weeks | Body weight gain ↓ |
PMID:31316465 · one of two readings recorded this
body weight; gut microbiota
modulates
PGC-1α knockout C57BL/6N mice | 4 g/kg diet | 16 weeks | Body weight ↓ | Erysipelotrichaceae and Allobaculum ↑ |
PMID:31316465 · one of two readings recorded this
body weight
decreases
C57BL/6J mice high-fat diet | 5, 22.5, or 45 mg/kg/day by oral gavage | 12 weeks | Body weight ↓ |
PMID:31316465 · one of two readings recorded this
clinical and histological NAFLD (no changes)
no effect
Overweight or obese men with NAFLD | 3,000 mg/day | 8 weeks | No changes |
PMID:31316465 · one of two readings recorded this
fasting blood glucose and HDL-C; gut microbiota
modulates
Wistar rats | 400 mg/kg | 8 weeks | Fasting blood glucose levels ↓ HDL-C ↑ | Blautia and Dorea ↑ Bacteroides and Desulfovibrionaceae sp ↓ |
PMID:31316465 · one of two readings recorded this
fat mass and glucose homeostasis; gut microbiota
modulates
C57BL/6N mice | 0.4% | 8 weeks | Fat mass ↓ Improves glucose homeostasis | Bacteroides and Parabacteroides ↑ Turicibacteraceae, Moryella, Lachnospiraceae, and Akkermansia ↓ |
PMID:31316465 · one of two readings recorded this
glucose homeostasis in obese recipient mice of resveratrol-fed donor feces
increases
the resveratrol-FMTs were sufficient to improve glucose intolerance in the recipient obese mice, also independently of the changes in body weight
PMID:31316465 · one of two readings recorded this
insulin sensitivity and basal metabolic rate; gut microbiota
modulates
C57Bl/6N mice | 450 mg/kg/day | 2 weeks | Skeletal insulin sensitivity and basal metabolic rate ↑ | Bacteroidetes/Firmicutes ratios, Parabacteroides, Bilophila, and Akkermansia ↑ Lachnospiraceae ↓ |
PMID:31316465 · one of two readings recorded this
insulin sensitivity; PGC-1α and AMPK
increases
C57BL/6NIA mice high-fat diet | 0.4% in the diet | 6 months | Insulin sensitivity ↑ PGC-1α and AMPK ↑ |
PMID:31316465 · one of two readings recorded this
internal and total adipose tissue weights
decreases
Wistar rats high-fat high-sucrose diet | 30 mg/kg/day in the diet | 6 weeks | Internal and total adipose tissue weights ↓ |
PMID:31316465 · one of two readings recorded this
liver lipid content
decreases
Overweight patients with NAFLD | 1,500 mg/day | 6 months | Liver lipid content ↓ |
PMID:31316465 · one of two readings recorded this
sleeping and resting metabolic rate; TG, ALT and inflammation markers
decreases
Obese men | 150 mg/day | 30 days | Sleeping and resting metabolic rate ↓ TG, ALT, and inflammation markers ↓ |
PMID:31316465 · one of two readings recorded this
systolic and diastolic blood pressure; gut microbiota
modulates
Sprague-Dawley rats | 50 mg/L | 2 months | Systolic and diastolic blood pressure ↓ | Firmicutes/Proteobacteria ratio ↑ |
PMID:31316465 · one of two readings recorded this
TC, HDL-C, ALT, AST, glucose, insulin and HOMA-IR
decreases
C57BL/6 mice high-fat diet | 100 mg/kg/day by oral gavage | 4 weeks | TC, HDL-C, ALT,AST, glucose, insulin, and HOMA-IR ↓ |
PMID:31316465 · one of two readings recorded this
TMAO-induced atherosclerosis; gut microbiota
modulates
C57Bl/6J and ApoE−/−mice | 400 mg/kg/day | 1 or 2 months | TMAO-induced atherosclerosis ↓ | Bacteroides, Lactobacillus, Bifidobacterium, and Akkermansia ↑ Prevotella, Ruminococcaceae, Anaerotruncus, Alistipes, Helicobacter, and Peptococcaceae ↓ |
PMID:31316465 · one of two readings recorded this
total weight, BMI, fat mass and waist circumference
decreases
total weight, body mass index (BMI), fat mass, and waist circumference (WC) were all significantly decreased after the intervention, compared with those of the placebo group
PMID:31316465 · one of two readings recorded this
UCP1, SIRT1 and PGC-1α in BAT
increases
Sprague-Dawley rats high-fat high-sucrose diet | 30 mg/kg/day in the diet | 6 weeks | UCP1, SIRT1, and PGC-1α in BAT ↑ |
PMID:31316465 · one of two readings recorded this
VAT mass
decreases, p = 0.09
The VAT mass tended to be decreased in the intervention group compared with the placebo group (p = 0.09)
PMID:31316465 · one of two readings recorded this
visceral adipose weight
decreases
Overweight and obese subjects | EGCG + resveratrol (282 + 80 mg/day) | 12 weeks | Visceral adipose weight ↓ |
PMID:31316465 · one of two readings recorded this
WAT size
decreases
Sprague-Dawley rats high-fat high-sucrose diet | 30 or 60 mg/kg/day in the diet | 6 weeks | WAT size ↓ |
PMID:31316465 · one of two readings recorded this
WAT weight
decreases
Sprague-Dawley rats high-fat high-sucrose diet | 30 mg/kg/day in the diet | 6 weeks | WAT weight ↓ |
PMID:31316465 · one of two readings recorded this
WAT weight
decreases
C57BL/6J mice high-fat diet | 0.005 or 0.02% in the diet | 10 weeks | WAT weight ↓ |
PMID:31316465 · one of two readings recorded this
weight, BMI, WC and hepatic steatosis
decreases
found significant improvements in weight, BMI, WC, and hepatic steatosis, compared with those of the placebo control group
PMID:31316465 · one of two readings recorded this
fat browning activation (myokine and adipokine secretion)
increases
Recent studies have paid a lot of attention to that resveratrol may act as a fat browning activator, involved in the secretion of many myokines and adipokines
PMID:31449976 · one of two readings recorded this
gene expression profile (microarray) in liver, skeletal muscle and peripheral blood mononuclear cells
gene expression changes typically mimicked those of calorie restriction and lifespan extension and opposed changes induced by an atherogenic diet
Resveratrol-induced changes of gene expression typically mimicked those associated with calorie restriction and lifespan extension.
PMID:32067842 · one of two readings recorded this
hepatic, skeletal-muscle and PBMC gene expression profile (microarray)
Resveratrol-induced changes of gene expression typically mimicked those associated with calorie restriction and lifespan extension.
PMID:32067842 · one of two readings recorded this
accumulation of advanced glycation end products (AGE) or receptor for AGEs
decreases
Not recorded as a finding: a review that discusses its trials without pooling them
All the included studies, except one, showed inhibitory effects of resveratrol on the accumulation of AGE or receptor for AGEs.
PMID:32125189 · one of two readings recorded this
accumulation of advanced glycation end products (AGEs) / receptor for AGEs in diabetes models
decreases
Not recorded as a finding: a review that discusses its trials without pooling them
All the included studies, except one, showed inhibitory effects of resveratrol on the accumulation of AGE or receptor for AGEs.
PMID:32125189 · one of two readings recorded this
accumulation of advanced glycation end products (AGEs) / receptor for AGEs
decreases
All the included studies, except one, showed inhibitory effects of resveratrol on the accumulation of AGE or receptor for AGEs.
PMID:32125189 · one of two readings recorded this
all-cause mortality
decreases
dietary patterns rich in resveratrol were demonstrated to significantly reduce all-cause mortality
PMID:32183376 · one of two readings recorded this
total antioxidant capacity
increases
resveratrol intake (500 mg/day for 30 days) was demonstrated to reduce CVD risk factors by increasing SIRT1, enhancing total antioxidant capacity in healthy individuals
PMID:32183376 · one of two readings recorded this
SIRT1
increases
resveratrol intake (500 mg/day for 30 days) was demonstrated to reduce CVD risk factors by increasing SIRT1, enhancing total antioxidant capacity in healthy individuals
PMID:32183376 · one of two readings recorded this
adipogenic differentiation in pre-adipocytes
decreases
low concentrations of resveratrol (1–10 μM) suppressed adipogenic differentiation in pre-adipocytes
PMID:32183376 · one of two readings recorded this
bone density loss
decreases
resveratrol prevented bone density loss (500 mg/day for 6 months) in type-2 diabetic patients
PMID:32183376 · one of two readings recorded this
breast cancer risk
decreases
a case-control study reported a significant inverse association between resveratrol from grapes (but not from wine) and breast cancer risk
PMID:32183376 · one of two readings recorded this
cardiac outcomes after myocardial infarction, sex-dependent response
modulates
sex differences were observed in rats with surgically-induced myocardial infarction (MI) due to the resveratrol treatment (2.5 mg/kg/d)
PMID:32183376 · one of two readings recorded this
CVD risk factors
decreases
resveratrol intake (500 mg/day for 30 days) was demonstrated to reduce CVD risk factors by increasing SIRT1, enhancing total antioxidant capacity in healthy individuals
PMID:32183376 · one of two readings recorded this
dopamine transporter (DAT) in the striatum
increases
resveratrol (20 mg/kg) significantly increased dopamine transporter (DAT) in the striatum in female but not in male mice
PMID:32183376 · one of two readings recorded this
dopamine transporter (DAT) in the striatum
no effect
resveratrol (20 mg/kg) significantly increased dopamine transporter (DAT) in the striatum in female but not in male mice
PMID:32183376 · one of two readings recorded this
esophageal cancer risk
decreases
a lower risk of esophageal cancer was linked with higher resveratrol intake
PMID:32183376 · one of two readings recorded this
growth of ERα+ breast cancer cells
increases
high concentrations of resveratrol could inhibit the proliferation of estrogen receptor alpha positive (ERα+) breast cancer, while low concentrations increased the growth of ERα+ cells
PMID:32183376 · one of two readings recorded this
high blood pressure
increases
resveratrol intake (top quantile, 0.054 mg/day and more) was positively associated with high blood pressure (hazard ratios, HR: 1.52; 95% confidence intervals, 95% CI: 1.02–2.27)
PMID:32183376 · one of two readings recorded this
proliferation of ERα+ breast cancer cells
decreases
high concentrations of resveratrol could inhibit the proliferation of estrogen receptor alpha positive (ERα+) breast cancer, while low concentrations increased the growth of ERα+ cells
PMID:32183376 · one of two readings recorded this
SIRT1 and cardiovascular risk factors
no effect
resveratrol intake (250 mg/day for 8 weeks) did not increase SIRT1 nor improve many cardiovascular risk factors in healthy aged men
PMID:32183376 · one of two readings recorded this
adverse effects in rats
no effect
administration of an RE dosage of 20 mg/kg/day for 28 days to rats showed no adverse effects in the animals
PMID:32197410 · one of two readings recorded this
anti-cancer activity of paclitaxel in glioblastoma cells
increases
the anti-cancer activity of paclitaxel was significantly enhanced when glioblastoma cells were treated with 50 μM of RE
PMID:32197410 · one of two readings recorded this
apoptotic cells among rat thymocytes
increases
Resveratrol at 10 μM or higher led to a significant concentration-dependent increase in apoptotic cells
PMID:32197410 · one of two readings recorded this
bilirubin levels in rats
increases
A significant increase in bilirubin levels was observed in rats administered with the 1000 (mg/kg)/day dose of RE
PMID:32197410 · one of two readings recorded this
biomarkers of cardiovascular disease risk (ox-LDL, sE-selectin 1, sICAM-1, sVCAM-1, tPAI-1)
increases
In this context, a higher dose of RE (1000mg/day) was recently shown to elevate biomarkers of CVD risk
PMID:32197410 · one of two readings recorded this
cognitive function
no effect
administration of 300 mg/day of RE failed to induce changes in the cognitive function
PMID:32197410 · one of two readings recorded this
endothelial cell oxidation state
increases
However, higher in vitro concentrations of RE (≥10 μM and 25 μM) increased the endothelial cell oxidation state
PMID:32197410 · one of two readings recorded this
endothelial cell oxidative state
decreases
Low in vitro RE concentrations (0.5 μM) exhibited antioxidant effects by decreasing endothelial cell oxidative state
PMID:32197410 · one of two readings recorded this
formation of major blood vessels
decreases
RE (100 μM) inhibited the formation of major blood vessels by downregulating VEGF
PMID:32197410 · one of two readings recorded this
lymphocyte counts and enzymes involved in carcinogenesis and drug metabolism
modulates
when healthy subjects were given 1.0 g of RE for four -weeks, lymphocyte counts and levels of enzymes involved in carcinogenesis and drug metabolism were favorably modulated with no significant adverse effects
PMID:32197410 · one of two readings recorded this
oral bioavailability of resveratrol
increases
Loading RE into poly-lactic- co-glycolic acid (PLGA) nanoparticles increased RE oral bioavailability up to 335.7%, in comparison to RE, alone following administration in rats
PMID:32197410 · one of two readings recorded this
plasma IGF1 and IGFBP3 levels
decreases
Supplementation of 2.5 g/day RE for 29 days significantly reduced IGF1 and IGFBP3 levels in plasma
PMID:32197410 · one of two readings recorded this
proliferation of transformed macrophages, tumor-derived T cells and epidermoid carcinoma cells
increases
However, low concentrations of RE (5 µM) stimulated the proliferation of these cells
PMID:32197410 · one of two readings recorded this
proliferation of transformed macrophages, tumor-derived T cells and epidermoid carcinoma cells
decreases
High concentrations of RE (50 µM) inhibited the proliferation of transformed macrophages, tumor-derived T cells, and epidermoid carcinoma cells
PMID:32197410 · one of two readings recorded this
psychomotor speed
increases
the dosage of 1000/mg/day was able to selectively improve only the psychomotor speed
PMID:32197410 · one of two readings recorded this
renal fibrosis in unilateral ureteral obstruction mice
increases
high-dose administration of RE (≥50 mg/kg) lost its anti-fibrotic effect, aggravating renal fibrosis instead
PMID:32197410 · one of two readings recorded this
renal function in unilateral ureteral obstruction mice
increases
low-dose RE administration (≤25 mg/kg) partly improved renal function in mice with kidney damage caused by unilateral ureteral obstruction (UUO)
PMID:32197410 · one of two readings recorded this
renal toxicity in rats
increases
while dosage of 1000 and 3000 mg/kg/day induced renal toxicity
PMID:32197410 · one of two readings recorded this
safe dose in a 60-kg person
no effect
A 450 mg/day dose of RE was reported to be a safe dose for a 60-kg person
PMID:32197410 · one of two readings recorded this
tumor growth
decreases
When injected intratumorally in vivo, TriCurin was able to inhibit tumor growth by 85% as compared to the control
PMID:32197410 · one of two readings recorded this
Wnt signaling in cancerous colorectal mucosa
no effect
Neither RE nor grape powder administration had an effect on Wnt signaling in the cancerous mucosa
PMID:32197410 · one of two readings recorded this
Wnt target gene expression in adjacent normal colorectal mucosa
decreases
but their supplementation resulted in decreased Wnt target gene expression in adjacent normal mucosa
PMID:32197410 · one of two readings recorded this
blood pressure (BP)
Compared to response in healthy animals, studies in disease/clinical animal models saw significant improvements in the majority (88%) of studies, with 84% and 100% in blood pressure (BP) and vascular function measures, respectively.
PMID:32303823 · one of two readings recorded this
diastolic blood pressure
no effect, p = 0.139
No significant effects were found in DBP when considering overall effect estimate (− 1.0 mmHg, [− 2.2, 0.3], p = 0.139, I2 = 99.7%), or when subgroup analysis was carried out on resveratrol studies in isolation (− 0.9 mmHg, [− 3.2, 1.3]; p = 0.417, I2 = 99.6%).
PMID:32303823 · one of two readings recorded this
diastolic blood pressure
no effect, p = 0.08
Subgroup analysis based on health status showed no significance in healthy or at-risk cohorts. Specifically, there were non-significant changes in healthy individuals (0.6 mmHg, [− 2.6, 3.8], p = 0.725, I2 = 99.0%) and a relative decrease in at-risk cohorts (− 1.2 mmHg, [− 2.6, 0.2], p = 0.08, I2 = 99.7%).
PMID:32303823 · one of two readings recorded this
diastolic blood pressure
no effect, p = 0.725
Subgroup analysis based on health status showed no significance in healthy or at-risk cohorts. Specifically, there were non-significant changes in healthy individuals (0.6 mmHg, [− 2.6, 3.8], p = 0.725, I2 = 99.0%) and a relative decrease in at-risk cohorts (− 1.2 mmHg, [− 2.6, 0.2], p = 0.08, I2 = 99.7%).
PMID:32303823 · one of two readings recorded this
diastolic blood pressure
no effect, p = 0.417
No significant effects were found in DBP when considering overall effect estimate (− 1.0 mmHg, [− 2.2, 0.3], p = 0.139, I2 = 99.7%), or when subgroup analysis was carried out on resveratrol studies in isolation (− 0.9 mmHg, [− 3.2, 1.3]; p = 0.417, I2 = 99.6%).
PMID:32303823 · one of two readings recorded this
diastolic blood pressure
no effect
The combined effects of the three cohorts reported from these two studies showed an estimated mean difference of − 0.6 mmHg [− 2.4, 1.3] and 2.0 mmHg [− 0.4, 4.4] for systolic and diastolic blood pressure, respectively
PMID:32303823 · one of two readings recorded this
flow-mediated dilation (FMD), chronic human supplementation
no effect, p = 0.544
Not recorded as a finding: The quantitative pooled FMD estimate (4 studies) is pooled across red wine polyphenols generally (including grape extract and resveratrol together per Table 6), not isolated to resveratrol alone, so it cannot be attributed to this subject specifically.
Random effects modelling estimates showed no significant mean difference between placebo and intervention supplements (− 1.08, [− 4.57, 2.41], p = 0.544, I2 = 99.40%).
PMID:32303823 · one of two readings recorded this
flow mediated dilation (FMD)
no effect, p = 0.544
Random effects modelling estimates showed no significant mean difference between placebo and intervention supplements (− 1.08, [− 4.57, 2.41], p = 0.544, I2 = 99.40%).
PMID:32303823 · one of two readings recorded this
flow mediated dilation (FMD)
no effect, p = 0.57
Model refitting excluding this outlier resulted in reversal of the effect of supplementation over placebo, but no change in significance (0.526, [− 1.291, 2.343], p = 0.570)
PMID:32303823 · one of two readings recorded this
flow mediated dilation (FMD)
increases
All three acute FMD studies showed a significant improvement in the FMD response following resveratrol supplementation across a wide range of doses (75–2547 mg/kg/day), as well as supplementation with whole grape extract.
PMID:32303823 · one of two readings recorded this
MCAv response to hypercapnia (cerebrovascular responsiveness)
increases
Moreover, Evans et al. showed that chronic (14 weeks) of resveratrol (150 mg/day) supplementation in a cohort of postmenopausal women significantly increased MCAv response to hypercapnia (i.e., cerebrovascular responsiveness), without a significant increase in resting MCAv.
PMID:32303823 · one of two readings recorded this
middle cerebral artery velocity (MCAv)
increases
Wong et al. examined acute effects in type 2 diabetics at both high and low doses of resveratrol (75, 150 and 300 mg), reporting significant improvements in middle cerebral artery velocity (MCAv) for all doses
PMID:32303823 · one of two readings recorded this
posterior cerebral artery velocity (PCAv)
increases
while only low-dose resveratrol resulted in a significant improvement in posterior cerebral artery velocity (PCAv).
PMID:32303823 · one of two readings recorded this
resting MCAv
no effect
Moreover, Evans et al. showed that chronic (14 weeks) of resveratrol (150 mg/day) supplementation in a cohort of postmenopausal women significantly increased MCAv response to hypercapnia (i.e., cerebrovascular responsiveness), without a significant increase in resting MCAv.
PMID:32303823 · one of two readings recorded this
systolic blood pressure
decreases, p = 0.01
The overall mean difference following RWP supplementation across all included studies was significant for SBP (− 2.6 mmHg, [− 4.8, − 0.4], p = 0.010, I2 = 99.77%).
PMID:32303823 · one of two readings recorded this
systolic blood pressure
no effect, p = 0.194
This subgrouping resulted in the maintenance of a significant mean difference in resveratrol studies (− 3.7 mmHg, [− 7.3, − 0.0], p = 0.047), but not in the non-resveratrol supplement groups (− 1.4 mmHg, [− 3.4, 0.7], p = 0.194)
PMID:32303823 · one of two readings recorded this
systolic blood pressure
decreases, p = 0.01
Subgroup analysis revealed a divergence in effect estimates when healthy and at-risk populations were separated, with a loss of the significant effect in healthy cohorts (0.7 mmHg, [− 2.5, 3.8], p = 0.673), while a clear significant effect was seen in at-risk populations (− 3.2 mmHg, [− 5.7, − 0.8], p = 0.010).
PMID:32303823 · one of two readings recorded this
systolic blood pressure
no effect, p = 0.673
Subgroup analysis revealed a divergence in effect estimates when healthy and at-risk populations were separated, with a loss of the significant effect in healthy cohorts (0.7 mmHg, [− 2.5, 3.8], p = 0.673), while a clear significant effect was seen in at-risk populations (− 3.2 mmHg, [− 5.7, − 0.8], p = 0.010).
PMID:32303823 · one of two readings recorded this
systolic blood pressure
decreases, p = 0.036
Model refitting showed a reduction in the overall effect of supplementation when the outlier was excluded, without a loss of significance or notable change in heterogeneity (− 2.1 mmHg, [− 4.1, − 0.1], p = 0.036, I2 = 99.73).
PMID:32303823 · one of two readings recorded this
systolic blood pressure
decreases, p = 0.047
This subgrouping resulted in the maintenance of a significant mean difference in resveratrol studies (− 3.7 mmHg, [− 7.3, − 0.0], p = 0.047), but not in the non-resveratrol supplement groups (− 1.4 mmHg, [− 3.4, 0.7], p = 0.194)
PMID:32303823 · one of two readings recorded this
systolic blood pressure
no effect
The combined effects of the three cohorts reported from these two studies showed an estimated mean difference of − 0.6 mmHg [− 2.4, 1.3] and 2.0 mmHg [− 0.4, 4.4] for systolic and diastolic blood pressure, respectively
PMID:32303823 · one of two readings recorded this
vascular function in arterial rings ex vivo (EVVR)
n = 10
Significant improvements in vascular measures were seen after supplementation in 24% of studies in healthy animals, with specific significant effects on blood pressure (n = 21) and vascular function in arterial rings ex vivo (n = 10) in 24% and 40% of studies, respectively.
PMID:32303823 · one of two readings recorded this
vascular function measures
Compared to response in healthy animals, studies in disease/clinical animal models saw significant improvements in the majority (88%) of studies, with 84% and 100% in blood pressure (BP) and vascular function measures, respectively.
PMID:32303823 · one of two readings recorded this
vascular measures (composite: blood pressure or vascular function)
n = 21
Significant improvements in vascular measures were seen after supplementation in 24% of studies in healthy animals, with specific significant effects on blood pressure (n = 21) and vascular function in arterial rings ex vivo (n = 10) in 24% and 40% of studies, respectively.
PMID:32303823 · one of two readings recorded this
anti-inflammatory mediator production in LPS-treated RAW 264.7 macrophages
decreases, strong anti-inflammatory activity inhibiting NO, PGE2, IL-1β, IL-6 and TNF-α production, promoting IL-10 release, and inhibiting TLR4 expression and JNK/ERK1/2/p38/MAPK phosphorylation
Cell culture studies suggested that En-RES exhibited a strong anti-inflammatory activity by inhibiting the production of NO, PGE2, IL-1β, IL-6, TNF-α, promoting IL-10 release, inhibiting expression of TLR4, and inhibiting phosphorylation of JNK, ERK1/2, p38 and MAPK.
PMID:32322856 · one of two readings recorded this
cellular uptake into Caco-2 cells over time
increases, encapsulated resveratrol uptake reached ~1.06 ug/mL at 2 h versus free resveratrol reaching 0.62 ug/mL at 4 h
The cellular uptake of encapsulated resveratrol increased appreciably with observation time (1-4 h), reaching a maximum value (≈1.06 μg mL-1) after 2 h, whereas that of free resveratrol (in DMSO) only increased slightly, reaching 0.62 μg mL-1 after 4 h.
PMID:32322856 · one of two readings recorded this
cellular uptake of resveratrol in Caco-2 cells over 1-4 hours
increases, encapsulated resveratrol uptake reached a maximum of approximately 1.06 μg/mL at 2 h versus free resveratrol reaching 0.62 μg/mL at 4 h
The cellular uptake of encapsulated resveratrol increased appreciably with observation time (1-4 h), reaching a maximum value (≈1.06 μg mL-1) after 2 h, whereas that of free resveratrol (in DMSO) only increased slightly, reaching 0.62 μg mL-1 after 4 h.
PMID:32322856 · one of two readings recorded this
oral bioavailability / plasma concentration-time profile of resveratrol in rats
increases, encapsulated resveratrol reached a plasma Cmax of 1.35 ± 0.26 μg/mL at 4 h and remained detectable to 48 h, versus a Cmax of 0.31 ± 0.05 μg/mL at 0.5 h and total clearance by 8 h for free resveratrol
The plasma level reached a maximum value of 1.35 ± 0.26 μg mL-1 at 4 h after feeding the En-RES formulation, and then decreased to 0.19 ± 0.04 μg mL-1 after 48 h.
PMID:32322856 · one of two readings recorded this
resveratrol oral bioavailability / plasma concentration-time profile, rat plasma, encapsulated (En-RES) vs free (RES) formulation
increases, plasma Cmax 1.35 ± 0.26 ug/mL at 4 h post-dose for the encapsulated (En-RES) formulation
Not recorded as a finding: no outcome node exists for resveratrol plasma concentration/bioavailability
The plasma level reached a maximum value of 1.35 ± 0.26 μg mL-1 at 4 h after feeding the En-RES formulation, and then decreased to 0.19 ± 0.04 μg mL-1 after 48 h.
PMID:32322856 · one of two readings recorded this
resveratrol plasma concentration-time profile / oral bioavailability
increases, plasma Cmax 1.35 ± 0.26 ug/mL at 4 h (En-RES) vs 0.31 ± 0.05 ug/mL at 0.5 h (free RES)
The plasma level reached a maximum value of 1.35 ± 0.26 μg mL-1 at 4 h after feeding the En-RES formulation, and then decreased to 0.19 ± 0.04 μg mL-1 after 48 h.
PMID:32322856 · one of two readings recorded this
resveratrol transmembrane transport, Caco-2 monolayer Transwell assay, encapsulated (En-RES) vs free (RES)
increases, 4.7-fold higher transmembrane transport for encapsulated resveratrol versus free resveratrol
Not recorded as a finding: no outcome node exists for in-vitro intestinal transmembrane transport of resveratrol
The transmembrane transport of En-RES was significantly higher than that of RES (p < 0.05): the resveratrol concentration in the receiving compartment of Costar trans-wells was 4.7-fold higher for the encapsulated resveratrol.
PMID:32322856 · one of two readings recorded this
transmembrane transport across Caco-2 monolayer (Transwell)
increases, 4.7-fold higher transmembrane transport for encapsulated vs free resveratrol
The transmembrane transport of En-RES was significantly higher than that of RES (p < 0.05): the resveratrol concentration in the receiving compartment of Costar trans-wells was 4.7-fold higher for the encapsulated resveratrol.
PMID:32322856 · one of two readings recorded this
transmembrane transport of resveratrol across Caco-2 trans-well monolayers
increases, resveratrol concentration in the receiving compartment was 4.7-fold higher for the encapsulated form
The transmembrane transport of En-RES was significantly higher than that of RES (p < 0.05): the resveratrol concentration in the receiving compartment of Costar trans-wells was 4.7-fold higher for the encapsulated resveratrol.
PMID:32322856 · one of two readings recorded this
effects in certain cancers and NAFLD
unclear
Nevertheless, in certain types of cancers and in NAFLD, resveratrol had unclear and sometimes even detrimental effects
PMID:32422008 · one of two readings recorded this
tolerability and disease biomarkers in neurological disorders, cardiovascular diseases and diabetes
unclear
The latest preclinical studies and clinical trials reported that resveratrol was well tolerated and beneficially influenced biomarkers of disease for neurological disorders, cardiovascular diseases, and diabetes
PMID:32422008 · one of two readings recorded this
inflammatory markers, atherogenic profile, glucose metabolism, endothelial function
Preclinical studies have demonstrated these effects exerted via improved inflammatory markers, atherogenic profile, glucose metabolism, and endothelial function and are further supported by clinical trials.
PMID:32428778 · one of two readings recorded this
Blood pressure
no effect
No postintervention differences were found in IHL, body composition, blood pressure, energy metabolism, physical performance, or quality of life and sleep between treatment arms
PMID:32492138 · one of two readings recorded this
Body composition
no effect
No postintervention differences were found in IHL, body composition, blood pressure, energy metabolism, physical performance, or quality of life and sleep between treatment arms
PMID:32492138 · one of two readings recorded this
HbA1c, adjusted postintervention mean
decreases
postintervention HbA1c was lower on resveratrol (35.8 ± 0.43 mmol/mol) compared with placebo (37.6 ± 0.44 mmol/mol)
PMID:32492138 · one of two readings recorded this
HbA1c, adjusted postintervention mean
decreases
postintervention HbA1c was lower on resveratrol (35.8 ± 0.43 mmol/mol) compared with placebo (37.6 ± 0.44 mmol/mol)
PMID:32492138 · one of two readings recorded this
HbA1c, postintervention difference between arms
decreases, p = 0.007
there was a significant difference in postintervention glycated hemoglobin (HbA1c) between the arms (P = 0.007)
PMID:32492138 · one of two readings recorded this
Insulin sensitivity (Matsuda index), adjusted postintervention mean
no effect
Insulin sensitivity was not affected after 6 mo of resveratrol treatment (adjusted mean Matsuda index: 5.18 ± 0.35 in the resveratrol arm compared with 5.50 ± 0.34 in the placebo arm)
PMID:32492138 · one of two readings recorded this
Insulin sensitivity (Matsuda index), adjusted postintervention mean
no effect
Insulin sensitivity was not affected after 6 mo of resveratrol treatment (adjusted mean Matsuda index: 5.18 ± 0.35 in the resveratrol arm compared with 5.50 ± 0.34 in the placebo arm)
PMID:32492138 · one of two readings recorded this
insulin sensitivity, Matsuda index (primary outcome)
no effect
Not recorded as a finding: no outcome node for the Matsuda index
After 6 mo of resveratrol supplementation, insulin sensitivity was unaffected in the resveratrol arm compared with the placebo arm.
PMID:32492138 · both readings recorded this
Intrahepatic lipid content
no effect
No postintervention differences were found in IHL, body composition, blood pressure, energy metabolism, physical performance, or quality of life and sleep between treatment arms
PMID:32492138 · one of two readings recorded this
Physical performance
no effect
No postintervention differences were found in IHL, body composition, blood pressure, energy metabolism, physical performance, or quality of life and sleep between treatment arms
PMID:32492138 · one of two readings recorded this
Sources cited
36 papers
- Subject
- resveratrol
- Findings
- 69
- Papers
- 36
Does Resveratrol Impact Oxidative Stress Markers in Patients with Head and Neck Cancer Receiving Home Enteral Nutrition?record2025PMID:399403621 finding
Effects of resveratrol supplementation on inflammatory markers, fatigue scale, fasting blood sugar and lipid profile in relapsing-remitting multiple sclerosis patients: a double-blind, randomized placebo-controlled trial.record2025PMID:395650382 findings
Effects of resveratrol supplementation on renal function in adults: a systematic review and dose-response meta-analysis.record2025PMID:405803092 findings
Preliminary, randomized, double-blinded, placebo-controlled cross-over study with resveratrol in hypertensive patients.record2025PMID:408549841 finding
Resveratrol improves lipid profile and recovers heart function in postoperative CABG patients.record2025PMID:406764005 findings
Resveratrol supplementation improves functional performance in knee osteoarthritis by upregulating sirtuin 1: a randomized study.record2025PMID:410371251 finding
Supplementation with resveratrol modified gut microbiota improving insulin sensitivity and lipid metabolism in subjects with obesity and insulin resistance.record2025PMID:413590541 finding
The effect of resveratrol supplementation on obesity indices: a critical umbrella review of interventional meta-analyses.record2025PMID:413172271 finding
Time Does Matter: The Cellular Response to Resveratrol Varies Depending on the Exposure Duration.record2025PMID:405650042 findings
Effect of Resveratrol on Endothelial Function in Patients with CKD and Diabetes: A Randomized Controlled Trial.record2024PMID:378438431 finding
Effects of resveratrol on the anthropometric indices and inflammatory markers: an umbrella meta-analysis.record2024PMID:383743522 findings
The Effects of Resveratrol in a Randomized Clinical Trial on Drug-Induced Hyperlipidemia and Psychiatric Factors in People Living with HIV.record2024PMID:395284543 findings
The efficacy of resveratrol supplementation on inflammation and oxidative stress in type-2 diabetes mellitus patients: randomized double-blind placebo meta-analysis.record2024PMID:398723182 findings
Efficacy of resveratrol in women with polycystic ovary syndrome: a systematic review and meta-analysis of randomized clinical trials.record2023PMID:373337867 findings
Integrative evidence construction for resveratrol treatment of nonalcoholic fatty liver disease: preclinical and clinical meta-analyses.record2023PMID:377673995 findings
The effect of resveratrol supplementation on biomarkers of liver health: A systematic review and meta-analysis of randomized controlled trials.record2023PMID:366424441 finding
Effect of Resveratrol Combined with Donepezil Hydrochloride on Inflammatory Factor Level and Cognitive Function Level of Patients with Alzheimer's Disease.record2022PMID:353689301 finding
Effects of Resveratrol on Metabolic Indicators in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis.record2022PMID:356856023 findings
Efficacy of Resveratrol Supplementation on Glucose and Lipid Metabolism: A Meta-Analysis and Systematic Review.record2022PMID:354319942 findings
The Effect of Resveratrol on Blood Lipid Profile: A Dose-Response Meta-Analysis of Randomized Controlled Trials.record2022PMID:361451311 finding
Correlation between serum pro inflammatory cytokines and clinical scores of knee osteoarthritic patients using resveratrol as a supplementary therapy with meloxicam.record2021PMID:344149041 finding
Effect of resveratrol on C-reactive protein: An updated meta-analysis of randomized controlled trials.record2021PMID:344721501 finding
Effect of resveratrol on inflammatory cytokines: A meta-analysis of randomized controlled trials.record2021PMID:343036652 findings
No effect of resveratrol supplementation after 6 months on insulin sensitivity in overweight adults: a randomized trial.record2020PMID:324921381 finding
Resveratrol Adjunct Therapy for Negative Symptoms in Patients With Stable Schizophrenia: A Double-Blind, Randomized Placebo-Controlled Trial.record2020PMID:333726791 finding
The effects of resveratrol intake on weight loss: a systematic review and meta-analysis of randomized controlled trials.record2020PMID:304219602 findings
Therapeutic effect of resveratrol supplementation on oxidative stress: a systematic review and meta-analysis of randomised controlled trials.record2020PMID:316282123 findings
The Effects of Resveratrol Supplementation on Endothelial Function and Blood Pressures Among Patients with Metabolic Syndrome and Related Disorders: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.record2019PMID:312640841 finding
Effect of resveratrol on cognitive and memory performance and mood: A meta-analysis of 225 patients.record2018PMID:288448411 finding
Effect of Resveratrol Supplementation on Inflammatory Markers: A Systematic Review and Meta-analysis of Randomized Controlled Trials.record2018PMID:300171721 finding
Effects of resveratrol supplementation on risk factors of non-communicable diseases: A meta-analysis of randomized controlled trials.record2018PMID:289335782 findings
Resveratrol supplementation and plasma adipokines concentrations? A systematic review and meta-analysis of randomized controlled trials.record2017PMID:280899432 findings
Efficacy of Resveratrol Supplementation against Non-Alcoholic Fatty Liver Disease: A Meta-Analysis of Placebo-Controlled Clinical Trials.record2016PMID:275604821 finding
Effect of resveratrol on blood pressure: a meta-analysis of randomized controlled trials.record2015PMID:247316502 findings
Effect of resveratrol on glucose control and insulin sensitivity: a meta-analysis of 11 randomized controlled trials.record2014PMID:246958903 findings
The effect of resveratrol on longevity across species: a meta-analysis.record2012PMID:227189561 finding
Other names
2 names
Resolves to: resveratrol
- Also called
- 3,4',5-Trihydroxystilbene
- Systematic name
- 5-[2-(4-hydroxyphenyl)ethenyl]benzene-1,3-diol